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ABSTRACT

Since the large-scale metaproteome was first reported in 2005,
metaproteomics has advanced at a tremendous rate both in its quantitative and
qualitative metrics.

Furthermore metaproteomics is now being applied as a

general tool in microbial ecology in a large variety of environmental studies.
Though metaproteomics is becoming a useful and even a standard tool for the
microbial ecologist, standardized bioinformatics pipelines are not readily
available. Therefore, we developed quantitative and functional analysis pipeline
for

metaproteomics

(QFAM)

to

help

analyze

large

and

complicated

metaproteomics data in a robust and timely fashion with outputs designed to be
simple and clearly understood by the microbial ecologist.
QFAM starts by running peptide-spectrum searches against resultant
MS/MS datasets with mixed metagenome/appropriate protein FASTA database.
Its primary search algorithm is MyriMatch/IDPicker.

MyriMatch/IDPicker uses

multi-CPUs effectively, has an accurate scoring-system, correctly use the high
MS accuracy data, and finally has a robust method for protein determination.
These are required features for metaproteomics requiring large protein database
and complicated peptide-structure.
QFAM has quantitative (QAM) and functional (FAM) analysis to provide
dependable protein signatures and confident information for understanding the
characteristics of the metaproteome. QAM employs a ’selfea’ R package, which
v

provides probability models as well as Cohen’s effect sizes. Our benchmark data
test and Monte Carlo simulation results show that selfea can reduce false
positives efficiently while losing few true positives; one of the key goals of
proteomics and/or metaproteomics experiments.
FAM has two modules: BioSystems and COG analysis. The BioSystems
module is most appropriate for well-annotated model organisms, such as
humans, whereas the COG module is useful for less-annotated microorganisms
and metagenome sequences. Both modules provide an enrichment test using
Fisher’s exact-test and a significance test using selfea. With two statistics, FAM
generates differentially enriched functional terms that are insightful for discerning
biological information held behind the metaproteome data.
Two application studies in chapter 4 and 5 show how QFAM can be
employed for metaproteomics data analysis. QFAM is distinguished from other
proteomics pipelines by multiprocessing as well as quantitative and functional
analysis.
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CHAPTER I
INTRODUCTION

Metaproteomics
Metaproteomics in proteomics
The goal of proteomics is to obtain an all-inclusive quantitative collection
of proteins in a cell, a multicellular organism, an extracellular environment and/or
a community of multiple organisms.

This comprehensive analysis is

accomplished through protein extraction, identification and comparative analysis
via liquid chromatography mass spectrometry (LC-MS), one-dimensional or twodimensional gel electrophoresis-mass spectrometry (1D-GeLC-MS/2DE-MS),
affinity purifications-mass spectrometry (AP-MS) and protein- or antibody-based
microarray [1]. The goals of proteomics research are various and extensive,
such as protein quantification on a large scale, finding drug targets, exploring
clinical protein markers, structural characterization of protein complexes, imaging
protein traffic in multicellular system and discovery of significant proteins from
disease states such as neurodegenerative [2], coronary artery [3] and Lyme
disease [1,4,5] (Fig. 1).
Proteomics has rapidly grown in technology, scope, and application over
the last 20 years from the first simple proteomics experiments, which attempted
to separate all of the proteins from E. coli on a 2d-PAGE system followed by the
extremely laborious cutting out of spots one by one.

1

Figure 1 Applications of proteomics. Proteomics is applied to a diverse set of
life science fields including basic scientific research, clinical protein marker
discovery, and drug discovery. This figure was adapted from a book, ‘Molecular
Biologist's Guide to Proteomics’ [5].
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These spots are identified by either MALDI-TOF peptide mass finger
printing and/or direct infusion nano-spray followed by tandem mass spectrometry
(MS/MS) [6,7]. Today in numerous laboratories around the world, proteomics is
a massive endeavor with sometimes 10-20 high throughput 2d-LC-MS/MS
instruments (i.e., hybrid Velos Orbitraps, QExactives or Fusion MS systems)
running 24/7 in “discovery mode” with another 10 or so 1d-LC-MS/MS
instruments (i.e., high resolution triple quadruple instruments) running in very
accurate targeted quantitation mode. These labs attempt to use the power of
MS-based proteomics to rapidly define protein biomarkers, novel protein
therapeutics and many other novel human heath applications.

Furthermore,

high-throughput proteomics laboratories are now expanding into metabolomics
and lipidomics, for a holistic “omics” approach to understanding disease, human
health, drug mechanism and a host of other biological applications. Clearly it can
be stated that mass spectrometry is the fastest growing analytical application in
the biological sciences today.
Metaproteomics (also called Community Proteomics, Environmental
Proteomics, or Community Proteogenomics) can be defined as “the study of all
proteins recovered directly from environmental sources and is an extension of
MS-based proteomics [8]. Wilmes primarily used and defined metaproteomics as
“the

large-scale

characterization

of

the

entire

protein

complement

of

environmental microbiota at a given point in time” [9,10]. Per Wilmes definition,
metaproteomics involves studying the protein complement of microbial
communities that consist of multiple species. To date metaproteomics studies
3

have covered a diverse set of environmental samples including acid mine
drainage biofilms [11], wastewaters [12], ocean sampling [13], soil systems [14],
permafrost [15] and the human microbiome [16] (Table 1). Since the first largescale metaproteome data was generated in 2005 [11], metaproteomics has
rapidly advanced in terms of scale, depth, speed and quality.

For example,

Lichtman et al. [17] in 2013 identified 234 proteins human and microbial proteins,
but with today's technology and improvements in metaproteomics, now over 56k
proteins have been identified in fecal material, as described in our diet proteome
study in Chapter 5.
Shotgun metaproteomics
Metaproteomics studies are generally based on bottom up approach, also
known as shotgun proteomics [10,18,19]. The bottom-up method aims to identify
and quantify peptides that are generally 7-20 amino acids in length, which are
obtained from digesting proteins with sequencing grade trypsin although
sometimes other proteolysis enzymes are used. The peptides are then injected
onto a high performance liquid chromatography (HPLC) coupled with data
dependent tandem mass spectrometer (LC-MS/MS) [18-20].

The top-down

method directly investigates intact proteins either via LC-MS and/or LC-MS/MS
analyses [20-22]. The bottom-up or shotgun proteomics methodologies tend to
dominate MS-based proteomics in general and metaproteomics as well.

4

Table 1 Overview of metaproteomics studies. This table was adapted from
VerBerkmoes et al [21].
Microbiome

Number of
peptides/
proteins
identified
184/NA

Protein/peptide MS platform
separation
method

2D nano-LC

Lake and soil

6,188/2,033
(2p)
6,931/5,090
(1p)
NA/513 (1p)

Estuary

7/3 (2p)

Ocean

3/1 (2p)

2D-PAGE +
LC
1D-PAGE

Riftia symbionts

NA/220 (2p)

Infant
gastrointestinal
tract
Acid mine
drainage
Waste water
treatment
reactor
Contaminated
soil/groundwater
Sludge

11/1 (1p)

Sludge

4,472/2,378
(2p)

2D nano-LC

Sludge EPS

50/10 (1p)

Ocean

6,533/1,042
(1p-2p)

1D-PAGE +
LC
2D nano-LC

Ocean
Acid mine
drainage

2D-PAGE, 2D
nano-LC

2D nano-LC

2D-PAGE, 1DPAGE + 2D
nano-LC
2D-PAGE

LCQ, MS/MS Spectral
matching, de
novo
LTQ MS/MS Spectral
matching
Q-ToF,
MS/MS
Q-ToF,
MS/MS
MALDI-ToF,
MS
MALDI-ToF
MS, Q-ToF
MS/MS
MALDI-ToF
MS

Spectral
matching
De novo

Spectral
matching
Spectral
matching, de
novo
Spectral
matching
Spectral
matching

8,137/3,234
(2p)
NA/109 (2p)

2D nano-LC

LTQ MS/MS

2D-PAGE

MALDI-ToF,
MS/MS

NA/59(1p)

1D+2D-PAGE
+ LC
2D-PAGE

MS/MS

NA/46 (2p)

5

Peptide
identification
method

MALDI-ToF
MS, Q-ToF
MS/MS
LTQ MS/MS,
Orbitrap,
MS/MS
4000Qtrap,
MS/MS
LTQ MS/MS

Spectral
matching
Spectral
matching
De novo

Spectral
matching
Spectral
matching
Spectral
matching

Table 1 continued.
Microbiome

Acid mine
drainage
Gut

Number of
peptides/
proteins
identified
NA/2,752 (2p)

Protein/peptide MS platform
separation
method

Peptide
identification
method

2D nano-LC

NA/2,214 (2p)

2D nano-LC

Spectral
matching
Spectral
matching

6

Orbitrap,
MS/MS
Orbitrap,
MS/MS

Its advantages include large-scale data acquisition, improved ability to handle
high-complexity samples, higher overall sensitivity, higher overall dynamic range,
more accurate quantitation and better front-end separation of peptides vs. intact
proteins via HPLC [20].
These advantages are all required features to profile highly complicated
metaproteomes. Therefore, bottom-up proteomics is currently the most common
methodology found in metaproteomics studies [21].

Although bottom-up

approach is mainly used in metaproteomics studies, the top-down approach has
its unique advantages. Top-down approach provides a holistic view of intact
proteins and can assist post-translational modification (PTM) identification.
Integration of bottom-up and top-down approaches was successfully applied in
studies of microbial isolates Shewanella oneidensis and Rhodopseudomonas
palustris [23,24].
The typical shotgun metaproteomics consists of five crucial steps: sample
collection, protein extraction, protein digestion, LC-MS/MS analysis and
bioinformatics analysis (Fig. 2).

It’s essential that each of these steps are

optimized, biases minimized and carried out with great care and attention to all
details as the entire experimental protocol can fail based on a single mistake in
any step in any of the four critical steps.
Sample collection is the first step in metaproteomics studies. Piehowski et
al showed that the biggest variation observed in proteomics experiments can be
generated from sample collection [25].

7

Figure 2 Overview of typical shotgun metaproteomics steps.

Microbial

ecologist carefully collects a sample containing the desired microbial community
with great care to obtain a true in situ representation. Proteins are then extracted
from the microbial community with an un-biased methodology, with goal of
obtaining a true representation of the protein abundances. Then, the collected
proteins are proteolytical digested by an enzyme, typically trypsin. The resultant
peptides are desalted, concentrated, filtered and analyzed via 2D-LC-MS/MS.
Finally, the resultant MS/MS spectra are identified and analyzed by many
bioinformatics tools to obtain protein identification and quantification.

This

illustration was adapted from Tanca et al [10] and http://www.planetorbitrap.com.
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Also, careful and appropriate sample collection and archiving are important
issues in microbial ecology [26,27].

Biomolecules, such as DNA, RNA, and

proteins should be protected from chemical and physical shock. Importantly,
during the collection of the microbial community, great care should be taken so
as to obtain a true in-situ snapshot of the proteome as it is in the natural
environment; not as it is after extensive sample handling. Therefore, every
environmental sample is generally stored in deep freezer at -80°C immediately
after collection until protein extraction.
The second step major goal is the un-biased extraction of the proteome
followed by complete protein denaturation and di-sulfide bond breakage. This
prepares the proteome for enzymatic digestion via trypsin and/or other proteolytic
enzymes. There are various methods of protein extraction by combining various
detergents (e.g., sodium dodecyl sulfate (SDS), CHAPS or Triton X-100),
organic/inorganic compounds (e.g., phenol, NaOH), chaotropic agents (e.g., urea
or guanidine hydrochloride), reducing agents (e.g., dithiothreitol (DTT),
tributylphosphine) and thermal treatments (e.g., boiling) and/or sonication/beadbeating/French press and etc. Detergents like SDS are used for cell lysis and
chaotropic agents can denature proteins.

Reducing agents are employed to

break disulfide bonds and further denature proteins.

Rapid and controlled

thermal treatment can inactivate native enzymatic activity and prevent unwanted
nonspecific proteome degradation [28]. Because there is no gold standard for
metaproteome extraction, it is important to consider the characteristics of the
given community and target proteins to maximize extraction yield. Very often
9

metaproteomics experts will try different methodologies on the environmental
sample of interest until one obtains an optimal method. Because environmentally
derived samples are often biomass limited due to difficulties and cost of sample
acquisition, protein extraction is more challenging than proteomics studies of
laboratory-grown microbes [29]. This is even more pronounced in the sub-field of
soil metaproteomics, where the presences of humic acids, excess plant material
and other abundant small molecules can make an efficient extraction of the
microbial metaproteome difficult.

Indeed, my PhD advisor, Dr. Nathan

VerBerkmoes, has called the complex high organic soil metaproteome the most
difficult analytical challenge on the planet to date.
After proteins are extracted from a sample, the next step is protein
digestion. Before proteins are digested, chemical compounds, added for protein
extraction, should be removed or diluted as not to disturb the following enzymatic
digestion. This cleaning step is traditionally fulfilled by protein precipitation using
trichloroacetic acid (TCA), followed by excess washing with chilled acetone or
ammonium acetate/methanol to the protein extract solution [10]. However, these
classical methods may lose certain types of proteins.

Another alternative

approach recently employed is filter-aided sample preparation (FASP),
developed in 2009 by Mann et al [30] and modified by the VerBerkmoes lab for
metaproteomics applications. This methodology has been successfully applied in
many metaproteome studies [31-34] and it can combine sample cleanup and
protein digestion on a centrifuge filter. This FASP methodology showed improve
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performance over several competing methods, especially for low abundance
proteins [31].
Protein digestion is an important step in shotgun metaproteomics because
all the proteins in a bottom up approach are assembled from the digested
peptides. Trypsin is widely used for proteolysis in metaproteomics because it is
highly specific and generates a positively charged N-terminus and C-terminus,
which aids in obtaining high quality MS and MS/MS spectra [35]. Because MSbased metaproteomics are usually run in positive ion mode, the positively
charged ends are ideal for obtaining high quality MS and MS/MS spectra.
Trypsin specifically targets carboxyl side of arginine and lysine of proteins in a
weakly basic environment (Table 2). Nevertheless, trypsin has difficulty digesting
tightly folded proteins that may not be denatured by the denaturing reagents and
an inadequate distribution of trypsin cleavage sites may generate too many short
peptides for proper analysis [36]. Furthermore, membrane proteins tent to be
resistant to trypsin due to their limited number of lysine and arginine residues
[36].

According to Wu et al, trypsin generates predominantly small peptides

shorter than 20 amino acid length (Fig. 3) [37]. The small size of these peptides,
which average between 7~20 residues [36], can facilitate MS detection, but
cause a number of redundant peptides that are derived from more than two
proteins. This is termed the uniqueness problem in metaproteomics and limits
the analysis.

11

Table 2 Common proteases use in metaproteomics. This table is adapted
from

the

website:

http://www.proteinsandproteomics.org/content/free/tables

_1/table11.pdf.

Protease

Class

Cleavage site

Chymotrypsin

Serin protease

After F, T, or Y

Endoproteinage Arg-C

Serin protease

After R

Endoproteinage Asp-N

Metalloprotease

Before D and cysteic acid

Endoproteinage Glu-C

Serin protease

After E, or after D or E

Endoproteinage Lys-C

Serin protease

After K

Pepsin

Acid protease

Broad specificity

Trypsin

Serin protease

After K or R
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Figure 3 in silico digestions of the human HeLa cell proteome with assorted
proteases. A) The number of peptides predicted without mis-cleavage and
B) cleavage assuming two mis-cleavages. This figure is adapted from Wu et
al [37].
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Redundant non-unique peptides, often generated by trypsin digestion, are
the biggest hurdle to accurately identifying proteins from the peptides identified
by LC-MS/MS.

This problem is exaggerated in metaproteomics due to the

increase in database size and the fact that very often microbes carry very
homologous proteins with very similar sequences.

For example EF-TU,

ribosomal,

glycolsis/TCA/oxidative

GroEL/GroES,

other

chaperones

and

phosphylation pathway proteins can be highly conserved across a wide range of
microbes in a given environmental sample.
Because redundant peptides can be found in more than two proteins, we
cannot be sure where those peptides originate. Hence, these are termed as nonunique. Non-unique peptides limit the confidence of protein identification and
quantification.

In other words, we cannot know from which proteins these

redundant peptides arose from and which protein they should be assigned to. To
reduce the number of the problematic peptides, middle down proteomics is new
method that attempts to use alternative proteases, which produce longer
peptides [37-39]. Wu et al introduced the OmpT enzyme as replacement for
trypsin to produce lengthy peptides longer than 3 kDa (Fig. 3) [37]. Peptide
redundancy is generally dependent on the average length of produced peptides.
While this methodology has not been widely used in metaproteomics, we feel
that this is the next step in metaproteomics and would improve protein
identification and quantification by limiting the “non-unique” problem, which has
plagued metaproteomics studies.
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In addition to a decrease in redundant peptides, longer peptides have less
probability of false positive identification (Fig. 4) [40]. Figure 4 shows that the Pscore Bayesian probability model in MaxQuant [40] changes based on peptide
length. P-score distribution of false positive identifications shown in red gets
smaller and narrower than true positive distribution shown in blue as the peptide
length (L) gets longer. Metaproteomics studies using the middle down approach
have not been published, but we believe this could be a potential path forward for
solving the “non-unique” peptide problem.
LC-MS/MS analysis
The digested peptides are separated by their chemical and physical
characteristics through high-performance liquid chromatography (HPLC), ionized
by electrospray ionization and measured on an MS instrument. For most bottomup proteomics and metaproteomics experiments the mass spectrometer is
operated in data-dependent mode. This means that at any given point in time
during the LC-MS/MS analysis, 50-100 peptides enter the mass spectrometer.
Modern mass spectrometers have very high duty cycle (i.e., the speed going
from one scan type to the next). In the data-dependent mode the peptides mass
(i.e., m/z) are accurately measured by the mass spectrometer in the full scan
mode. For example an Orbitrap mass spectrometer provides mass accuracies at
~1-10 p.p.m or generally the third decimal place of the peptide mass.
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Figure 4 These panels display distribution of P-scores, which is the peptide
identification score of MaxQuant.

Blue color shows peptide identifications

from a forward database search and red colors are from the reverse database,
intended to be a false positive peptide database. L is the peptide length. This
illustration was adapted from Cox et al [40].
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Next the mass spectrometer picks the top 10-20 observed ions from the previous
full scan, isolates them one by one and fragments them via energy deposition
also termed MS/MS, CID, CAD, or now often called HCD. Peptide sequence
information is obtained at this step.

The intact peptides are isolated and

fragmented down the peptide backbone thus providing sequence information.
The accurate mass from the full scan coupled with the sequence information
from the MS/MS scan are the two key points of information needed to confidently
identify peptides via database searching (described below).

The instrument

cycles between full scans and data-dependent MS/MS scans during the entire
LC-MS/MS analyses.
The key technology for this entire process is the simple but brilliant
electrospray ionization (ESI) invited by John Fenn in 1984. This revolutionary
technique allowed for the soft ionization of large biomolecules into the gas phase
directly from a flowing liquid stream simply by the application of high voltage to a
metal needle. The peptides are ionized by Coulomb explosion at Rayleigh limit
[41,42].

ESI has revolutionized large molecule measurements using MS

instrumentation. ESI does not require any chemical reagents besides water,
methanol, and a small amount of organic acid. It is sensitive up to atto-mole
levels and can easily ionize proteins up to 100,000 Da and much higher MW can
be achieved with special instrumentation. ESI enables the analyses of all major
biomolecules (i.e., DNA/RNA, proteins, lipids, sugars, and small metabolites) via
mass spectrometry.
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Because microbial communities usually have more proteins than single
isolated microorganisms, high quality peptide separation is essential to achieve
high quality metaproteomic analyses. If a massive number of peptide ions are
ionized into the MS instrument at the same time, some of ions may not be
appropriately measured or missed entirely due to the limitations of the MS scan
speeds and MS dynamic range. Peptide separation should be designed by first
considering the ability of MS instrument available to the metaproteomics
researcher. Besides the scan speed, good peptides separation can reduce the
density of the peptides entering the MS at any given time. In other words, similar
m/z peptides can be pulled apart by the LC separation. Close m/z ions within the
isolation window, which is generally 1-3 m/z units, are often sequenced together
during MS/MS phase of the experiment. This is undesirable to say the least.
This co-isolation and resultant MS/MS sequencing makes peptide identification
difficult. To obtain better dynamic range, enhanced peptide identification and
more confident protein quantification, the level of LC separation should be
increased as much as possible. In order to obtain the maximum proteome depth
and protein quantitation, the LC-MS/MS was run for 24 hours with 2-dimensions
of liquid chromatography separation, strong cation exchanged (SCX) coupled
with (reverse-phase) RP separation for the human fecal proteome study (Chapter
4) and influence of diet on the metaproteome (Chapter 5), we have termed this
approach “deep and wide metaproteomics”. This means that the goal of this
proteome experiment is to measure deep into the proteome of each microbial
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species with wide coverage across all the microbial species present in the
community.
High resolving power is an important virtue of the MS instrument for
unambiguous protein identification in metaproteomics.

The higher the mass

accuracy, the more exact peptide identification. Low-resolution MS (LRMS) is
less expensive and relatively easy to maintain, but cannot provide exact mass
measurements. The high-resolution MS (HRMS) can determine several decimal
places of mass accuracy.

This high precision of HRMS can narrow down

candidate peptides to only a few possibilities (Fig. 5). HRMS can give more
exact p.p.m. mass accuracy than LRMS. P.P.M is calculated by (((exact mass –
accurate mass) / exact mass) x 106). Lower p.p.m. means small mass error.
Smaller p.p.m. (i.e., mass difference between observed and expected mass) can
reduce false matches by removing similar weighted false peptide candidates.
For metaproteomics experiments high mass accuracy for the full scan MS is
absolutely essential. High resolution for the MS/MS spectra provides even better
results. Because the potential metaproteome of a complex community is much
more complicated than a single species proteome, it requires HRMS to narrow
down candidate peptides. Due to the need for high mass accuracy, the Orbitrap
MS is widely used in metaproteomics studies because they offer higher
resolution/accurate mass analyses in a stable instrument platform.
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Figure 5 The effect of increasing mass accuracy for unambiguous
identification of compounds. P.P.M. is a parts per million (((exact mass –
accurate mass) / exact mass) x 106). Lower p.p.m. means small mass error. If
mass accuracy is low (i.e., p.p.m. is high), the number of candidate compounds
increases linearly. As the slope gets steeper, the molecular weight gets larger.
This illustration is adapted from Quenzer et al [43].
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The Orbitrap MS is easy to use and maintain, produces high quality data, has
excellent dynamic range and sensitivity and enables tandem in space and time
MS/MS measurements.
Even though high mass accuracy can provide better resolution for peptide
identification, it is not enough to identify peptides, especially from highly complex
metaproteomics samples. Tandem mass spectrometry or MS/MS is required for
exact peptide identification and sequencing. In the MS/MS step, target ions from
the survey full-scan mass spectrum (MS1) are selected, isolated, fragmented and
the mass analyzed. This MS/MS peak selection can be modified for different
acquisition

approaches,

data

dependent

acquisition

(DDA),

and

data

independent acquisition (DIA) (Fig. 6).
In DDA approach, a fixed number of peaks from the MS1 scan are
selected, isolated, and subjected to MS/MS analysis (Fig. 6). DDA is powerful
and versatile, but it limits the number of peptides sampled for fragmentation
regardless of dynamic range and peak capacity of the MS system [44]. In a
complex protein mixture, up to 84% of peptides are not sampled for MS/MS,
while at most 30% of peptides are analyzed by MS/MS [45] via the DDA
approach. DIA is an alternative approach to DDA. DIA collects holistic MS/MS
spectra of all the peaks systematically and independently of the precursor ions
(Fig. 6).
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Figure 6 Data dependent acquisition (DDA) and data independent
acquisition (DIA).

DDA targets MS/MS scans with narrow isolation windows

centered on specific precursor ions in a survey MS1 scan. DIA acquired MS/MS
scans with wide isolation windows acquiring many peptide precursors. Peptide
precursor VLENTEIGDSIFDK++ is present in a single MS/MS spectrum in a DDA
analysis, while it can be extracted from all retention times in DIA. This image
was adapted from Egertson et al [46].
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For example, DIA collects MS/MS data either without precursor ion selection [47],
ion mobility–collision-induced dissociation–time-of-flight mass spectrometry [48],
wide isolation windows [49], narrow isolation windows combined with many
injections [50] or multiplexing strategies [44]. Even though DIA theoretically may
acquire more peptide information than DDA, its data complexity is much higher
than DDA because the MS/MS spectrum of DIA has fragment peaks arising from
a wide number of peptides. Thus data de-convolution and peptide identification
for the DIA experiment is difficult to say the least.
Traditional protein reference database search, widely used for DDA data,
is not effective for DIA data due to the presence of multi-peptides in the MS/MS
data.

There are several tools for DIA data analysis, such as Skyline [51],

OpenSWATH [52] and UDMSE [53], but DIA still has a long way to go in spite of
its rapid development to be accepted by the proteomics community and
employed as routinely as the DDA method [54].
metaproteomics

publications

using

DIA

Currently there are no

because

it

makes

intricate

metaproteomics data even more complicated. However, DIA might enhance the
depth of metaproteome experiments if the bioinformatics can de-convolute the
highly complex MS/MS data.
Quantification of proteins is a major goal for metaproteomics. The number
of proteins identified gets smaller and smaller following each experimental step
as proteins are lost during the experimental procedures (Fig. 7).
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Figure 7 Relative amount of proteins in original sample, that are identified
and quantified by metaproteomic analysis. Proteins are lost during protein
extraction, digestion, and LC-MS/MS steps. Low-abundant proteins are difficult
to identify due to limited dynamic range.

Specific types of proteins can be

missed by the protein extraction method. Only a fraction of the original proteins
is reliably quantified. This illustration was adapted from Bantscheff et al [55].
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There are two major methodologies for protein quantification in proteomics.
These are termed label-free quantification and labeled quantification. Labeling
methods can be categorized into metabolic labeling (SILAC [56] and isotopes),
chemical labeling (ICAT [57,58], iTRAQ [58] and TMT[59]) and finally spiked
isotopically labeled proteins.
The label free methodology uses intrinsic data obtained during the LCMS/MS analyses of the sample such as counting spectra identified to each
identified peptide. This is termed peptide-spectrum match (PSM) (Fig. 8).

The

label free methods are the simplest to employ and cheapest but provide limited
quantitation accuracy.
Of the labeling methods, metabolic labeling is by far the most accurate
(Table 3), but often cannot be employed in metaproteomics experiments due to
difficulties in labeling an environmental sample with heavy nitrogen or carbon.
Chemical labeling methods target specific residues for ICAT or the N-terminus for
iTRAQ and TMT.

These methods have medium accuracy and quantitative

coverage (Table 3). These approaches can be used in metaproteomics as long
as one is sure the environmental sample does not contain contaminants, which
could interfere with the labeling process. For example, chemical labeling cannot
be used in soil samples due to the presences of humic acids, which will adsorb
the entire label. The spiked protein method compares the fixed amount of spiked
heavy labeled internal standard proteins with environmental derived proteins.
This method has low coverage and medium accuracy, but is rarely used due to
cost restraints (Table 3).
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Figure 8. Common quantitative mass spectrometry workflows. Boxes in
blue and yellow indicate experiments to be compared. Solid line means that
labeled sample is mixed.

Dashed line indicates points were experimental

variation during quantification errors can occur. This illustration was adapted
from Bantscheff et al [55].

26

Table 3 Accuracy and quantitative coverage of various labeling methods in
proteomics.

“Accuracy” means how a labeling method can reflect exact

difference between experimental groups. “Quantitative proteome coverage” is
how many proteins are quantitatively measured and identified by a labeling
method. “Linear dynamic range” is the number of digits for measurement of a
labeling method. This table was adapted from Bantscheff et al [55].
Accuracy
(process)
Metabolic protein labeling
Chemical protein labeling (MS)
Chemical peptide labeling (MS)
Chemical peptide labeling (MS/MS)
Enzymatic labeling (MS)
Spiked peptides
Label free (ion intensity)
Label free (spectrum counting)

+++
+++
++
++
++
++
+
+
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Quantitative
proteome
coverage
++
++
++
++
++
+
+++
+++

Linear
dynamic
range
1-2 logs
1-2 logs
2 logs
2 logs
1-2 logs
2 logs
2-3 logs
2-3 logs

Label-free quantification has excellent coverage, but low accuracy. It is easily
employed in metaproteomics and the one most widely used (Table 3). Overall,
Label-free quantification is the most commonly used in metaproteomics though
extensive isotopic labeling of an environmental sample has recently been
demonstrated [60-63].

Bioinformatics for metaproteomics
Peptide-spectrum search and identification
Bioinformatics analysis is conducted to identify peptides from MS/MS
spectra to reconstruct and quantify proteins. Bioinformatics analysis is the most
challenging in all the steps of metaproteomics. The difficulty of computational
analysis is due to the intricate data structure of the metaproteome and the lack of
prior information about the microbial communities as well as limited or low quality
reference metagenome databases.
The species co-habiting a natural community may not be fully known,
which means that we cannot construct a protein database collected from
reference databases (DB), such as RefSeq [64], UniProt [65] or IMG [66]. Even
though metagenome sequencing can replace or enhance an isolated reference
DB, the metagenome databases are often not complete, contain unclosed
genomes, and many have sequencing errors and/or partial protein sequences.
There are two ways to construct protein sequence DB for metaproteomics.
First, the protein DB is constructed by a collection of reference isolated microbial
genome DB. Specific microbes can be expected to be in environmental samples
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based on previous studies or based on assumptions. For example, we collected
gut-isolated microorganisms for the human fecal protein study in Chapter 4 and
the diet proteome study in Chapter 5.

The NIH funded Human Microbiome

Project (HMP) has comprehensive gene and protein databases from microbes
isolated from the gastrointestinal tract. We obtained referenced proteins from a
subset of isolates from the HMP DB that we used to construct our protein DB.
Next, metagenome sequencing provides deep genome information for the
community of interest. Thus, metagenome sequence can complement proteins
that were not anticipated to be in the samples. Also, metagenome sequencing
can predict potential coding sequences from unknown organism in the
environment of interest. However, metagenome sequences are often partial and
incomplete.

Mixing the reference DB sequences and the metagenome

sequences is the best method for construction of a comprehensive potential
protein DB for metaproteomics.
Because protein identification of the MS/MS spectrum via the database
search method is based on having the correct peptide and thus the correct
protein in the composite metagenome/isolate database, deficiencies in this
composite database can severely hamper peptide and subsequent protein
identification and quantification.

If the appropriate reference protein DB is

unavailable or has limitations, de novo sequencing could theoretically be an
alternative way for identification of the MS/MS spectra.

However, de novo

sequencing based on MS/MS searches in metaproteomics has been found to be
extremely time consuming with limited effectiveness.
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Cantarel et al [67]

compared the number of peptides identified by DB search using SEQUEST [68],
and de novo sequencing using PEAKS [69] and PepNovo [70]. Interestingly, this
study showed that de novo sequencing could find almost 9,000 peptides that
were not detected by the DB search.

At the same time, however, de novo

sequencing missed more than 10,000 proteins identified by SEQUEST.
Therefore, some PSM search pipeline, such as Proteome DiscovererTM (Thermo
Fisher Scientific Inc.), combines DB searches and de novo sequencing to
maximize metaproteome coverage.
One of the advantages of de novo sequencing is that it does not require
any prior database information. The MS/MS spectrum is a collection of ions
derived from the fragmentation of a precursor parent peptide ion but the
observable fragmented ions will vary depending on the fragmentation method.
Collision induced dissociation (CID) and higher-energy collision dissociation
(HCD) produce b and y ions, while electron-transfer dissociation (ETD) generates
c and z ions. For example, when the MS/MS peptides are fragmented by CID
and HCD, de novo peptide sequencing starts from the b and y ions that differ by
the molecular mass of the amino acid residues.

By comparing ion mass,

sequence order is determined (Fig. 9). However, de novo sequencing from the
MS/MS spectrum is generally not successful for the following reasons: 1. Low ion
intensity causes incomplete detection of the sequence ions; 2. Many peptide
sequences do not provide the full complement of potential y and b ions upon
fragmentation; 3. Unusual amino acid and uncommon covalent modifications can
prevent correct amino acid assignment [71].
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Figure 9 Example of de novo sequencing from MS/MS spectrum. This
tandem mass spectrum of the [M+2H]+2 ion m/z 955.03 in LC/ESI/MS analyses
of tryptic peptides from a 70 kDa iPLA2 digest. This illustration was borrowed
from http://msr.dom.wustl.edu/ms-peptide-mapping/.
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De novo sequencing is the ideal way to identify MS/MS, but is dependent on
charge state of precursor ions and fragmentation efficiency, which limits its
usefulness.
De novo sequencing is often used to support and improve DB-based
MS/MS searches (DB search).

In contrast to de novo sequencing in

metagenomics, peptide de novo sequencing cannot be confirmed by overlapping
sequences. Thus building the identified peptides into proteins is a serious
bioinformatics challenge.

Therefore, de novo sequencing methodologies are

currently only used to support DB searches in metaproteomics.
The most widely used method for MS/MS identification in proteomic and
metaproteomic studies is the DB search method. The MS/MS search engines,
such

as

SEQUEST[68],

MASCOT[72],

X!Tandem[73],

OMSSA[74],

MyriMatch[75] and MS-GF+[76], use an assembled protein DB for peptide
identification and subsequently build the peptides into proteins (i.e., assembly).
These search methods compare the 100,000s of MS/MS spectra from the LCMS/MS analyses to the theoretical computational derived peptides MS/MS
spectra generated from the protein DB based on the enzymatic digestion method
used. The major difference in these algorithms is their use of different scoring
systems (Fig. 10). The first step for all search engines generate is to generate
all the possible peptides from protein DB based on the experimental proteolytic
enzyme used. Then, candidate peptides are selected from the peptide library
using the mass of the precursor ion.
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Figure 10 Schematic diagram of the DB search for MS/MS spectrum
analysis. First, search engines are used to generate all the possible peptides
from the protein DB while figuring in the number of allowed miss-cleavage based
on the digestion enzyme.

Then, candidate peptides are selected from the

peptide library using the mass of the precursor ion.

The next step is the

calculation of scores, probability, correlation coefficient or similarity, between
candidate peptides and MS/MS spectrum.

Through calculation of the score

matrix top hits are determined. With top hits, FDR is calculated based on decoy
identification and final hits are selected.
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The next step is to calculate the scores, probability, and correlation coefficient
between the candidate peptides and the MS/MS spectrum. It is at this step
where the different algorithms show their biggest differences between the
different analysis programs.
Since SEQUEST was developed in 1994, many algorithms for MS/MS
identification have been developed, such as MASCOT in 1999, X!Tandem in
2004, OMSSA in 2004, MyriMatch in 2007 and MS-GF+ in 2014. SEQUEST is
the gold standard DB search engine and was commercialized and is included in
the Thermo software package Proteome DiscovererTM 2.0. SEQUEST calculates
cross-correlation coefficient (XCorr), similarity score between theoretically
generated peaks and query MS/MS spectrum, and DeltaCn, which is the
difference of XCorr from the next candidate following an initial screen using the
Sp score. MASCOT is the other gold standard search engine and it is based on
MOWSE algorithm, is the first probability-based scoring for mass finger printing,
and provides a probability of observed matches between the queried MS/MS
spectra and the peptide library. Even though MASCOT and SEQUEST were
released more than 15 years ago, these are still the most widely used DB search
engines in proteomics.

However, the basic design of the scoring system in

SEQUEST and MASCOT is for traditional CID and low-resolution MS [76].
Because SEQUEST and MASCOT are old and commercialized, there
have been numerous attempts to develop more accurate, faster, and free search
engines. X!Tandem, OMSSA, MyriMatch and MS-GF+ were developed to fill this
need.

OMSSA has a probability-based scoring system like MASCOT but
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employs a Poisson distribution. OMSSA is faster and much cheaper due to its
open source algorithm. X!Tandem is another engine that has a probability-based
score (i.e., hyperscore) that is a combination of hypergeometric distribution and
dot product.

X!Tandem collects common MS/MS peaks between theoretical

peaks and actual query peaks which are filtered by their expected intensities,
then generates a dot product matrix.

This dot product result is modified by

multiplying by N factorial for the assigned b and y ions. The factorial modification
is determined based on the hypergeometric distribution. X!Tandem calculates an
E-value by extrapolating the linear regression line of the log histogram (i.e., the
number of results) and measuring the difference between the top hit from the
following hit.

This E-value plays a similar role to DeltaCn of SEQUEST.

MyriMatch uses multivariate hypergeometric distribution (MVH) to calculate
probability of matches between query and DB by chance.
MS-GF+ has a different approach from the other DB search engines (Fig.
11).

Most DB search engines compare one spectrum to all the candidate

peptides filtered from the library according to their preliminary score, such as Sp
of SEQUEST and the noise filter of X!Tandem. However, MS-GF+ generates a
peptide dictionary of all possible de novo sequences from an MS/MS spectrum
and searches for their presence in the peptide library [77]. MS-GF+ compares
the log likelihood ratio of vectors of peptides and its spectra and calculates Evalue to find the best hit. While traditional DB searches compare every spectrum
against every peptide in the library, which increases the run time depending on
the size of the library,, MS-GF+ execution time is not dependent on DB size.
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Figure 11 DB search of MS-GF+.

MS GF+ is an updated version of the

Spectral Dictionary [77]. Red line is a traditional DB search comparing spectra
against the peptide library generated from the protein DB. Blue line is the de
novo based DB search constructing all the possible de novo sequences from a
MS/MS spectrum. This illustration was adapted from Kim et al [77].
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This is a very important advantage for metaproteomics analysis because these
experiments generally have a much larger protein DB than single species
proteomics experiments. Because MS-GF+ is based on de novo sequencing and
is independent of DB size, it can provide more sequences that are not found in
the reference DB.

This is important in the proteomics analysis because the

traditional search algorithms will miss peptides from unknown species in a
microbial community because they are not in the predicted protein DB,
In addition to different scoring metrics, every DB search engine has a preprocessing step prior to computing the scoring matrix. This filtering step is to
remove noise peaks and to collect valid b and y ions, but can also introduce
problems. If the filtering threshold is too low, noisy matches will hinder true
matches; if it is too high, true fragment ions may be lost. These different preprocessing methods used by the different DB search engines can result in
different peptide identifications.
Besides the accuracy of peptide identification, the speed of the MS/MS
search is critical issue because the metaproteome databases tend to be very
large. MS-GF+ has an advantage on this issue because its search speed is not
slowed by the protein DB size. However, because the MS/MS search is parallel,
which means it can be easily divided into small pieces, other MS search engines
can make up for its need for searching all of the databases by simultaneously
running the search on a cluster server or supercomputer. For example, one LCMS/MS run consists of many of MS/MS spectra, so if we have 1,000,000 CPUs
in a supercomputer, we can search a million MS/MS spectra at the same time.
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This means that a million spectra can be processed at the same time it takes for
one spectrum search. There are several ways to parallelize the MS/MS peak
search engines, such as X!!Tandem [78], wrapper for MS [79] and MyriMatch
[75]. In contrast to the other programs, MyriMatch does not require additional
installed parameters to work effectively in a parallel environment. It can utilize
available cores with a simple option when executed. MASCOT and SEQUEST
also has a platform for a multi-core environment, but these commercial products
are very expensive to put onto large Linux clusters. Due to the very large protein
DB size and the large number of MS/MS spectra along with potential PTMs, the
analyses of metaproteomics datasets can near impossible on a single CPU
Windows environment. Thus a parallel computing environment is recommended
for bioinformatics analysis of metaproteomics.
The target-decoy search strategy has revolutionized peptide and protein
identification. Before this methodology was introduced proteomics datasets were
plagued with high false positive rates putting the whole field of proteomics in a
questionable light. Elias et al. suggested generating decoy databases. These
databases have the same characteristics to the protein DB, but contain a
competing target DB, and a decoy DB during the MS/MS search [80]. The decoy
DB is generally engineered by reversing or random mixing of protein sequences
of target DB (i.e., the original protein DB).

By reversing sequences, decoy

proteins have same characteristics as the target DB in terms of digested peptides
length and monoisotopic mass (Fig. 12).
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A)

C)

B)

Figure 12 Target-decoy DB comparison.

The number of trypsin-derived

peptides plotted against the calculated monoisotopic mass of A) the target DB
and B) a decoy DB from in silico tryptic digestion of IPI human protein DB. C)
The number of trypsin-derived peptides using the target (red line) and decoy
(green line) DB. The inset is a plot of the percentage of proteins that were
identified in both target and decoy DB searches versus peptide length. This
illustration was adapted from Elias et al [80].

39

Because the decoy sequences are not in the sample, if a protein is identified
during a search, it is considered a false positive. The number of false positives
from decoy hits can then be used to calculate the false discovery rate (FDR)
using the following formula:
𝐹𝐷𝑅 =

2×𝐷𝑒𝑐𝑜𝑦  ℎ𝑖𝑡𝑠  (𝐹𝑃)
𝐷𝑒𝑐𝑜𝑦  ℎ𝑖𝑡𝑠  (𝐹𝑃) + 𝑇𝑎𝑟𝑔𝑒𝑡  𝑡ℎ𝑖𝑠  (𝑇𝑃)

Generally, a < 5% FDR threshold is considered a publishable proteomics
dataset. The FDR formula is different for different analysis. Software packages
such as Peptide Protein Prophet, MASCOT, and Percolator have their own
modified FDR formulas. After the decoy search a FDR calculation is necessary.
However, the arbitrarily generated decoy can not cover all the possible false
positives, so there are concerns about using FDR as the gold standard method
for MS/MS search assessment [81].
Applying FDR to metaproteomics is tricky because of the large number of
non-unique peptide sequences and the amount of unknown genomic sequence
in the samples. With unique peptides, FDR is often overestimated (e.g., 6-8% in
Wilkins et al [82]) because of the large reduction in real peptides that are
redundantly matched. With all the unique and non-unique peptides the rate is
decreased to 0.6-0.9% [82] which is probably an underestimation due to the
addition of many redundant peptides. An adjustment of the FDR is required
when evaluating the metaproteome considering its complex characteristics.
As more and more peptide-spectrum matches (PSM) are published by
proteomics laboratories world wide, a new method for searching MS/MS spectra
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is becoming more popular. The Spectral Library Method has a greatly reduced
DB search time. This is achieved by not using redundant searches of the same
post-translational modifications (PTM) and peptides, especially from abundant
common proteins found in all samples. The National Institute for Standards and
Technology (NIST) and the Global Proteome Machine (GPM) provides spectral
libraries for proteomics studies. X!Hunter [83], Spec2Spec [84] and Pepitome
[85] use PSM searches against spectral libraries that do not need to generate
theoretical MS/MS spectrum.

However, a spectral library search is not an

appropriate method for metaproteomics because the spectral library requires
samples that have been analyzed by a large number of labs with a high number
of replicates such as serum/plasma studies.
Post-process of PSM search results
After a PSM search, post-processing is required to validate the PSMs and
assemble the appropriate proteins. Assessing the MS/MS identification is always
important. The threshold scoring metrics that gives reliable peptide identification
is ambiguous.

Since the development of the first MS/MS search engines in

1994, different evaluation methods for peptide identification have been
evaluated.

DTASelect [86], developed in 2002 and widely used for protein

assembly of SEQUEST results, suggests the following guideline for a SEQUEST
search: > 1.8 XCorr for +1 charged ion, > 2.5 XCorr for +2 charged ion, > 3.5
XCorr for +3 charged ion and > 0.08 DeltCN for every charged ions.

By

providing filters, and simple protein assembly, DTASelect is widely used for
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assembling SEQUEST search outputs. Protein Prophet [87], also developed in
2002 and incorporated into the trans proteomics pipeline (TPP), calculates
probability based on a mixture-model EM method using a Bayesian approach for
MS/MS identification. Protein Prophet gives statistical guidelines for assessing
the correct and incorrect peptide assignments.

It also estimates and the

likelihood of proteins corresponding to those peptides in a sample. To maximize
peptide identification, Scaffold [88] employs various search engines and
integrates its results from Protein Prophet.

Scaffold obtains MS/MS search

results from SEQUEST, MASCOT, OMSSA, X!Tandem and etc.

Then, it

evaluates peptide identifications of each engine using Protein Prophet. These
results are aggregated and re-evaluated by Protein Prophet. By aggregating
multiple evaluation methods, Scaffold provides a platform-independent result with
maximized peptide and thus protein identifications.
Protein assembly is a challenging step after peptide identification of the
MS/MS. Generally, assembly is more difficult than disassembly because some
parts dissociate from a protein. This may or may not have arisen from that
specific protein.

Redundant peptides, found in two or more proteins, makes

protein reconstruction and quantification difficult. Metaproteomes generally have
more shared peptides due to orthologous and paralogous proteins from multiple
species. Orthologous and paralogous proteins have similar protein sequences,
so they generate shared or redundant peptides.
Meyer-Arendt et al. demonstrated that the human protein database has
89,486 entries in the international protein index (IPI) DB v3.75. This would have
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almost 2 million shared peptides with the 4 million trypsin-derived peptides
(length > 7 amino acids allowing up to 2 miss-cleavages) [89]. Moreover, a
metaproteome has a number of microbial species, which means there will be a
greater chance for overlapping peptides than Meyer-Arendt’s human database
only example. Therefore, metaproteomics datasets have many shared peptides
making ambiguous protein identifications common and problematic.
How ambiguous protein identifications are dealt with has a direct impact
on the final protein identification and quantification. If an identified peptide A can
be generated from protein 1, 2 and 3 in the protein DB, several interpretations
are possible. For example, peptide A may be derived only from 1, from 1 and 3
together or from 1, 2, and 3 at the same time.

The ource of peptide A is

uncertain due to lack of information, but different final protein identifications are
possible based on how the ambiguous protein identifications are handled. Using
DTASelect, would identify all possible proteins, such as protein 1, 2 and 3 of
above example.

However, IDPicker [90], developed in 2007 and linked to

MyriMatch, reports a minimal protein list. Protein assembly of IDPicker is based
on a bipartite graph and greedy algorithm (Fig. 13). First, IDPicker connects
peptides and proteins in a bipartite graph (Fig. 13A). Next, indistinguishable
peptides and proteins are collapsed (Fig. 13B). The collapsed bipartite graph is
deconvoluted into separate protein clusters with connected peptides (Fig. 13C).
Proteins that have uniquely matched peptides or supported by more than two
different peptide groups are identified and added to the minimal protein list (Fig.
13D). IsoformResolver [89] accesses shared peptides differently.
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Figure 13 Overview of bipartite graph model and analysis procedure of
protein assembly in IDPicker.

Pro: protein, pep: peptide. This figure was

adapted from Zhang et al [90].
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It uses a peptide-centric approach.

This approach is similar to the

algorithm of MS-GF+ used for generating all possible de novo sequences.
IsoformResolver constructs unique peptide libraries from the protein DB and
assigns proteins to the corresponding peptides.

IsoformResolver is keeps

shared peptides as unique entries. However, it cannot provide any insight on how
to interpret the problematic peptides. Percolator [91] employs semi-supervised
machine learning to discriminate correct from incorrect PSMs, and calculates an
accurate FDR and posterior error probabilities.
Protein quantification varies based on the handling of ambiguous protein
identifications. Since shotgun metaproteomics explores peptides, not proteins,
the quantitative measurement of peptides should be transferred to the
corresponding proteins. Processing of unique peptides, matched solely to one
protein, makes it easy to assign the matched protein.

However, assigning

shared peptides to candidate proteins is ambiguous due to the uncertainty of its
origin.

DTASelect redundantly assigns SC of overlapping peptides to every

candidate protein. This leads DTASelect to amplify the expression level
according to the numbers of ambiguous peptides in the DB search results.
IDPicker employs a greedy algorithm following a winner takes all approach. After
protein and peptide groups are separated, IDPicker prioritize proteins by whether
a unique peptide is linked or not and the number of SC from linked unique
peptides. Greedy algorithm iteratively chooses proteins by order of priority and
gives all the shared peptides to the winner. IDPicker generates parsimonious
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protein identification and amplifies their expression level by casting all the
available votes.
In label-free shotgun proteomics, SC of redundant peptides are
sometimes distributed to the corresponding proteins (i.e., spectral balancing)
[92,93]. Spectral balancing considers only proteins that have more than one
unique peptide (i.e., unique proteins). SC of a redundant peptide is divided into
unique proteins by calculating the ratio of their unique peptide SC. Divided SC of
a shared peptide for its member unique protein is calculated as described below:
𝐷𝑖𝑣𝑖𝑑𝑒𝑑  𝑆𝐶 =

𝑢𝑆𝐶
!
!!! 𝑢𝑆𝐶!

×𝑠𝑆𝐶

Where uSC is SC of a unique peptide, sSC is SC of the shared peptide and n is
the number of unique proteins linked to the shared peptide.

This spectral

balancing can be connected to the normalized spectral abundance factor (NSAF)
if desired [92-94].
If we have more than two MS runs, technical replicates and/or biological
replicates, as well as different biological or ecological samples, we need to
normalize the total number of spectra to quantitatively compare across samples
and LC-MS/MS runs. There are systematic errors including instrumental error
and human error even though MS runs were carried out by the same
experimenter using the same instrument for the same sample.

The goal of

normalization is to adjust and minimize these errors. Generally, normalization
methods are designed for a label-free experiment. NSAF is the most widely used
normalization method. It considers spectral balancing as well as protein length
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effect on probability of peptide assignment. NSAF assumes that long proteins
have a better chance of having identified peptides associated with it than short
proteins. Distributed NSAF (dNSAF) for i-th protein is calculated as described
below:
𝑑𝑆𝐴𝐹!
𝑑𝑁𝑆𝐴𝐹! =    !
  𝑤ℎ𝑒𝑟𝑒, 𝑑𝑆𝐴𝐹! =   
!!! 𝑑𝑆𝐴𝐹!

𝑢𝑆𝐶! +

𝑢𝑆𝐶!
!
!!! 𝑢𝑆𝐶!

×𝑠𝑆𝐶!

𝐿𝑒𝑛𝑔𝑡ℎ!

Where, N = the number of total identified proteins, uSC is SC of a unique
peptide, sSC is SC of a shared peptide, Length is the protein length and M is the
number of unique proteins. The sum of dNSAF within an MS run is 1, so the
dNSAF number is very small. This small number of dNSAF is often logged to
make it easy to analyze.
In addition to NSAF, there are a few normalization methods including total
PSM normalization, exponentially modified protein abundance index (emPAI),
and quantile normalization. Normalization by total sum of PSM is also widely
used in label free metaproteomics studies [95] and is calculated as described
below:
!
!!!

𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝑆𝐶! =   

!
!!! 𝑆𝐶!

𝑀

!
!!! 𝑆𝐶!

×𝑆𝐶!

Where, N = the number proteins and M = the number MS runs. The total sum
normalization assumes that all the MS runs should have same amount of PSMs
theoretically. This makes MS runs have same total PSM. However, the total
sum normalization tends to amplify a small sum of PSM too much. A small sum
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of PSM runs generally has a small number of proteins, so the total sum
normalization method can make false positives by distorting the data.

To

complement this disadvantage of total sum normalization, average normalization
can be used as described below:
!
!!!

!
!!! 𝑆𝐶!

𝑁
𝑀
!
!!! 𝑆𝐶!
𝑁

𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝑆𝐶! =   

×𝑆𝐶!

Where, N = the number proteins and M = the number MS runs.
Normalization using emPAI method is used in MASCOT searches [96].
emPAI is also designed for label-free proteomics and considers the number of
experimentally observed peptides and observable peptides calculated as
described below:
!!"#$%&$'

𝑒𝑚𝑃𝐴𝐼 = 10!!"#$%&'"($ − 1
Where, Nobserved = the number of experimentally observed peptides and Nobservable
= the number of theoretically observable peptides. Nobservable is calculated by in
silico protein digestion considering the digestion enzyme, allowed misscleavages, and the mass range of the instrument. Even though emPAI normalize
SC based on the potential number of peptide identifications, it does not correct
systemic errors between different MS runs.
Quantile normalization is a technique for making two distributions identical
in rank statistics. Quantile normalization considers the rank of SC within an MS
run and makes the same rank proteins have the same SC across MS runs.
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Since quantile normalization makes MS runs and SC have the same rank, it can
make the data to lose variation within replicates, which is important to ANOVA.
Statistical analysis in proteomics is not really any different from other
large-scale biology data analysis. Student’s t test, ANOVA, and quasi-Poisson
modeling are used for statistical comparisons between different experimental
groups. Student’s t test and ANOVA requires a normal distribution assumption,
but typical SC distributions from MS runs do not follow a normal distribution (Fig.
14). In Figure 14, the empirical estimation (red line) is not similar to normal-fitted
line (blue line). The left half of normal line is missing because negative values
are not in SC. Therefore, other distributions besides a normal distribution are
required for proteomics data analysis. However, the different distributions are not
tested in proteomics data analysis.

Recently Li et al [97] tested the quasi

likelihood Poisson modeling (quasi-Poisson). They compared the quasi-Poisson
model to many methods including Fisher’s exact test, Wilcoxon rank test, and
Student’s t test for processing LC-MS/MS data.

They concluded that quasi-

Poisson could be applied to proteomics data like other methods.
Because Student’s t test is not appropriate for multiple comparisons,
ANOVA is the analysis of choice for large biology data sets. Whenever a t test is
conducted, there is a chance of Type I error, which is typically 5%. If we a run t
test three times, the potential for a Type I error increases up to 15% [98]. If we
conducted t test over 1,000 proteins collected from LC-MS/MS runs, the
accumulated Type I error approaches 100%, which makes this analysis
unreliable because it contains too many false positives.
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Figure 14 Comparison of the distributions fitted to spectral counts in labelfree metaproteomics data. Blue line is a normal distribution fitted to spectral
counts and the red line is an empirically fitted line.
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However, ANOVA can limits Type I errors even when it is repeatedly applied to a
data set. The difference between ANOVA and a t test is based on what these
analysis tools test. Student’s t test compares the mean of each sample, while
ANOVA analyzes the variance within groups and between groups. Therefore, t
test is not the appropriate statistical method for proteomics as well as other large
biology data analysis.
Quantitative and functional analysis pipeline for metaproteomics
Even though there is a growing sense that metaproteomics studies are
important, very few bioinformatic analysis pipelines are publicly available.
GalaxyP (https://usegalaxyp.org/) is a proteomics application of the Galaxy
platform [99]. Galaxy platform is a scientific workflow and data analysis pipeline
for computational biology for wet-lab biologists who have limited programming
skills. Galaxy is written in Python and JavaScript and provides a simple threecolumn interface (Fig. 15). Galaxy is easy to install and free so any user can use
it. Adding bioinformatics tools to Galaxy is possible. However many Galaxy
servers

already

have

many

publicly

(https://wiki.galaxyproject.org/PublicGalaxyServers).

available

tools

Current GalaxyP provides

X!Tandem and Protein Prophet as well as data management. However, GalaxyP
may not be appropriate for metaproteomics because X!Tandem is not run in a
parallel environment and Protein Prophet is not the best tool for handling
redundant peptides. Also GalaxyP does not have functional analysis modules,
which is limiting.
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Figure 15 The interface of GalaxyP.

Its three-column interface consists of

available tools, main screen for analysis for results and parameter input and
status of analysis steps from left to right. This illustration is screen-captured from
http://www.usegalaxyp.org.
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MetaProteomeAnalyzer (MPA) [100] was recently published and is
designed for metaproteomics (Fig. 16). While GalaxyP has a web-interface and
server-oriented pipeline, MPA is simply a client-server communication system. In
MPA the client-side uploads MS/MS experimental data and the server-side
deposits and analyzes the uploaded data. MPA focuses on data interpretation
rather than parallelized MS/MS searches. MPA employs four DB search engines
(X!Tandem, OMSSA, Crux [101] and InsPecT [102]) and aggregates four DB
searchs to increase PSMs.

MPA groups proteins into meta-proteins due to

redundant peptides. Based on meta-proteins, MPA provides functional analysis
using the Kyoto encyclopedia of genes and genomes (KEGG) pathways [103],
enzyme commission (EC) [104] and National Center for Biotechnology
Information (NCBI) Taxonomy [105]. MPA generates visualized reports drawing
figures and produces analysis reports.

MPA is the first analysis pipeline,

equipped with a visual interface, but it does not provide multiprocessing and
sequence-based functional analysis. MPA’s functional analysis is based on the
reference DB at the current time. However, metagenome sequences, which are
used for metaproteome DB construction, cannot be annotated and many of
microbes within the reference DB are not well annotated.

Therefore, MPA’s

functional analysis is very limited in its current form.
An analysis pipeline for metaproteomics should have two important
requirements. First, simultaneously running MS/MS search engine is necessary
(i.e., multi-processing on multiple computer cores).
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Figure 16 A schematic diagram of workflow in MetaProteomeAnalyzer.
Server side and client side communicate and the uploaded data is deposited in
server SQL DB. The illustration is adapted from Muth et al [100].
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Since metaproteomics experiments generally have a highly complicated protein
sequence DB, DB search take much longer than single species proteomics.
Even though the search speed of MyriMatch is also dependent on protein DB
size, it is designed for multi-threading on computer clusters. Therefore, it can
use multiple CPUs simultaneously for DB searches.

Secondly, an analysis

pipeline for metaproteomics should provide functional analysis based on the
protein sequences, not based on the reference DB only.

Human, mouse,

Escherichia coli and yeast DB are manually curated with high quality annotation.
However, most microbes in an environmental sample are unknown and do not
have basic annotation. Functional analysis based on the reference DB that is
used in MPA is not very valuable in metaproteomics analysis.

Therefore, a

metaproteomics pipeline should have at least these two required features.
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CHAPTER II
QUANTITATIVE AND FUNCTIONAL ANALYSIS PIPELINE FOR
METAPROTEOMICS DATA

Quantitative and functional analysis for metaproteomics (QFAM)
Objectives of QFAM
Quantitative and functional analysis pipeline for metaproteomics (QFAM)
is an analysis pipeline for the metaproteome, which is highly complicated and
large data. The goal of QFAM is to offer fast and reliable functional analysis of
metaproteomics data. Since the metaproteome consists of a large proteomics
database, QFAM enables multiprocessing where many jobs can be processed at
the same time.

Also, QFAM provides sequence-based functional analysis

because the metaproteome cannot distinguish proteins with similar sequences
and less-annotated microbial proteins. Lastly, QFAM produces reliable statistics
including a significance test, an enrichment test, and the effect sizes in order to
reduce potential false positives in the analysis.

General information of QFAM
QFAM is installed on the Newton cluster at the University of TennesseeKnoxville.

The Newton cluster has 4,200 processor cores (400 nodes).

All

nodes are connected via 1Gb Ethernet and Infiniband interconnected (up to
40Gb/sec).

The operating system is Scientific Linux 6.5, which is Redhat

Enterprise compatible, and sun grid engine (SGE), also known as N1 grid
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engine, controls batch-queue system.

Newton is designed for scientific high

performance computing and is freely available to students and faculty of the
University of Tennessee. Generally Newton allows only a 24 hour run for single
job, but QFAM is allowed to use 48 cores for unlimited time because the PSM
search of the metaproteomics analysis sometimes takes more than two weeks in
spite of using 48 CPUs, which is the maximum number allowed by the server
administrators.
QFAM is designed for label-free shotgun metaproteomics data obtained
from microbial communities in environmental samples. The pipeline consists of
five modules: PSM search module, contrast file module, normalization module,
statistical analysis module, and functional analysis module (Fig. 17). The PSM
search module employs MyriMatch and IDPicker for fast and exact peptide and
protein identifications.

The PSM search module produces tab-delimited files

containing protein ID, spectrum counts, and decoy-target information. If running
multiple MS runs, spectrum counts of multiple MS runs are summarized into one
contrast file that has protein IDs in rows and spectrum counts in columns. This
output file is tab-delimited and can be opened in excel. The module that makes
the contrast output file also compares each of MS run by calculating the Pearson
coefficient correlation (PCC) for technical replicate. If the experimental datasets
has many technical replicates and thus a need to pick high quality technical runs,
the algorithm preferentially selects MS runs that have high PCC.
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Figure 17 A schematic diagram of QFAM. QFAM consists of seven modules
and is designed to process metaproteome data rapidly to give functional reports
to users.
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This repeated selection process could improve statistical analysis using ANOVA.
The next module is for normalization. The module provides three options: total
sum normalization, same average normalization, and NSAF.

The statistical

analysis module is programmed by an R statistics script to apply the three
methodologies: quasi-Poisson model with Cohen’s f, negative binomial model
with Cohen’s w, and Normal ANOVA with Cohen’s f. The next module applies
functional analysis based on the NCBI Biosystems DB [106] and cluster of genes
(COG) terms [107]. The last module draws charts/graphs for publication. This
module draws bar and line graphs using the ‘ggplot2’ R package [108].
QFAM is distinguished from other proteomics pipelines, such as MPA and
GalaxyP, by its PSM search speed, quantitative analysis module (QAM) and
functional analysis module (FAM). QFAM controls the PSM search module using
MyriMatch and IDPicker, which are able to do multithreading processing, which is
absolutely necessary for large databases common to metaproteomics studes.
QAM of QFAM uses the ‘selfea’ R package for discerning false positives
efficiently. Selfea tests the significance of FAM using NCBI BioSystems DB and
COG terms. FAM provides a COG enrichment and significance test, which are
not incorporated in other pipelines.

Module for LC-MS/MS data analysis
Automated module for DB search and protein assembly
PSM search speed is dependent on protein DB size because each PSM
comparison checks the protein DB and this process is repeated for each MS/MS
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spectra in a run. Since metaproteomics has large protein DB (> 100 megabytes),
the PSM search speed is much slower than single species proteomics studies.
The slow search speed increases the total time of the PSM search. This timeconsuming process is the first bottleneck of the analysis pipeline for
metaproteomics. To improve search speed and the overall process timing, a
multiprocessing technique is needed.

Multiprocessing executes multiple

processes within a single process, which means running multiple jobs
simultaneously using multiple CPU resources. Because the PSM search is an
independent process, it is simple to parralize. This means that it is possible to
run each PSM searches individually on multiple CPUs.

Multiprocessing is

applied using MyriMatch for QFAM.
MyriMatch and IDPicker v3.0 are incorporated to QFAM for DB searches,
post-processing, and protein assembly. Gross et al [109] showed that using
MyriMatch can efficiently reduce run times (Table 4). We also tested MyriMatch
in our Newton cluster where QFAM is installed and could confirm that MyriMatch
can reduce PSM search times by using more CPUs (Table 5).

Table 4 MyriMatch search time. This table was adapted from Gross et al [109]
Protein Database

1 CPU

SwissProt Human (20,348 proteins)

02:24:54 01:30:23 00:07:28 00:03:57

IPI Human (87,925 proteins)

06:51:21 04:31:19 00:22:15 00:11:06
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2 CPU

20 CPU

40 CPU

Table 5 MyriMatch run time on the Newton cluster. We tested MyriMatch
using a 500-megabyte protein DB containing 176,620 proteins to search 41,079
peaks. Increasing the number of CPU cores dramatically decreases running
time.

Run time for single RAW file

1 CPU

2 CPUs

12 CPUs

48 CPUs

49:03:45

40:53:07

08:27:34

02:51:06

Since the PSM search process is the major bottleneck of LC-MS/MS data
analysis, saving significant time in the search process is particularly important for
metaproteomics studies.

IDPicker has three sub-modules: IDPQonvert,

IDPAssemble and IDPQuery.

IDPQonvert creates idpDB from pepXML or

mzIdentML files produced by MyriMatch as PSM search results. IDPAssemble
analyzes peptide-protein matches by using bipartite graphs and calculates
spectrum counts following greedy algorithm. IDQuery is a data-retrieving tool
from the idpDB processed by IDPAssemble. Total execution with five RAW data
runs took almost ten and half hours when tested on a 500 megabytes protein DB
(Table 6).

Table 6 Run time of LC-MS/MS data analysis in the pipeline.

Run time

MyriMatch

IDPQonvert

IDPAssemble

IDPQuery

Total

10:24:55

0:01:07

0:00:31

0:00:15

10:26:48
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DTASelect generally takes more than a week to assemble peptides and calculate
spectrum counts, while IDPicker only took two minutes to do the same job (Table
6).

This enhanced speed is essential for processing large and complicated

metaproteome data. IDPicker’s MaxFDR is 0.05 as the default setting. QFAM
reports peptides and proteins at a 0.05 FDR level.
This module for MyriMatch and IDPicker is fully automated. Only one job
submission to Newton is needed. This job controller is programmed in Python
2.7.6 and requires one configure file named as “BMI_pipeline.cfg”.

This

configure file contains information on the data file path, program (MyriMatch and
IDPicker) path, the number of CPUs for pipeline execution, and a job list file
location. The PSM search module produces a tab-delimited file that has the
protein ID, spectrum counts from unique peptides, the number of unique
peptides, DB source (i.e., target or decoy), protein length, percentage of protein
sequence coverage, and spectrum counts.
Making contrast file, comparing MS runs, and normalization
Every metaproteomics experiment has more than two MS runs for
comparison unless it is a test run.

Multiple MS runs are included in the

experimental design for comparisons of the treatment and control groups.
Multiple MS runs and technical or biological replicates are needed for each
experiment. Multiple MS runs are summarized into one data file (i.e., contrast
file), usually in a tab- or comma-delimited file, and contain the MS run names in
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columns and protein IDs in rows.

QFAM provides a module for making a

contrast file from multiple PSM search results. Also, QFAM reports the protein
FDR, the number of decoy protein identifications divided by the total number of
proteins, and removes decoy protein identifications.
In addition to making a contrast file, QFAM calculates the Pearson
correlation coefficient (PCC) of every possible pair in one contrast file.

By

comparing PCC within replicates and between different groups, users can
choose the more similar replicates and different MS runs from other experimental
groups. This module is necessary for the comparison of technical replicates and
biological replicates in Chapter 4. The PCC comparison module is programmed
in R statistical programming script.

Also the PCC comparison can group MS

runs that are very similar (PCC >= 0.90). Generally technical replicates have
much better PCC than biological replicates and other experimental groups.
Picking MS runs for further analysis is not automated and requires user input.
The next module is normalization followed by contrast file creation and
picking MS runs. Normalization is necessary step for label-free proteomics data
to standardize different MS runs for comparison.

Piehowski et al examined

source of errors during proteomics data generation [25]. They considered four
variance sources, protein extraction, digestion, instrument stability and
instrument variance (Fig. 18). Dissecting different parts from the same sample
made different protein extraction replicates.

Protein digestion, instrument

stability and instrument variance were measured by repeating experiments at
different stages.
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Figure 18 Boxplots showing the distribution of Pearson correlation
coefficients among the different of replicates during the different stages of
the proteomics analysis. This illustration was adapted from Piehowski et al
[25].
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Interestingly, MS instrument related variances were negligible when compared to
protein extraction and digestion (i.e., average PCC: 0.99 for instrument variance
and 0.97 for instrument stability). Despite of using the same patient’s sample,
protein extraction variability was much higher than others (i.e., average PCC:
0.86). Normalization is used mainly for sample variation rather than instrument
variability. Our module for normalization provides total sum normalization and
average normalization.

Since QFAM employs IDPicker, which uses greedy

algorithms for assigning redundant peptide matches, spectral balancing is not
included in the pipeline as IDPicker already accomplishes it.
Even though normalization is employed to correct potential systematic
errors, sometimes normalization can make serious changes in a dataset. This
means that normalization can make unwanted differences between experimental
groups. When we standardize our data, we should be aware of this potential
data distortion.

Interestingly, normalization can have a huge impact on data

analysis, but only a few papers discuss data normalization in proteomics. As
with any step of computational analyses the user should check the results to be
sure that obvious errors have not been introduced into the dataset by an
automated bioinformatics process.

Module for quantitative and functional analysis
Quantitative analysis module (QAM)
QFAM’s quantitative analysis module (QAM) is a major improvement
compared to other proteomics analysis pipelines, in our opinion. QFAM uses
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‘selfea’ R package as the core statistics calculator. Selfea will be explained in
Chapter 3 in greater detail. The analysis module has several R and Python
scripts to execute ‘selfea’ simultaneously using multiple cores.

As with any

analysis on a metaproteome, the running time for the statistics computation takes
a relatively long time. It took more than 12 hours to calculate the statistics of 55k
proteins with single core. However 1 hour was enough to finish the computation
via the parallel-running module.
The QAM has four steps.

First, the normalized expression profile is

divided into small pieces. Users can decide the size of data pieces. Python
script for the fragmentation produces job files for parallel execution as well as
reduced data chunks. Job files have information for module loading, change
directory and R script execution. R script is prepared for statistical calculation
using ‘selfea’ package.

Next, job files are submitted to SGE of the Newton

cluster. All the submitted jobs are executed on computing cores that is dedicated
only for computation, not for systems administration or control. After all the jobs
are completed, a Python script for gathering the results of the executed jobs is
carried out.

All the separately calculated statistics results are collected and

compiled. P-values, calculated from three models (i.e., quasi-Poisson model,
negative binomial model and Normal ANOVA model) are adjusted by userselected methods including Benjamini and Hochberg correction (FDR) [110]. At
the same time, insignificant proteins are filtered out and a protein scatter plot
drawn.
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QFAM provides six statistics for every protein: Cohen’s w, Cohen’s f,
maximum fold change and adjusted p-values from quasi-Poisson model,
negative binomial model, and normal ANOVA model (Table 7). Cohen’s w and f
measure effect sizes (ES) by comparing how many of the detected proteins exist
in the different experimental groups. The measurement of the ES is important to
maintain the statistical power in the resultant signature. Maximum fold change is
the biggest fold change among all the possible pairs in the experimental groups.
Selfea provides three probability models as well as various ES calculations. Li et
al [97] use the quasi-Poisson model for label-free proteomics data analysis. The
negative binomial model is similar to quasi-Poisson and is used for analysis of
count-type data, such as spectrum counts of label-free proteomics and the
number of reads in RNA sequencing (RNA-Seq) data.
Selfea calculates the ES threshold according to the statistical power
where the default is 90% ~ 0.90, but the user can change this. By combining
selected methods, such as quasi-Poisson and Cohen’s f, significant proteins are
selected at the designated statistical power. Statistical power is the probability
correctly of rejecting the null hypothesis when it is false. Hence, it is directly
related to reliable protein selection. Selfea enhances the statistical power by
removing underpowered hypotheses tests using Cohen’s ES. The higher the
Cohen’s ES is, the stronger the statistical power, which generates higher quality
data. Making a higher statistical power can reduce the number of false positives
in the final output dataset.
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Table 7 An example result of the QAM. “Cohen’s w“: Calculated Cohen’s w for
expression profile of a protein, “Cohen’s f“: Calculated Cohen’s f for expression
profile of a protein, “Max_FC”: maximum fold change, “QP_Pval_adjusted”:
adjusted p-value from quasi-Poisson model, “NB_Pval_adjusted”: adjusted pvalue from negative binomial model and “Normal_Pval_adjusted”: adjusted pvalue from Normal ANOVA model.
Protein
SERPI
NA1
UBC
IGLL5
FCGBP
CELA3
A
ACTB
ACTG1
UBB
DMBT1
IGJ

Cohen’ Cohen’
sw
sf
0.4988 1.7646

Max_ FC

0.8655
1.2780
0.9688
0.4067

0.7157
1.0265
4.9266
1.5158

7.4570
96.4830
266.0565
6.8717

0.6098
0.6098
0.8595
1.5035
1.0418

1.5480
5.0740
1.5480
5.0740
0.7446
7.4849
3.7198 296.4068
1.3838 Inf

3.1710

QP_Pval_a
djusted
3.9790E-04

NB_Pval_a
djusted
4.9878E-05

Normal_Pv
al_adjusted
3.0741E-04

1.3285E-01 5.2853E-02
2.4177E-03 5.1797E-07
2.9330E-11 0.0000E+00
4.7076E-04 1.7161E-05

4.3099E-01
7.6510E-02
1.8945E-10
1.8453E-03

3.2750E-04
3.2750E-04
1.1914E-01
3.4727E-09
4.1234E-05

1.4676E-03
1.4676E-03
3.6476E-01
1.2735E-08
4.9763E-03
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2.6138E-06
2.6138E-06
4.8966E-02
1.9259E-12
2.7157E-11

However, many biological experiments may have limited statistical power
due to limited budgets and time. Selfea can complement low statistical power
experiment by increasing ES. For example, significance is usually determined
based on p-value that is calculated from a Student’s t-test. P-value can indicate
statistical significance at high statistical power.

Therefore, Cohen’s ES is

required to complement the p-value’s weakened selection power. By applying
Cohen’s d statistics into a Student’s t-test at higher than 90% statistical power in
concert with a p-value significance test, there is increased confidence in those
values. Selfea provides probability-based thresholds and ES thresholds at the
same time for reliable selection.
Finally, the QAM module supplies a protein scatter plot showing how
significant proteins were selected from the total proteins (Fig. 19). In this example
the red dots are insignificant proteins, while blue dots are significant. The
horizontal line shows the p-value threshold, while vertical line indicates the ES
threshold.
Functional analysis module (FAM)
Since metaproteome experiments generally have a large number of
undistinguishable proteins, functional analysis improve the metaproteome’s
output rather than focusing on individual proteins. For this QFAM provides the
FAM module.

This consists of two modules: biosystems and COG analysis.

Both modules use two statistical tests: the enrichment test and significance test.
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Figure 19 Protein scatter plot for the quasi-Poisson model and Cohen’s f
combination.

Selfea provides a protein scatter plot for explaining how

significant proteins were distinguished. Horizontal black line is false discovery
rate (FDR) = 0.05, user-defined p-value threshold, and vertical black line is
Cohen’s f at 80% statistical power, which is typically the recommended power for
reliable feature selection. Red dots are insignificant proteins, while blue dots are
significant.
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The enrichment test measures how significantly specific functional terms are
enriched from total proteins. The significance test examines how the different
terms are detected between independent experimental groups.

These two

statistical methods can report differential and abundant functions in these
microbial communities.
Of the many functional analysis tools, FAM could be categorized as a
second-generation functional class-scoring module (FCS).

Khatri et al [111]

grouped pathway analysis tools into three categories: over-representation
analysis (ORA), FCS, and pathway topology (PT) (Fig. 20). FCS tools utilize
expression profiles for finding significant functions, which is similar to FAM’s
significance test using selfea. The first generation ORA relied on pre-selected
features such as differentially expressed genes or proteins. FAM’s enrichment
test is close to the ORA method. Therefore, FAM functions by using two kinds of
analytical methodologies, ORA and FCS. The enrichment and significance test
are used to identify important and differential functions. FAM does not consider
network topology or different weights that are important issues in TP.
BioSystems analysis of FAM
The application of FAM to biosystems uses KEGG, BioCyc [112],
Reactome [113], National Cancer Institute (NCI) pathway interaction database
(PID) [114] and GO [115] to analyze the pathways based on the proteomics data.
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Figure 20 Overview of existing pathway analysis methods using gene
expression data as an example.
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These are functional annotations of biosystems, such as biological pathways and
disease, which can involve any components of the cell (i.e., genes, proteins,
metabolites and drugs). Of these programs, KEGG and GO are most widely
used. BioCyc, Reactome and NCI PID have their additional advantages, such as
pathway integration in BioCyc, reaction-focused responses in Reactome and PID
for pathway interactions.
FAM consists of an enrichment test and annotation pipeline, downloads of
source files, parsing and updating reference files for FAM analysis. This helps to
maintain up-to-date information (Fig. 21). FAM annotation pipeline downloads
and parses NCBI Entrez Gene [116], RefSeq [117] and BioSystems through file
transfer protocol (FTP). Then, FAM parses the downloaded files and updates
flat-files for NCBI BioSystems analysis. This process is automated and can be
run regularly to keep up-to-date status.
Next, FAM executes enrichment tests for the different pathways. Proteins
in the user’s expression profile will have NCBI RefSeq, Entrez Gene or UniProt
IDs because FAM’s annotated reference files are based on NCBI GenBank and
UniProt’s SwissProt and TrEBML IDs. These IDs are transformed to an Entrez
Gene ID that is directly connected to NCBI BioSystems IDs.

After

transformation, a Python script collects all the BioSystem terms found in the
Gene IDs of the query expression profile. The number of proteins is counted for
every BioSystem term.
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Figure 21 A diagram of the biosystems analysis of FAM. FAM has two parts,
a script updating reference file and enrichment test. QAM is incorporated into
FAM for significance tests. The user receives results from the enrichment and
significance tests.
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Table 8 An example of a contingency table for a pathway ID using the
enrichment test of FAM. The numbers listed are the numbers of proteins in
each category.
Expression profile data
Matched

BioSystems DB

19

37

Unmatched

52,934

978,925

Total

52,953

978,962

Then, an enrichment test makes contingency tables using the number of found
pathway proteins, the total number of proteins in the expression profile, and the
total number of proteins in the BioSystems DB (Table. 8). With the constructed
contingency table, Fisher’s exact test is calculated using NumPy [118] and SciPy
[119] packages.

The acquired p-values for every spotted pathway ID are

adjusted according to the FDR. The FDR was calculated using the BenjaminiHochberg method for controlling of false positives caused by repeated
hypotheses tests.

This method is different from the one was used in PSM

identification.
The significance test is conducted by calling QAM subsequent to the
enrichment test.

FAM produces an expression profile for all the detected

pathways during the enrichment test.

A pathway expression profile is

constructed by transferring spectrum counts of identified proteins to the different
pathways.
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QAM is executed in concert with FAM to compute p-values and Cohen’s ES for
the pathway expression profile.

The significance test identifies the different

pathways, while the enrichment test how quantifies how many proteins are
discovered. Hence, those two tests are mutually combined to report pathways
that should have the most significance in a biological context.

Basically,

significant pathways are identified that have p-values less than 0.05 for both of
tests and a Cohen’s ES larger than 90% statistical power (Table 9). There are
options for significance test methods, which selfea provides, such as quasiPoisson model and Cohen’s f and negative binomial model and Cohen’s w.
COG analysis of FAM
COG analysis is a better approach to interpret the characteristics of the
microbial community than pathway analysis. COG is not dependent on database
annotation so it has better coverage than pathway annotations.

Model

organisms, such as human, mouse, yeast and Escherichia coli, have very good
annotation because of they have been investigated for a very long time.
However, since almost all the microbes are not cultivable in laboratories, most
microbes encountered in environmental proteomics studies have limited or no
annotation available. Hence, there are limited annotations of microorganisms in
reference databases, such as NCBI Gene and BioSystems, compared to the
model organisms mentioned above. Many annotations of microbial proteins are
inferred by sequence alignment, but this has limited usefulness.
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Table 9 Example result of FAM. FAM provides three statistics: adjusted pvalue of enrichment test, significance test, and effect size. The table represents
filtered pathways from a whole FAM analysis result using KEGG pathway p-value
adjustment method for FDR, significance test method using quasi-Poisson and
Cohen’s f, enrichment test p-value < 0.05, significance test p-value < 0.05 and
80% statistical power.

“Enrich FDR” is the FDR of the Fisher’s exact test,

“Source ID” uses the original DB ID in Biosystems (KEGG ID in this table), “# of
prot” is the number of proteins and “Quasi-Poisson FDR” is the FDR calculated
by quasi-Poisson model.
BS ID

Description

287 Glycolysis /
Gluconeogenesis
296 Fatty acid
degradation
817567 Carbon metabolism
795174 Biosynthesis of
amino acids
478 Focal adhesion
498 Olfactory
transduction
169295 Pancreatic secretion
171868 Protein digestion
and absorption
516 Pathogenic
Escherichia coli
infection
167191 Amoebiasis
662842 Viral carcinogenesis

Enrich
FDR

2.49E-12 ko00010

38

2.5236

QuasiPoisson
FDR
4.24E-07

1.65E-06 ko00071

22

2.6618

4.81E-10

8.94E-11 ko01200
3.57E-09 ko01230

44
34

2.6143
2.5554

2.41E-07
6.84E-07

3.03E-06 ko04510
2.39E-06 ko04740

52
11

2.5316
1.6099

1.81E-07
1.25E-04

3.01E-10 ko04972
1.61E-09 ko04974

41
38

4.2238
2.9432

9.48E-10
2.82E-07

8.45E-08 ko05130

27

1.6479

1.07E-04

4.87E-08 ko05146
6.77E-09 ko05203

39
59

2.2770
1.5133

1.16E-06
2.16E-04
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Source
ID

# of Cohen’
prot
sf

Table 9 continued.
BS ID Description
468194 Glycolysis (EmbdenMeyerhof pathway),
glucose => pyruvate
468195 Glycolysis, core
module involving
three-carbon
compounds

Enrich Source
FDR ID
4.87E-07 M00001

18

2.4862

QuasiPoisson
FDR
6.24E-07

9.19E-06 M00002

12

2.3486

1.03E-06
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# of Cohen’
prot
sf

Table 10 Comparison of the number annotated proteins between KEGG and
COG. The total number of identified microbial proteins is 5,354.
KEGG Pathway
The number of proteins annotated

2,254 (42.1%)

COG
4,905 (91.6%)

For example, the coverage of KEGG and COG is different for the microbial
proteins discussed in application study in Chapter 4 (Table 10).
There are two reasons why COG has better coverage than pathways.
First, sequence comparisons are not an efficient way to annotate pathways, while
COG was originally based on sequence comparisons. Although there are shared
pathways in different species, many microbes have different pathways adapted
for survival in diverse environments.

Therefore, sequence comparisons for

pathway annotation is restricted to universally shared pathways.

However,

proteins can functions in ways that are not covered by the pathways analysis.
This limits the usefulness of using this pathway analysis. The pathways are
manually generated by reading manuscripts and organizing the accumulated
research findings into the determined pathways. Theoretically, all the proteins
should be involved in at least one pathway, but often it takes multiple studies to
uncover even single pathways.

Unfortunately, most microbes are not well

studied at this point. This limits pathway annotation to the many microbial
proteins observed in metaproteomics studies.
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COG assignment is built on protein sequences that are available in
metaproteomics. COG terms are annotated to proteins through comparing query
protein sequences with protein sequences in the COG DB.

Each COG has

protein paralogs from at least three lineages, so species information and
sequence similarity are required to decide the COG assignment. COG is widely
used to find microbial orthologous proteins, but NCBI stopped updating it after
2005. From 2010 NCBI released an updated COG DB by expanding species
coverage and introducing new a COG assignment algorithm (COG software)
[120]. Until the new COGnitor, a tool for COG allocation, came out, to find a
similar COG ID one would run the data through RPS-BLAST [121] or PSI-BLAST
[122] at certain E-value level, such as 0.00000001. COG requires at least three
proteins from different lineages and needs to have enough similarity to other
members of COGs, not to only one member. However, the simple method using
RPS-BLAST and PSI-BLAST were widely accepted because they were easy to
use and the original COG assignment algorithm, SymBet, was not. SymBet was
complicated and slow to run on a local desktop.
The newly released COGSoftware employs the EdgeSearch algorithm that
is faster and less complex than SymBet. This enables the new COGnitor to
assign COG IDs to proteins in our dataset and avoids violating COG construction
rules.

COG analysis of FAM employs COGSoftware for COG allocation.

COGSoftware goes through two steps to assign COG to new proteins. Prior to
COG assignment, COGSoftware requires PSI-BLAST results to be compared to
the query protein sequences run against COG DB. With these multiple sequence
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alignments, the COGSoftware finds the best COG terms related to the query
proteins.
FAM controls the COGSoftware and distributes the PSI-BLAST jobs to 48
CPUs for increased speed (Fig. 22). Sequence comparisons using PSI-BLAST
take most of time of COG analysis.

Basically, PSI-BLAST execution time

depends on BLAST DB size and query protein size. In the FAM module, the size
of the BLAST DB and the query protein FASTA file are large because FAM
requires a whole protein for PSM searches of LC-MS/MS data.
metaproteomics, the DB is several hundred megabytes.

In

To run PSI-BLAST

simultaneously FAM divides the large protein DB into small chunks and runs PSIBLAST simultaneously. In spite of parallel operations, if the protein DB is large
PSI-BLAST sometimes takes up to several days because of the limited number
of available CPUs (e.g., 12 hours for the human fecal proteome study in Chapter
4).
The next step of COG analysis is the enrichment test (Fig. 22). This
enrichment test is similar to the BioSystems analysis.

However, COG

identification of the whole protein DB is limited or not provided by publicly
available databases, while BioSystems access this information from NCBI
BioSystems.

Therefore, FAM identifies all the possible COGs in the whole

metaproteomics protein DB despite of long PSI-BLAST running time (Fig. 22).
Because the enrichment test measures how significantly proteins in the
expression profile are enriched from the total DB, FAM needs COG identification
of the whole protein pool.
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Figure 22 COG analysis of FAM.

COG analysis runs PSI-BLAST and the

COGSoftware to identify COG IDs of the query proteins. With the identified COG
IDs, enrichment and significance tests are conducted by the R and Python scripts
of FAM. Orange color box: input files; blue oval shape: python and R scripts;
green box: COGSoftware and PSI-BLAST; purple box: distributed jobs; and light
purple box: output files.
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FAM makes a contingency table for every COG (Table 11) and calculates a pvalue using Fisher’s exact test.
The COG enrichment and significance tests are combined to provide
significant and differentially enriched COG terms. All the p-values are adjusted
by user-selected method, such as FDR, following the enrichment test. Three
statistics, adjusted p-values from two statistics tests, and Cohen’s effect size are
integrated and finally significant COGs are reported as described in table 12.
COG analysis of FAM enables us to obtain differentially and abundantly
expressed proteins.

The same analysis used for COG and BioSystems is

repeated for assigning the COG functional categories to provide a wider view of
the functional features of the microbial community. Because the COG analysis
tools do not provide enrichment and significance tests at the same time, FAM is
unique tool among functional analysis software.
Other modules of QFAM
QFAM has other modules besides the PSM search, QAM, and FAM.
First, it has a module for metagenome proteins, translated proteins from
metagenome sequences. Metagenomes have a wide variety of un-annotated
sequences. Thus, metagenome sequences are not characterized even though
those are differentially detected in metaproteomics studies. The metagenome
can be functionally analyzed by COG identification in QFAM.

However,

annotation is required for BioSystems analysis of FAM. Therefore, QFAM has a
module for protein annotation of metagenomes via sequence comparison.
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Table 11 A contingency table for one COG ID from the enrichment test in
FAM. For every COG term, FAM counts the number of matched and unmatched
proteins in the expression profile data and entire metaproteomics DB. With these
counts FAM generates contingency table. P-value is calculated using Fisher’s
exact test on the contingency table.
Expression profile data
Matched

Entire proteins in
metaproteomics DB

34

77

Unmatched

48,934

263,921

Total

48,968

263,998
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Table 12 An example COG analysis in FAM. Same thresholds applied in table
9 were used for this table.

“Enrichment FDR”: FDR of Fisher’s exact test;

“Source ID”: Original DB ID in Biosystems (KEGG ID in this table); “Func cat.”:
COG broad functional category; “# of prot”: the number of proteins; and “QuasiPoisson FDR”: FDR calculated by quasi-Poisson model.
COG ID

Description

COG00542

ATPases with
chaperone activity;
ATP-binding
subunit
GTPases translation
elongation factors
Translation
elongation factors
(GTPases)
F0F1-type ATP
synthase; beta
subunit
ATP-dependent Zn
proteases
Preprotein
translocase subunit
SecA (ATPase;
RNA helicase)
DNA-directed RNA
polymerase; beta'
subunit/160 kD
subunit
Ribosomal protein
S12
Ribosomal protein
S11
DNA-directed RNA
polymerase; beta
subunit/140 kD
subunit

COG00050
COG00480
COG00055
COG00465
COG00653

COG00086

COG00048
COG00100
COG00085

Enrichme
nt FDR

2.33E-13 O

36

3.1885

QuasiPoisson
FDR
4.27E-07

5.32E-12 J

26

1.5264

8.32E-05

5.32E-12 J

32

2.5506

9.50E-07

1.42E-11 C

24

2.7013

1.14E-06

8.86E-11 O

27

3.3691

5.58E-08

1.99E-10 U

23

1.4936

2.55E-04

1.99E-10 K

22

1.5654

1.30E-04

1.99E-10 J

21

1.6682

1.27E-04

1.99E-10 J

21

2.0664

4.58E-06

2.75E-10 K

22

1.9143

4.63E-06
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Func
cat.

# of Cohen’
prot
sf

Table 12 continued
COG ID

Description

Enrichme Func
nt FDR cat.

COG00459

Chaperonin GroEL
(HSP60 family)
Ribosomal protein
S2
Ribosomal protein
S19

2.75E-10 O

22

2.9585

QuasiPoisson
FDR
7.46E-08

7.43E-10 J

20

1.5196

7.50E-05

7.43E-10 J

20

1.6309

6.39E-04

COG00052
COG00185

86

# of Cohen’
prot
sf

This module uses BLAST for sequence comparison with UniProt, which has an
extensive protein sequence pool collected over the years. The most similar
UniProt ID is assigned to a metagenome protein if their alignment does not have
open gaps and shows more than 95% sequence similarity. Sequence similarity
is calculated as described below:
𝑆𝑖𝑚𝑖𝑙𝑎𝑟𝑖𝑡𝑦 =

𝐴𝑙𝑖𝑔𝑛𝑒𝑑  𝑙𝑒𝑛𝑔𝑡ℎ
×𝑃𝑒𝑟𝑐𝑒𝑛𝑡  𝑖𝑑𝑒𝑛𝑡𝑖𝑡𝑦
𝑃𝑟𝑜𝑡𝑒𝑖𝑛  𝑙𝑒𝑛𝑔𝑡ℎ

Where the aligned length and percent identity of the BLAST result and protein
length is the number of amino acid residues.

Because generally the

metaproteme DB has a lot of metagenome proteins, running of the BLAST
assignments is divided into multi-cores and merged after all the jobs are
completed. With this annotation, we can apply the reference DB-based analysis
to metagenome proteins.
QFAM provides an R library for drawing graphs including bar- and linegraphs and heat-maps using ‘ggplot2’ package.

Because most biologically

meaningful images are manually drawn, QFAM does not provide an automated
module for making figures. However, if manually curated information is provided,
QFAM can produce publication quality figures. Bar- and line-graphs showing
expression

profiles

of

significantly

differential

experimental groups can be generated (Fig. 23).

proteins

across

Line graphs can show

expression profiles of multiple proteins over different samples.

Proteins are

colored differently to make clear distinctions between identified proteins.
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different

A)

B)

Figure 23 Examples of bar- and line-graph generated by QFAM.

QFAM

provides R library for drawing A) line graph and B) bar graph from analysis result
of QFAM.
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QFAM’s bar graph for showing multiple proteins, pathways, or COGs in different
experimental groups. Significance can be marked with red asterisks and error
bars can be added to show data variation.
QFAM’s R library Drawing heat maps are provided by (Fig. 24). Heat map
figures are widely used in Omics based studies to display expression profile of
many proteins or genes. Although heat-map can show global trends in whole
dataset, it is not able to exhibit detail information. Heat map graphs are often
combined with hierarchical clustering to group similarly expressed proteins.
QFAM provides protein and experiment group clustering. Coloring of expression
is standardized spectral counts calculated by (spectral counts – mean) / standard
deviation.

Colored bars located at upper side of heat-map can display

experimental groups. Color-key is also provided by QFAM.

Conclusion
We developed QFAM for quantitative and functional analysis of
metaproteome data. Since metaproteome data is highly complicated and less
annotated, analysis pipeline should be able to run its processes in parallel
computing environment and functionally interpret metaprotome proteins from
limited annotated metagenomes.

In terms of these requirements, QFAM is

excellent pipeline for metaproteome data analysis. QFAM can run MyriMatch
and IDPicker with 48 CPUs and automatically control all the processes of PSM
search.

MPA is another pipeline for metaproteome, but it doesn’t provide

multithreading and multiprocessing execution of PSM search steps.
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Figure 24 Example heat-map drew by QFAM’s R library. Heat-map, colored
by steel blue and white, can display global trend of protein expression.
Hierarchical clustering for proteins and for experimental groups are available in
QFAM’s R library. In this example, only proteins are clustered to show how
protein expressions are changed in different groups (color bars of upper side of
heat-map).

Heat-map’s cells are standardized spectral counts by mean and

variance.
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Therefore, QFAM has an important advantage to MPA in terms of PSM search
speed.

Furthermore, QFAM is simple to install and optimize on any Linux

cluster.
In addition to fast search speed, QFAM has QAM module for reliable
feature selection. QAM employs selfea R package for finding of differentially
expressed proteins. Selfea provides three widely used probability models, quasiPoisson, negative binomial and normal distribution, with Cohen’s effect-sizes,
such as Cohen’s f and w. Combination of p-values and effect-sizes is able to
produce reproducible research findings. Detail explanation about selfea is in
chapter 3.
QFAM services functional analysis module, FAM, for metaproteome data
interpretation. FAM has two parts, BioSystems and COG analysis. BioSystems
is based on reference databases of NCB, while COG is derived from sequence
comparisons.

BioSystems analysis is more appropriate for well-annotated

organisms, such as human, mouse and yeast, while COG is the best analysis
approach to metagenome proteins that takes biggest portion of metaproteome
data. Through COG analysis and BioSystems analysis, FAM can cover from
well-known species to undiscovered species. Since metaproteome has mixed
proteome with deeply studied organisms and potential microbes that have never
been observed to date, FAM is appropriate analysis pipeline for metaproteomics.
FAM provides two statistical tests, enrichment test and significance test,
for every functional term including pathways and COGs.

Enrichment test

measures how many proteins are enriched from total proteins, while significance
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test is for getting differentially detected terms over different experiment groups.
Both of two tests can be mutually analyzed to provide differentially and
meaningfully enriched characteristics of microbial communities.

This FAM’s

approach is unique in many of published functional analysis tools because FAM
integrates enrichment test and significance test together.
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CHAPTER III
Selfea: R package for reliable feature selection
All of the data presented below has been adapted from the following submitted
journal article:
Lang Ho Lee, Nathan VerBerkmoes and Arnold Saxton “Using Cohen’s Effect
Sizes for Reliable Feature Selection of Quantitative MS-based Proteomics Data”.
Nature Methods (In review).

Introduction
In data analysis from biological studies it’s often a struggle to obtain
reproducible confident results.

Most scientific discoveries, in the biological

sciences, are statistically supported by p-value that is not always reliable
evidence unless statistical power is high enough (≥90%) [123]. However, many
of biology experiments are not conducted with parameters that have enough
statistical power due to limited budget and time. Button et al showed that 42 of
49 neurological studies, published in 2011, have less than 90% power that is
typically recommended level for reliable hypothesis tests [123,124] (Fig. 25).
Since p-value is fickle at insufficient power, it is often accompanied by effect size
(ES), such as fold change (FC), in biological studies, to increase result
confidence[125,126].

ES can show the magnitude of difference between

experiment groups, while p-value assesses if an effect exists[125]. Combination
of ES and significance filter can improve reproducibility[126]. FC is, however, not
sufficient to supplement p-value.
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Figure 25 Median power of studies included in neuroscience metaanalyses.

This figure shows a histogram of median statistical power of

neuroscience papers published in 2011. If this figure was based on minimum
power as we used, the power of papers should be far more below than 80%.
This illustration was borrowed from Button et al [124]. N: the number of papers,
Power(%): median statistical power
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FC is easy to calculate and a ratio for relative comparison, familiar to
biological research, but it has obvious limits. First, FC threshold is rooted on
empirical evidence of biologists. FC is traditionally accepted because it means
observable changes that are clear to the naked eye.

However, this visible

difference doesn’t always mean significant effect, considering signal intensity and
variation within replicates. The same FC threshold is generally applied to various
data regardless of dataset’s characteristics, such as variance and sample size.
Furthermore, since FC is a relative ratio, it cannot distinguish absolute
quantitative difference, which is main purpose of ES[125]. For instance, in labelfree proteomics experiment, if expression level of proteinA has an observed 1
spectrum count (SC) in control and 2 SC in test group, FC of proteinA is 2. It is
still same 2-FC, however, to another proteinB whose expression level is 1,000
SC in control and 2,000 SC in test group.

Difference in the two groups for

proteinA is 1 SC while for proteinB is 1,000 SC. We may not be sure whether the
1 SC difference of proteinA is true or from systematic-error because protein
detection and quantitation are limited by the sensitivity of the instrumentation
making the measurement (low spectral count proteins in label free proteomics is
always suspect).

As was confirmed in microarray[127], FC is no-good at

handling low expression level features (genes or proteins) that are prevalent in
biological data.
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Methods
Label free LC-MS/MS Proteomics Data
Gregori data were obtained from ‘msmsTests’ R package[126,128]. Fecal
proteome data were generated in a study of chapter 4, human fecal proteome
study, via label free shotgun proteomics.

The detail information of data

generation is in method part of chapter 4.
Calculation of Cohen’s effect sizes and statistics
All the statistical analysis, used in this study, was done with R 3.1.3.
Cohen’s effect sizes, fold change and p-values were obtained by ‘selfea’ R
package

we

developed.

Selfea

project.org/web/packages/selfea/.

is

available

at

http://cran.r-

Selfea calculates Cohen’s f as described

below:

𝑓 =   

!
!!! 𝑝!

𝜇! − 𝜇
𝑀𝑆𝐸

!

Where pi = N/ni, k = the number of groups, ni = the number of observation in
group i, N = total number of observations, µi = mean of group i, µ = grand mean
over all the observations, and MSE = mean square error[129,130]. Cohen’s w is
calculated in selfea as described below:
𝑤 =   

(𝑝0! − 𝑝1! )!
𝑝0!
!!!
!

Where m = the number of cells, p0i = cell probability in i-th cell under null
hypothesis, and p1i = cell probability in i-th cell under alternative hypothesis. We
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used ‘ES.w1’ function of ‘pwr’ package[131] for Cohen’s w calculation because
we compare goodness of fit of two NB models[129,130,132]. Selfea calculates
minimum Cohen’s f using ‘pwr.anova.test’ function of pwr pacage with
parameters (k = the number of groups, n = the common sample size in each
group, sig.level = p-value threshold defined by an user (0.05 by default) and
power = statistical power defined by an user (0.90 by default)). Cohen’s w is
calculated in selfea through ‘pwr.chisq.test’ function of pwr package with
parameters (N = the total sample size, df = the degree of freedom, sig.level = pvalue threshold defined by an user (0.05 by default) and power = statistical power
defined by an user (0.90 by default)). Selfea calculates p-values from quasiPoisson, negative binomial and Normal distribution.

Since generalized linear

model of basic R does not provide negative binomial distribution, ‘glm.nb’
function of MASS package[133] was used for making a negative binomial linear
model.

Generated linear models for quasi-Poisson, negative binomial and

Normal distribution were compared against null linear model using ‘anova’
function. One-way ANOVA F-test is used to compare linear models based on
quasi-Poisson and Normal distribution, while chi square likelihood ratio test is
used for a negative binomial linear model. Since one-way ANOVA F-test is used
for quasi-Poisson and Normal distribution linear models, Cohen’s f is coupled.
Negative binomial linear model is paired to Cohen’s w due to chi-square
likelihood ratio test. All the p-values were adjusted by FDR[110]. Fold change
between experiment groups was calculated by selfea. Selfea returns maximum
fold change among all the possible pairs as representative fold change.
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Minimum statistical power is reported as representative statistical power in selfea
package.
Benchmark data test and fecal proteome data test
We employed the benchmark data generated by Gregori et al[126] and
fecal proteome data in order to test Cohen’s effect sizes. The dataset, termed
here as fecal proteomes, have 29 2D-LC-MS/MS runs from 11 fecal samples
from healthy adult volunteers (unpublished). Selfea was used to find differently
expressed proteins in 11 fecal samples. Gregori data consist of 19 label-free
liquid chromatography-tandem mass spectrometry runs and have 4 groups that
have a fixed loading amount of standard yeast lysates (500 ng) with different
amounts of 48 human proteins (100, 200, 400 and 600 fmol).

Differentially

expressed proteins over 4 groups were found by using selfea. As is assumed by
Gregori et al[128], we considered human proteins as true positives and yeast
proteins as false positives. Using selfea, we got differentially expressed proteins
of Gregori data and fecal proteome data through six methods; quasi-Poisson
(FDR < 0.05) and Cohen’s f (Power > 0.90), quasi-Poisson (FDR < 0.05) and 2
fold change, negative binomial (FDR < 0.05) and Cohen’s w (Power > 0.90),
negative binomial (FDR < 0.05) and 2 fold change, Normal ANOVA (FDR < 0.05)
and Cohen’s f (Power > 0.90), and Normal ANOVA (FDR < 0.05) and 2 fold
change.

With the significant proteins, we counted human proteins as true

positives and yeast proteins as false positives. Percentage of false positives in a
signature is the number of false positives divided by the total number of proteins
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in a signature. In addition to NB, QP and NOR model, we calculated p-values
using QProt to check if Cohen’s ES can be successfully combined with other type
method. QProt was downloaded from http://sourceforge.net/projects/qprot and
installed on the Newton computational cluster at the University of Tennessee.
Since QProt provides only two-sample test, we tested all the possible pairs of
experiments of Gregori data. After collection of all the FDR-adjusted p-values
from six two-sample tests, we picked minimum FDR as representative FDR.
Input parameter of QProt was nburnin=2,000, niter=10,000, and normalized=1.
Bar plots were drawn by Microsoft Excel. Scatter plots were drawn by ‘ggplots2’
package[108].
Monte Carlo simulation
We used ‘rpois’ function of R to generate random data based on Poisson
distribution with mean expression level of each groups in Gregori data. Since
Gregori data has four groups, we separately generated random data for each of
four groups (λ = mean spectral counts within groups).

From the randomly

generated data, p-values, fold change and Cohen’s effect sizes were computed
by selfea. Six methods, used for the benchmark data test, were examined. We
calculated minimum statistical power and counted human proteins as true
positives and yeast proteins as false positives in significant proteins. FP rate is
the number of false positives divided by the total number of yeast proteins in a
random data. This simulation was repeated 1,000 times. Box-plots were drawn
by ‘ggplot2’ package[108].
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User guide for selfea package
R document of selfea is available at CRAN, R package repository, and its
web addressed is http://cran.r-project.org/web/packages/selfea/selfea.pdf. This
R document provides detail information about every function and data as well as
examples.

Algorithm
To overcome limitations of FC, we developed an alternative approach
based on Cohen’s ES. Cohen’s ES are designed to measure difference between
groups and there are specific types for different hypothesis test methods, such as
Cohen’s d for Student’s t-test[134]. Cohen’s ES is, moreover, a parameter for
statistical power calculation of a hypothesis test[134,135]. The higher Cohen’s
ES is, the better statistical power is.

Statistical power is the probability of

correctly rejecting the null-hypothesis when it is false.

Therefore, higher

statistical power can improve reliability of quantitative biological studies. We can
obtain higher statistical power by increasing threshold of Cohen’s ES filter.
First, our approach calculates Cohen’s f and w for each comparison
between experiment groups for every individual feature[129,135]. Cohen’s f is
for one-way ANOVA F-test using quasi-Poisson (QP) or Normal distribution
(Normal). Cohen’s w is linked to the Chi-square likelihood-ratio test (LR-test) for
comparing goodness of fit of two generalized linear models based on negative
binomial distribution (NB). Those three, QP, Normal and NB, are widely used
distributions for treatment comparisons in biological data.
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Next, the minimum Cohen’s f and Cohen’s w are calculated for desired
statistical power, typically 90%, and alpha, typically 0.05, by using power analysis
function[129,131]. Features having Cohen’s f or w below the obtained minimum
are filtered out.

This gives a statistical basis to determine ES threshold by

considering sample size, significance and statistical power. In addition to the
statistical benefits, our approach can maintain the level of statistical power by
filtering out low-powered hypotheses tests.
We incorporated these concepts in an R package named ‘selfea’, freely
available on CRAN. To test if its performance was significantly better than
traditional FC approach, we employed benchmark data, generated by Gregori et
al[126], because it has clear true positive (TP) and false positive (FP)
identifications.

Gregori data consist of 19 label-free liquid chromatography-

tandem mass spectrometry (LC-MS/MS) runs and have 4 groups that have a
fixed loading amount of standard yeast lysates (500 ng) with different amounts of
39 purified standard human proteins (100, 200, 400 and 600 fmol). Theoretically,
the human proteins should show significant quantitative differences over the 4
groups while yeast proteins should not. As is assumed by Gregori et al[128], we
counted human proteins as TP and yeast proteins as FP in signatures of Gregori
data. At FDR[110]-adjusted p-value (FDR) < 0.05, we compared Cohen’s ES (>
0.90 power ) to 2-FC (> 2-fold change) (Fig. 26). We chose 90% power for ES
threshold because it is the level p-value requires for being reliable evidence[123].
We picked maximum FC as representative FC and minimum statistical power as
representative statistical power.
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Figure 26 Testing result with Gregori data and fecal proteome data. A)
Statistical power, B) the number of true positives (human proteins) and C) the
number of false positives (yeast proteins) in significant protein list of Gregori data
benchmark test for 6 method sets, QP_F, QP_FC, NB_W, NB_FC, NOR_F and
NOR_FC described in table 13. FDR thresholds for QP, NB and NOR are 0.05
and Cohen’s ES (f and w) threshold is 90% statistical power. Scatter plot of 39
human (red) and 646 yeat (blue) proteins comparing D) Cohen’s w and FC, E)
Cohen’s f and FC, F) QP model and Cohen’s f, G) NB model and Cohen’s w and
H) NOR model and Cohen’s f.
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A)

B)

C)

D)

E)

F)

G)

H)

Figure 26 continued.
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Benchmark test
Tests using Gregori data
We compared 2-FC and Cohen’s ES for three models (QP, NB and NOR)
using the benchmark data (Table 13). The benchmark data test showed that our
approach has significantly better statistical power than 2-FC, 0.90 for Cohen’s ES
vs. 0.08~0.59 for 2-FC (Fig. 26A).

Cohen’s ES has similar number of true

positives (TP) (Fig. 26B), while it has a lower number of false positives (FP) (Fig.
26C). This means that Cohen’s ES lost fewer of TP while filtering out many more
FP than 2-FC.
Protein scatter plots show that Cohen’s ES filters out FP efficiently.
Cohen’s w (Fig. 26D) and Cohen’s f (Fig. 26E) could remove more FP (blue dots)
while excluding less number of TP (red dots). Especially, Cohen’s f has superior
selection power than Cohen’s w and 2-FC (Fig. 26E). Also, Cohen’s f showed
that it could complement p-value by efficiently removing FP (Fig. 26F and 26H),
while 2-FC removed a smaller number of FP (Fig. 27A-C).

Relatively low

performance of Cohen’s w and NB (Fig. 26G) is speculated that these are not fit
to the benchmark data. Nevertheless, Cohen’s w showed better selection power
than 2-FC (Fig. 26A-C).
Tests using fecal proteome data
We also compared the statistical methods with a more complex and real
human dataset that is noisier than the well-organized benchmark data.
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Table 13 Six methods used for comparing Cohen’s ES and FC.

Three

probability models, widely used in biological data analysis, were employed for
comparison of Cohen’s ES with FC.

FC2
(> 2-fold change)
Cohen’s f
(> 90% power)
Cohen’s w
(>90% power)

Quasi-Poisson
model (QP)
(< 0.05 FDR)
QP_FC2

Negative binomial
model (NB)
(< 0.05 FDR)
NB_FC2

Normal ANOVA
model (NOR)
(< 0.05 FDR)
NOR_FC2

QP_F

-

NOR_F

-

NB_W

-
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Figure 27 Protein scatter plots comparing three models and FC.

False

positive yeast proteins (blue color cross) and true positive human proteins (red
color dot) were distributed on the plain of A) FDR-adjusted p-value of QP model
and FC, B) FDR-adjusted p-value of NB model and FC and C) FDR-adjusted pvalue of Normal model and FC. Vertical line is 2-FC and horizontal line is 0.05
FDR. Red-colored left-bottom section, divided by vertical and horizontal lines, is
filtered by 2-FC after probability filter (FDR < 0.05). Little or none of FPs (blue
dots) is removed by 2-FC.
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A)

Figure 27 continued.

107

B)

Figure 27 continued.
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C)

Figure 27 continued.
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The dataset, termed here as fecal proteomes, have 29 2D-LC-MS/MS runs from
11 fecal samples from healthy adult volunteers (chapter 4). The fecal proteome
is extremely complex having proteins coming from both human and bacterial
origin, over a wide dynamic range, and high variability between individuals.
Since we can’t know TP and FP of fecal proteomes, we compared statistical
power between Cohen’s ES and 2-FC (Fig. 27). Similar to Gregori data, Cohen’s
ES had higher statistical power than 2-FC (0.90 for Cohen’s ES vs. 0.16 ~ 0.70
for 2-FC).
Monte Carlo simulation
After the verifications of our method using the benchmark and actual
experiment data, we explored our method via the Monte Carlo simulation (MC).
We generated random data based on Poisson distribution with mean expression
level of each groups in Gregori data. Then, we calculated statistics and counted
TP and FP. These simulations were repeated 1,000 times in order to investigate
how much our approach is effective. The simulation results are summarized and
illustrated in Fig. 2. We could confirm that Cohen’s ES have better power (0.90
for Cohen’s ES vs. 0.06~0.55 for 2-FC) (Fig. 28A), reduced FP greatly (29~32 for
Cohen’s ES vs. 70~114 for 2-FC) (Fig. 28B) and lost fewer TP (20 for Cohen’s
ES vs. 27~32 for 2-FC) (Fig. 28C) when compared with 2-FC. FP rate is the
probability of falsely rejecting the null hypothesis and is calculated by FP divided
by total number of yeast proteins in Gregori data.
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A)

B)

C)

D)

Figure 28 Boxplots of 1,000 times Monte Carlo simulation of Gregori data.
A) Statistical power, B) the number of false positives (yeast proteins), C) the
number of true positives (human proteins) and D) FP Rate, FP/(FP+TN), of 1,000
times Monte Carlo simulation, based on Gregori data, for 6 method sets, QP_F,
QP_FC, NB_W, NB_FC, NOR_F and NOR_FC described in table 13.

FDR

thresholds for QP, NB and NOR are 0.05 and Cohen’s ES (f and w) threshold is
90% statistical power. TN: True Negative (The number of total yeast proteins in
Gregori data – FP).
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Cohen’s ES has a smaller FP rate than 2-FC (< 5% of Cohen’s ES vs. > 11% of
2-FC), which means that our method is better at discerning FP than 2-FC (Fig.
28D). Similar to Gregori data, Cohen’s ES had higher statistical power than 2-FC
(0.90 for Cohen’s ES vs. 0.16 ~ 0.70 for 2-FC).
Monte Carlo simulation
After the verifications of our method using the benchmark and actual
experiment data, we explored our method via the Monte Carlo simulation (MC).
We generated random data based on Poisson distribution with mean expression
level of each groups in Gregori data. Then, we calculated statistics and counted
TP and FP. These simulations were repeated 1,000 times in order to investigate
how much our approach is effective. The simulation results are summarized and
illustrated in Fig. 2. We could confirm that Cohen’s ES have better power (0.90
for Cohen’s ES vs. 0.06~0.55 for 2-FC) (Fig. 28A), reduced FP greatly (29~32 for
Cohen’s ES vs. 70~114 for 2-FC) (Fig. 28B) and lost fewer TP (20 for Cohen’s
ES vs. 27~32 for 2-FC) (Fig. 28C) when compared with 2-FC. FP rate is the
probability of falsely rejecting the null hypothesis and is calculated by FP divided
by total number of yeast proteins in Gregori data. Cohen’s ES has a smaller FP
rate than 2-FC (< 5% of Cohen’s ES vs. > 11% of 2-FC), which means that our
method is better at discerning FP than 2-FC (Fig. 28D).
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Conclusion
P-values should not be the only piece of information used to discern
reproducible findings in biological studies. Although effect size filters can
complement p-value information, fold-change, widely used effect size in
biological data analysis, is not sufficient. We suggest using Cohen’s effect sizes
at a desired statistical power. The benchmark test and MC simulation show that
our method can reduce a number of FP while losing relatively small number of
TP. This drop of FP is meaningful because many published research findings
are concerned by potential false positives due to misused statistical approaches
including low statistical power[124,136].

In addition to QP, NB and NOR,

Cohen’s ES can be associated with another type of probability-based method,
such as QProt[137], and showed good selection power when compared to 2-FC
(Fig. 27). We believe that Cohen’s ES can help biologists to report reproducible
discoveries. Even though selfea was tested only for label-free proteomics data,
we believe that it can be applied to other type of biological data, such as RNA
sequencing.
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CHAPTER IV
APPLICATION CASE 1 – HUMAN FECAL PROTEOME STUDY
Introduction
Microbes inhabit every part of human body including the skin, the gut,
mouth and the nose.

Sometimes they cause illness, but most of the time,

microorganisms commensally live with their human host organs. The number of
microbes in symbiosis with human is estimated to 100 trillion, while we have 10
trillion cells, thus outnumbering human cells by 10 to 1. The microbes are not just
living in human body, but they are interacting and playing a vital role in human
health and diet [138].

In recent years the human gut microbiome, all the

microbes living in human gastrointestinal tracts, has become an area of heavy indepth research by a large number of labs across the planet. Many of research
groups applied a wide range of analytical technologies for understanding
microbiome’s role in human health and how they interact with human host cells
[139,140]. Also, gut microbiota are known to be associated with disease states,
such as inflammatory bowl disease [140] and type-2 diabetes [141].

Since

microbiome has unique microbial communities related to human health, the
microbiome is an important target for metaproteomics [142].
Typically, metaproteome studies of gut microbiota have focused on fecal
samples because feces are considered a direct proxy for the gastrointestinal
tract.

Furthermore, fecal material has a large amount of microbial proteins,

convenience of sample collection interplay between the immune response of
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human intestinal cells and microbiome [143]. Also, feces have abundant host
proteins, so it enables us to explore biomarkers of disease and interactions
between microbes and human cells.

Therefore, fecal metaproteomics has a

great potential for disease diagnostics, studying host-microbes interaction and
microbial community cohabiting in gastrointestinal tracts.
Fecal metaproteomics has several unresolved problems that must be
overcome before it can really be used in biomarker studies, disease state
prediction, etc. First, we don’t know the overall diversity of microbes inhabiting
the fecal material. In other words, species composition of microbiome is not
uncovered. This is important issue to PSM search. However, many studies have
resolved this uncertainty by employing metagenome sequence directly from fecal
material [142-144].

Another challenge is variation of individual microbiomes.

Naturally, people have different microbiome due to diets, origin, drugs and
genetic backgrounds. Probably, personal microbiome may be the most varying
organ in entire human body, if the microbiome is considered as a 13th organ. We
are not sure if there is normal microbiome shared by all the people. This large
variation of the microbiome may make effective metaproteomics difficult.
The potential high variation of fecal proteomes will make the statistical
analysis of resultant datasets difficult. Indeed, sample size is very limited for
many biological studies due to finite budget and time; hence low statistical power
is ineluctable destiny of biology researches conducted by small labs including
fecal metaproteomics studies.

At low-powered studies, high variance within

biological replicates, caused by dissimilar microbiomes corresponding to different
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environmental factors, impedes obtaining reproducible results via comparison
between different individuals, disease states or diets. Thus the chance of false
positive findings may be relatively high in fecal metaproteomics. This application
study shows if there is large variation within fecal proteomes from healthy
volunteers and how QFAM can be employed to analyze such a dataset.

Methods
Sample preparation and LC-MS/MS experiment
Proteins from all fecal samples were extracted by the direct cell lysis
method (Fig. 29). Direct cell lysis method is preferred to collect host proteins,
while indirect method is better for microbial proteins. Proteins of all the samples
were digested by trypsin and analyzed via two-dimensional (2D) nano-LC MS/MS
system with a split-phase column (SCX-RP) Velos Orbitrap Pro (Thermo Fisher
Scientific) for feces and LTQ-Velos (Thermo-Fisher) for PBMC with 22 hour runs
per sample as shown in Figure 29. The Orbitrap settings were as follows: 30K
resolution on full scans in Orbitrap, data-dependent MS/MS in LTQ (Top 10
peaks were chosen), two micro-scans for both full and MS/MS scans, centroid
data for all scans.
PSM search and protein identification
All MS/MS spectra were searched against our customized sequence
database.
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Figure 29 Experiment workflow of fecal metaproteome data generation.
This illustration was adapted from Xiong et al [143].
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Our database consists of human protein sequences, microbial proteins isolated
from human gut and common contaminants (i.e., trypsin and keratin; 36 protein
sequences). We collected ~36,000 human protein sequences from NCBI RefSeq
DB and microbial proteins databases from JGI IMG human microbiome project
(http://img.jgi.doe.gov/) as is described in our previous paper [95]. For PBMC
samples, we used human protein sequences only for the MS/MS search while
microbiome proteins were included in the DB used for MS/MS search of fecal
samples. All MS/MS individual runs were searched with the SEQUEST (v.27)
algorithm [68] against our customized FASTA sequence database.

Search

parameters were followed to our prior study (<4 miscleavages, 3 Da mass
tolerance window around the precursor ion mass and 0.5 Da for fragment ion
masses). All SEQUEST output files were gathered and filtered using DTASelect
(1.9) [86] at ≥ 2 peptides per protein and the following widely accepted
parameters for all the MS runs: XCorr of at least 1.8, 2.5, 3.5 for +1, +2, and +3
charge states, respectively and a minimum deltCN for 0.08.

All the peptide

spectrum matches (PSM) that could not satisfy a post-database search filter, 10≤ ppm ≤10, were excluded out to remove false positives as described in
previous study [95]. In this study, only human proteins were analyzed, but we
included microbial proteins in the FASTA database to remove false positives.
We calculated spectral counts of human proteins via DTASelect. We removed
redundant protein sequences in the result proteome using NCBI Entrez Gene
[116] so that one gene symbol have one sequence. Spectral counts (SC) were
normalized by scaling factor αi for i-th protein described as below:
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Where N = the number MS runs, n = the number of proteins, SC is spectral
counts of i-th protein in j-th MS run.
Statistical analyses
All the statistical analysis including hierarchical clustering were done by R
version 3.1.0 and Python 2.7.3 in-house scripts. We used vegan, cluster, psych
and gclus library of R to calculate distances between MS runs and draw
dendrogram.

To maximize clustering efficiency we calculated Cophenetic

correlation coefficient and Gower similarity coefficient of several distance
methods, such as single linkage, complete linkage, Unweighted pair-group
method using arithmetic averages (UPGMA) and Ward’s minimum variance
matrixes.

UPGMA matrix shows highest Cophenetic correlation coefficient

(93.3%), so we used UPGMA for hierarchical clustering. Pearson correlation
coefficients (PCC) between 29 MS runs were calculated by in-house R scripts.
Shapiro-Wilk normality test was used to test our dataset if it is following Normality
using shapiro.test function of R.
The proteomics results were also analyzed by using ‘selfea’ R package,
described in chapter 3, providing quasi-Poisson Generalized Linear Modeling
(QP) and Cohen’s f [145].

We applied QP model to find significantly varied
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proteins in 11 fecal proteomes.

Poisson distribution is usually assumed to

analyze frequency-based data like spectral counts [97].

However, Poisson

distribution assumes that its parameter λ = E(X) = Var(X).

Because of the

assumption, Poisson distribution cannot bear over-dispersion. Quasi maximum
likelihood approach can alleviate Poisson test’s less flexibility by employing
variance function based on given data [97]. Our QP model is Spectral count ~
Fecal sample. P-value was calculated by QP model and adjusted by BenjaminiHochberg method (FDR) [110]. Cohen’s f was used as effect size filter. Cohen’s
f is ES linked with ANOVA F-test, which was used for QP model comparison.
Important advantage of using Cohen’s f is that we can filter out underpowered
hypotheses tests.

P-value cannot play its statistical evidence role at low

statistical power (< 90%)[123,124]. Selfea provides minimum Cohen’s f at 90%
statistical power and reliable results using ES filter and FDR filter. Cohen’s f is
calculated as described below:

𝑓 =   

!
!!! 𝑝!

𝜇! − 𝜇
𝑀𝑆𝐸

!

Where, pi = N/ni, k = the number of groups, ni = the number of observation in
group i, N = total number of observations, µi = mean of group i, µ = grand mean
over all the observations, and MSE = mean square error. The minimum Cohen’s
f at 90% statistical power was 1.3769 given sample size and p-value 0.05
threshold. We accepted proteins that have bigger Cohen’s f than 1.3769 and
less than 0.05 FDR for further analysis.
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Functional analysis of fecal proteome was done by enrichment test and
significance test. These analyses were done by in-house Python and R script.
We annotated the dataset with GO terms [115] for human proteins and Cluster of
orthologous genes (COG) terms [146] for microbial proteins. GO terms were
downloaded from NCBI BioSystems database [106] via FTP. COG terms were
assigned to fecal microbial proteins by using COGSoftware [120]. We followed
steps recommended by COGSoftware to identify COG terms. With COG and GO
terms, we conducted enrichment test using Fisher’s exact test and significance
test using selfea. Same filtering threshold, FDR < 0.05 and Cohen’s f > 1.3769,
were applied to find significant GO and COG terms.

Results
Data generation from 11 fecal and 5 PBMC samples
The 11 healthy volunteer fecal samples metaproteomic datasets were
generated by nano 2D-LC-MS/MS on an OrbiVelos Pro (Thermo-Fisher). Of
these 11 samples four were duplicated and others were triplicated, for a total of
29 MS run.. The datasets were searched against human NCBI RefSeq and 21
microbes

isolates

from

human

gut,

downloaded

(http://img.jgi.doe.gov/), by using SEQUEST/DTASelect.

from

JGI

IMG

From these 29 MS

runs, we were able to identify 7,455 proteins, 2,102 human proteins and 5,353
microbiome proteins, after excluding out of redundant sequences using NCBI
Entrez Gene DB (Table 14).
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Table 14 Comparison of MS runs of fecal sample and PBMC. The number of
identified proteins was counted for fecal human, microbiome and PBMC human
data. Unshared proteins were uniquely identified in only one sample.
Feces
Total number of proteins
The number of MS Runs
Average number of proteins
detected/MS run
Average number of unshared
proteins
% of unshared proteins

PBMC

Human

Microbiome

Human

2,102
29
501

5,353
29
1,688

2,556
5
1,278
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213

158

22.88%

12.61%

12.37%

These redundant protein sequences have same spectral counts (SC) due to
short and redundant trypsin-digested peptides.

SC of 7,455 proteins were

normalized by scaled factor (αi) that is average number of total SC per run (N)
divided by sum of SC of run i (ni) as is used in our previous study of Crohn
disease [95]. This normalization makes 29 MS runs to have same total number
of PSMs.
We also collected five peripheral blood mononuclear cell (PBMC)
samples. PBMC is any blood cell that has a round nucleus, such as lymphocyte,
a monocyte or a macrophage. We applied same pre-processing steps to five
PBMC runs such as, normalization by total spectral counts and reduction of
redundant protein sequences by NCBI Gene ID. Finally, 2,556 human proteins
are identified from five PBMC replicates (Table 14). In terms of the number of
identified human proteins, PBMC has two times more proteins per MS run than
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feces, 501 in feces vs. 1,278 in PBMC, (Table 14).

Unshared proteins are

uniquely identified in only one sample. Percentage of unshared human proteins
in fecal samples is almost two times that of fecal microbiome and PBMC human
proteins (Table 14).

More than 20% of human fecal proteins are uniquely

identified from 11 healthy volunteers, which means that on average one fifth of
human fecal proteins are not shared.
Comparison of 29 fecal and 5 PBMC MS runs
All the fecal samples were collected from healthy volunteers who do not
have any of gastrointestinal disorders or other known disease states.

To

understand how their fecal proteomes are different, we first compared 29 MS
runs in a broad sense using hierarchical clustering method (Fig. 30). Unweighted
pair-group method using arithmetic averages (UPGMA) was used to calculate
distance between MS runs because its Gower similarity coefficient is lower than
other metrics, such as complete, average and single linkage metrics.

The

dendrogram of figure 30 shows that technical replicates of 11 fecal samples are
clustered together (Fig. 30), which means technical replicates are not biased nor
highly varied neither. Pearson correlation coefficients (PCC) between technical
replicates confirm their similarity ranged from 0.75 to 0.98, which means closely
correlated data (Fig. 31A).
In contrast to technical replicates’ high similarity, all the individual donors
of fecal proteomes are dissimilar with each other.
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Figure 30 Hierarchical clustering of 29 MS runs of 11 fecal samples.
Technical replicates are closely clustered together, which means small variance
within technical replicates.
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A)

B)

C)

Figure 31 Correlation coefficients between fecal and PBMC MS runs.
Pearson correlation coefficients between A) technological replicates of fecal
samples, B) biological replicates of PBMC samples and C) biological replicates of
fecal samples.
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In addition to hierarchical clustering result, we could confirm this dissimilarity
from comparing PCC between biological replicate MS runs.

PCC between

biological replicates of feces are ranged from 0.15 to 0.81 (Fig. 31C).

A

difference between maximum and minimum PCC is 0.23 in technical replicates,
but 0.66 in biological replicates. Moreover, minimum PCC in technical and in
biological replicates ws much different, 0.77 for technical replicates and 0.10 for
biological replicates. Also, average PCC of biological replicates is 0.50 that is
much lower than one of technical replicates (0.91).

PCC in the biological

replicates is relatively low and widely ranged. This shows the diversity between
individual fecal proteomes.

The highest PCC of biological replicates, 0.81, is

similar to the lowest PCC of technical replicates, 0.77, showing dissimilarity of
biological replicates and high similarity of technical replicates.
Comparing PCC of biological replicates between feces and PBMC
proteome confirms that the heterogeneity of fecal proteome is especially high.
PCCs between PBMC biological replicates are ranged from 0.62 to 0.95 (Fig.
31B). This range is much narrower and relatively higher than the fecal proteome
(PCC: 0.15~0.81). The difference between minimum and maximum of PCC in
PBMC is 0.33 that is half of the fecal proteome, 0.66. Also, minimum PCC of the
fecal proteome, 0.15, is one fourth to one of PBMC, 0.62. All in all, we could see
high variability in individual human fecal proteomes when compared to PBMC.
In addition to PCC comparisons, frequency of protein identifications within
11 fecal samples shows non-uniformity in protein identifications (Table 15). We
counted how many times proteins were identified in 11 fecal samples.
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Table 15 Protein identification frequency in fecal and PBMC proteomes.
Protein
Frequency

1
2
3
4
5
6
7
8
9
10
11
Total

Fecal Human

PBMC Human

Fecal Microbiome

# of
% of
# of
% of
# of
% of
proteins frequency proteins frequency proteins frequency
1,261
59.99%
947
37.05%
2,342
43.75%
287
13.65%
540
21.13%
738
13.79%
116
5.52%
342
13.38%
479
8.95%
86
4.09%
299
11.70%
315
5.88%
64
3.04%
428
16.74%
233
4.35%
32
1.52%
226
4.22%
30
1.43%
175
3.27%
32
1.52%
158
2.95%
37
1.76%
140
2.62%
54
2.57%
236
4.41%
103
4.90%
311
5.81%
2,102 100.00%
2556 100.00%
5,353 100.00%

Surprisingly, of overall 7,455 proteins, the number of proteins with frequency 1 is
3,603, which means that almost half of total proteins are not redundantly
detected in 11 healthy volunteers (Table 15).

This percentage of unshared

proteins is increased up to 60% in human proteins (Table 15). This 60% is much
higher than one of PBMC, 37%. As protein frequency is increased, the number
of proteins is drastically decreased in fecal samples, 60% to around 1%, when
compared to PBMC samples, 37% to about 12% (Table 15). It is significant that
almost 74% of human fecal proteins were discovered just once or twice in 11
fecal samples (Table 15). PCC comparison and identification frequency of fecal
proteins shows its seriously high dissimilarity.
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Human proteins in 11 fecal proteomes
Even though many of human fecal proteins are low abundant and
unshared, about one hundred proteins were repeatedly and abundantly identified
in 11 healthy volunteers (Table 15). Many of these high-spectral-count proteins
are related to digestion, such as chymotrypsin like elastases (CELA3A and
CELA3B), alpha-amylases (AMY1A, 1B, 1C and 2A), trypsins (PRSS1 and
PRSS2) and chymotrypsinogen B (CTRB1 and CTRB2) (Table 16).

Also,

immune response related proteins are frequently spotted such as, IgG Fc binding
protein, DBMT1 that is related to innate immunity [147,148], SERPINA3 that is
related to inflammation [149] and PIGR that is polymeric immunoglobulin
receptor precursor (Table 16). Polyubiquitin-C (UBC) is also in top-25 list and is
related to innate immunity according to Gene Ontology DB (GO) [115].
Polyubiquitin B, isoform of UBC, is also discovered in all the fecal samples.
Various myosin isotypes were found in fecal proteomes, such as myosin type 1,
2, 4, 6 and 8 (Table 16). Interestingly, transthyretin precursor (TTR) is copiously
identified in 11 fecal samples. TTR is thyroid hormone-binding protein and is
considered that it transports thyroxine from the bloodstream to the brain. TTR is
found in various tissues including colon muscle according to Proteomics DB [31].
We searched top 25 abundant proteins of table 16 using Human Proteome
Map (Fig. 32A) [150] and Proteomics DB (Fig. 32B) [31] to know where these
came from. Human Proteome Map is a database that has proteins profiled from
17 adult tissues, 6 primary hematopoietic cells and 7 fetal tissues.
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Table 16 Top 25 abundant human proteins in 11 fecal samples.

“ * ”:

Immune response related proteins, “Frequency”: Identification frequency in 11
fecal samples of healthy volunteers and “Sum of SC”: total count of SC from 29
MS runs.
Rank

Gene Symbol

Description

1

CELA3A

2
3

*FCGBP
*DMBT1

4
5

SERPINA1
AMY2A

6
7
8
9

AMY1A
AMY1B
AMY1C
CELA3B

10
11
12
13
14
15
16
17
18
19
20
21
22
23

AMY2B
MYH2
MYH1
TTR
PRSS1
MYH4
MYH8
UBC
PRSS2
MYH6
MYH7
CTRB2
CTRB1
*PIGR

24

*IGLL5

25

*SERPINA3

Chymotrypsin-like elastase
family member 3A preproprotein
IgGFc-binding protein precursor
Deleted in malignant brain
tumors 1 protein isoform c
precursor
Alpha-1-antitrypsin precursor
Pancreatic alpha-amylase
precursor
Alpha-amylase 1 precursor
Alpha-amylase 1 precursor
Alpha-amylase 1 precursor
Chymotrypsin-like elastase
family member 3B preproprotein
Alpha-amylase 2B precursor
Myosin-2
Myosin-1
Transthyretin precursor
Trypsin-1 preproprotein
Myosin-4
Myosin-8
Polyubiquitin-C
Trypsin-2 preproprotein
Myosin-6
Myosin-7
Chymotrypsinogen B2 precursor
Chymotrypsinogen B precursor
Polymeric immunoglobulin
receptor precursor
Immunoglobulin lambda-like
polypeptide 5
Alpha-1-antichymotrypsin
precursor [Homo sapiens]
129

Frequency

Sum of
SC
11 7,562.19
11 5,582.98
11 4,793.61
11 4,089.48
9 3,367.48
9
9
9
11

3,225.87
3,225.87
3,225.87
3,176.00

9
11
11
10
11
11
11
11
11
11
11
10
10
10

3,015.61
2,067.20
1,984.50
1,860.49
1,654.03
1,577.53
1,572.74
1,568.63
1,178.51
1,134.14
1,126.16
1,041.42
997.56
950.77

11

938.32

11

935.14

Figure 32 Expression location of top 25 abundant human fecal proteins.
Origin of fecal proteins were estimated by two databases, A) Proteomics DB and
B) Human Proteome Map.
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A)

Figure 32 continued.
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B)

Figure 32 continued.
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Proteomics DB is developed by Technische Universität München (TUM) and
dedicated to deposit and share proteomics data to the scientific community. We
compared our top-25 list to Proteomics DB through its provided analysis tool.
The most frequently matched tissue in Proteomics DB is colon (22 proteins) and
pancreas (19 proteins) (Fig. 32A), whereas is adult pancreas (16 proteins) and
adult gallbladder (14 proteins) in Human Proteome Map (Fig. 32B).
All those tissues, frequently matched in both of Proteomics DB and
Human Proteome Map are related with digestion. MYH1, MYH7 and MYH8 are
not detected in colon tissue of Proteomics DB, but these are previously identified
in esophagus among digestion related tissues. Therefore, we guess that MYH1,
MYH7 and MYH8 come from esophagus unlike other isotypes of myosins. Many
tissues involved in the digestion are found in the search result of Proteomics DB,
such as colon muscle, saliva, salivary gland, rectum, pancreatic juice, pancreas,
oral epithelium, esophagus and colon (Fig. 32B).

Besides tissues on the

digestion tract, immune response related cells are spotted in the result of
Proteomics DB and Human Proteome Map (Fig. 32). Some of proteins in the
top-25 list are reported that these are expressed in Natural killer cell, monocyte,
helper T-cell, cytotoxic T-cell and B-lymphocyte according to previous studies of
Proteomics DB (Fig. 32B).

Human Proteome Map also shows similar result

including B cells, CD4+ T cells, CD8+ T cells, NK cells and Monocytes (Fig. 32A).
On top of proteins related with digestion, proteins associated with immune
response were also repeatedly identified in the 11 fecal samples. We expected
that feces have abundant immune proteins because of innate and adaptive
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immune responses against microbiome, pathogens or vaccines.

Immune

proteins were recognized by combining several annotation resources that are
WikiGO [12], Immunome [151,152], Innate DB [153], 19 immune response GO
terms [154] and immune response keyword search against protein description,
such as immunoglobulin and IgA that were missed by other methods. Of 2,102
total human fecal proteins, 214 immune response proteins were discovered. We
recognized frequently and abundantly identified 25 immune proteins in table 17.
IgGFc-binding protein precursor (FCGBP) is the most abundant protein in table
17. FCGBP is not directly related to immune response, but it is interacting with
FC portion of IgG and indirectly involved in the mucosal immunity by making gellike mucosa [155]. FCGBP also interacts with Mucin-2 (MUC2) [156] and is
expressed at colon, colon epithelium, colon muscle and gut according to
Proteomics DB (Fig. 32B). Some of inflammatory proteins, such as S100-A8,
S100-A9, lactotransferrin (LTF) and Keratin type II cytoskeletal 1 (KRT1) were
copiously detected in the fecal proteomes.

LTF is antimicrobial protein by

removing essential substrate required for bacterial growth and stimulateTLR4
signaling pathway [157,158]. KRT1 is also reported that it is involved in the
inflammatory network in a skin by interacting with interleukin-18 [159]. S100A8
binds to S100A9 in order to be heterodimer named as Calprotectin that is
secreted by Neutrophils and acts as important pre-inflammatory mediator in
acute and chronic inflammation [160].

IGLL5 and IGJ are immunoglobulin

subtypes, detected in the fecal proteome. IGLL5’s function is not clarified while
IGJ is known to interact with IGA and IGM to form polymers.
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Table 17 Top 25 abundant immune response proteins in 11 fecal samples.
Frequency is identification frequency in 11 fecal samples of healthy volunteers.
“Sum of SC” is total count of SC from 29 MS runs.

“Freq.” is identification

frequency in 11 fecal samples. “Sources” is immune protein annotation source.
Gene
Symbol
FCGBP

Description

Freq.

IGJ

IgGFc-binding protein
precursor
Deleted in malignant brain
tumors 1 protein isoform c
precursor
Immunoglobulin lambdalike polypeptide 5
Alpha-1-antichymotrypsin
precursor
Polymeric immunoglobulin
receptor precursor
Immunoglobulin J chain

S100A9

Protein S100-A9

DMBT1
IGLL5
SERPINA3
PIGR

Sum of
Sources
SC
11 5,582.98 Keyword
11 4,793.61 WikiGO, GO term,
Innate DB
11

950.77 Keyword

11

938.32 WikiGO

10

935.14 WikiGO, Keyword

10

729.67 WikiGO, GO term,
Immunome,
Keyword
636.55 WikiGO, GO term,
Innate DB
414.82 WikiGO,
Immunome

11

CEACAM5

Carcinoembryonic
antigen-related cell
adhesion molecule 5
preproprotein
GP2
Pancreatic secretory
granule membrane major
glycoprotein GP2 isoform
4
CEACAM1 Carcinoembryonic
antigen-related cell
adhesion molecule 1
isoform 2 precursor
LGALS3BP Galectin-3-binding protein

11

DEFA1

Neutrophil defensin 1
preproprotein
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10

414.06 GO term, Innate
DB

11

395.66 WikiGO, Innate
DB, Immunome

11

369.90 WikiGO

11

293.57 WikiGO, GO term,
Innate DB,
Immunome

Table 17 continued.

Gene
Symbol
DEFA3

Description

LTF
MPO

Lactotransferrin isoform 1
precursor
Myeloperoxidase

LYZ

Lysozyme C precursor

9

KRT1

Keratin, type II
cytoskeletal 1
Serum albumin
preproprotein
Protein S100-A8

8

Sum of Sources
SC
273.66 WikiGO, GO term,
Innate DB,
Immunome
227.05 WikiGO, GO term,
Immunome
224.96 WikiGO, GO term,
Immunome
214.56 WikiGO,
Immunome
196.43 WikiGO, GO term

8

187.45 WikiGO

8

172.26 WikiGO, GO term,
Innate DB,
Immunome
167.92 WikiGO,
Immunome

ALB
S100A8
CEACAM6

Freq.

Neutrophil defensin 3
preproprotein

11
7
10

Carcinoembryonic
antigen-related cell
adhesion molecule 6
precursor
Dipeptidyl peptidase 4

10

9
10

DEFA5

Annexin A2 isoform 1
Aminopeptidase N
precursor
Defensin-5 preproprotein

CTSG

Cathepsin G preproprotein

DPP4
ANXA2
ANPEP

6

5

136

8

150.79 WikiGO, GO term,
Immunome
142.79 Innate DB
137.01 WikiGO,
Immunome
108.09 WikiGO, GO term,
Innate DB,
Immunome
101.60 WikiGO, GO term,
Innate DB,
Immunome

Even though IGA and IGM were not found in 11 fecal proteomes, we can
speculate that there are IGA or IGM from IGJ identification.

CEACAM5,

CEACAM1 and CEACAM6 are another immunoglobulin superfamily called as
CEA family. They are glycoprotein and their function is not clearly known, but
CEACAM5 is reported that it is located on the cell surface and stimulates
intracellular signaling by binding to adhesins of Escherichia coli [161].
Quasi-Poisson model construction using QFAM
After we confirmed variation of the fecal proteome by PCC and protein
frequency, we constructed a linear regression model of the fecal proteins in order
to find proteins significantly varied in 11 fecal proteomes. Since protein spectral
counts of our proteome dataset deviate from Normality (Shapiro-Wilks normality
test p-value = 2.2E-16) and are frequency-based data, we employed Poisson
distribution via Generlized Linear Model (GLM) for hypothesis tests. Poisson
distribution is usually assumed to analyze frequency-based data like spectral
counts and shows better or equal performance for label-free proteomics data
than other methods, such as Fisher’s exact test, G-test, student’s t-test
[97,137,162]. However, Poisson distribution has less-flexibility to over-dispersion
in terms of empirical fitting because of its assumption that its parameter λ = E(X)
= Var(X). GLM can handle non-normal response variables and Quasi maximum
likelihood (QP) approach can alleviate Poisson test’s less flexibility by employing
variance function based on given data [97]. We used F-test to calculate p-values
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that were adjusted by False Discovery Rate (FDR) method to correct multiple
hypothesis testing [110].
In addition to QP model, we also calculated fold changes (FC) from all the
possible pairs of 11 fecal samples and picked maximum-FC as representative FC
of a protein because hypotheses test and fold change filtering can give us better
selection power [126]. Interestingly, maximum-FC of all the 7,455 fecal proteins
is over 2-fold change. Since many of fecal proteins are sparsely identified, many
of proteins have infinite FC even though these are identified in only one fecal
sample at low level of SC. Thus, we utilized another type of effect size, Cohen’s
f [145], to figure out how much different is reliable when considering sample size,
significance threshold (FDR < 0.05) and desired statistical power (power > 90%).
Statistical power is a probability rejecting correctly null hypothesis when it is
false. The certain level of power (90%) is required to correctly find significant
proteins [123]. Cohen’s f is designed for ANOVA’s F-test and was used to keep
our model to have enough statistical power, 90%, given samples size and
significance level. Minimum Cohen’s f for effect size filter was obtained by power
analysis. The minimum Cohen’s f for effect size filter is 1.3769 for 29 samples of
11 healthy volunteers for 90% power and 0.05 significance level. By combining
QP and effect size filter, of total 7,455 fecal proteins, 1,610 proteins were
categorized as differentially identified fecal proteins from 11 fecal proteomes (Fig.
33).

Of significant 1,610 proteins, 355 proteins are from human and 1,255

proteins are from microbiome.
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Figure 33 Protein scatter plot of human fecal proteome comparison. Blue
dots are significantly categorized proteins, while red dots are proteins that could
not passed two thresholds, FDR < 0.05 and Cohen’s f > 1.3769.
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More than 20% of total fecal proteins are significantly varied at 5% false
positive level and 90% statistical power. This is not comparison between control
and treatment group, but examining changes within biological replicates of
healthy normal volunteers. Studies using fecal samples should consider high
within-group variance.

High variance within replicates affects on comparison

between different experiment groups. To analyze highly varied data like fecal
proteomes, many biological and technical replicates are required. Otherwise,
strict threshold should be applied and reliable statistical methodology is required.
Functional analysis using QFAM
We analyzed fecal proteins in terms of functional terms, such as gene
ontology (GO) [115] enrichment test for human proteins and cluster of ortholog
groups (COG) [146] analysis for microbiome proteins, so that we understand
metabolic functions of identified human fecal proteins. GO and COG terms are
widely used to get to know functional features of proteomics data [163,164].
COG and GO terms were enriched over all the human fecal proteins by
using Fisher’s exact test. P-values of the enriched COG and GO terms were
adjusted by FDR. Also, significance test was conducted by employing QP model
and transferring SC of member proteins to COG and GO terms. Significantly
enriched and varied COG and GO terms have less than 0.05 p-value (Fisher’s
exact test FDR < 0.05 and QP FDR < 0.05) and more than 1.3769 Cohen’s f
(statistical power > 90%).
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Table 18 Significantly varied GO terms in human fecal proteins. “GO ID”:
Gene ontology ID obtained from BioSystems DB, “FDR”: FDR-adjusted
enrichment test, “Enrich. FDR”: FDR of enrichment test, “# of prots”: the number
of member proteins and “QP FDR”: FDR calculated by QP model.
GO ID

Description

GO:0070062 Extracellular exosome
GO:0065010 Extracellular membranebounded organelle
GO:1903561 Extracellular vesicle
GO:0043230 Extracellular organelle
GO:0031988 Membrane-bounded
vesicle
GO:0031982 Vesicle
GO:0044421 Extracellular region part
GO:0005576 Extracellular region
GO:0007586 Digestion
GO:0002385 Mucosal immune
response
GO:0050832 Defense response to
fungus
GO:0009620 Response to fungus
GO:0042742 Defense response to
bacterium
GO:0001906 Cell killing
GO:0005856 Cytoskeleton
GO:0071822 Protein complex subunit
organization
GO:0006936 Muscle contraction
GO:0004022 Alcohol dehydrogenase
(NAD) activity
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Enrich.
FDR
3.91E-98
3.91E-98

# of Cohen’
prot
sf
691 4.4624
691 4.4624

QP
FDR
3.29E-10
3.29E-10

1.17E-97 691
1.17E-97 691
2.12E-87 765

4.4624
4.4624
4.7401

3.29E-10
3.29E-10
1.66E-10

7.12E-84 770
2.02E-76 771
3.67E-55 804
7.80E-07
39
7.08E-05
17

4.7451
5.0905
5.2393
3.8928
2.0228

1.61E-10
3.40E-11
1.67E-11
3.28E-11
1.94E-05

1.18E-03

13

4.1696

1.17E-08

8.80E-03
3.15E-02

14
38

4.1802
3.4573

1.03E-08
4.33E-09

3.39E-02
15
2.14E-40 418
8.08E-42 356

4.5767
4.2486
1.6116

2.52E-11
1.08E-09
1.44E-04

1.91E-12
4.42E-02

3.4826
2.4551

2.61E-08
1.16E-11

70
5

The result of GO term analysis includes interesting GO terms.
Extracellular location related GO cellular component terms, extracellular
vesicular

exosome

extracellular

(GO:0070062),

membrane-bounded

extracellular
organelle

vesicle

(GO:1903561),

(GO:0065010),

vesicle

(GO:0031982), extracellular organelle (GO:0043230), extracellular region
(GO:0005576) and extracellular region part (GO:0044421), were understandably
enriched (Enrichment FDR <1.07E-55) from the significant human proteins
(Table 18). This shows that many of the significant human fecal proteins are
secreted into extracellular regions and excreted into feces.
Besides of extracellular location GO terms, digestion (GO:0007586) and
mucosal immune response (GO:0002385) were enriched (Table 18). Mucosal
immune response GO term was enriched from RYR1, TPM4, VCL, FLII, myosin
proteins and actin proteins (FDR = 7.08E-05). In addition to mucosal immunity,
immune defense-related GO terms were enriched (FDR < 0.05), such as defense
response to fungus (GO:0050832), response to fungus (GO:0009620), defense
response to bacterium (GO:0042742) and cell killing (GO:0001906) (Table 18).
Digestion related proteins, such as AMY2B, CTRB1, CTRB2 and CELA2A, are
abundantly identified in the fecal proteomes (Table 17) and also included in the
355 significant protein list. Digestion proteins are required to obtain nutrition and
energy for everybody, but abundance of those proteins is very dissimilar. For
example, average spectral counts of digestion related proteins, assigned to
digestion (GO:0007586), is 24.2904 in 174c while it is 289.1341 in 196N. The
fold change between 174c and 196N is more than 10.
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Since cytoskeleton

proteins including keratins, tubulins, actins and myosins are significantly and
differentially detected in the fecal proteomes, cytoskeleton (GO:0005856), protein
complex

subunit

organization

(GO:0071822)

and

muscle

contraction

(GO:0006936) are enriched with remarkable FDR (FDR < 1.91E-12) (Table 18).
We guess that these cytoskeletal proteins are excreted from the dead
intestinal cells and immune cells, and their amount is different from person to
person.

Interestingly, alcohol dehydrogenase (GO: 0004022) was also

differentially detected over healthy volunteers (Table 17). Its QP model FDR
(1.16E-11) and Cohen’s f (2.4551) shows how it was variously expressed from
person to person.
Functional features of microbial proteins were analyzed by employing
COG terms. We tested COG terms by enrichment test using Fisher’s exact test
and quantitative QP model with conferred SC from member protein to COG
terms.

Lots of ribosome related COG terms were frequently found in the COG

analysis result, such as ribosomal protein L1 (COG00081), S2 (COG00052), S10
(COG0051), S11 (COG00100), L11 (COG0080), S12 (COG00048) and S19
(COG00185) at enrichment FDR < 2.95E-09 and QP FDR < 0.0007 (Table 19).
Since ribosome is the most abundant protein in microorganism cells, many
ribosome-related COGs were detected in the COG analysis. Different ribosome
complex may mean different biomass of microbiome rather than expression level
of ribosomal proteins.

Energy-required (ATP or GTP) enzyme activity COG

terms were also frequently enriched besides ribosomes (Table 19).
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Table 19 Significant COG terms in microbial fecal proteins. “COG ID”: COG
term ID assigned by COGSoftware, “FDR”: FDR-adjusted enrichment test,
“Enrich. FDR”: FDR of enrichment test, “# of prots”: the number of member
proteins and “QP FDR”: FDR calculated by QP model.
COG ID

Description

COG00542

ATPases with
chaperone activity; ATPbinding subunit
Translation elongation
factors (GTPases)
GTPases - translation
elongation factors
F0F1-type ATP
synthase; beta subunit
ATP-dependent Zn
proteases
Ribosomal protein S11
Ribosomal protein S12

COG00480
COG00050
COG00055
COG00465
COG00100
COG00048
COG00086
COG00653
COG00459
COG00085
COG01592
COG00057

COG01629

DNA-directed RNA
polymerase; beta'
subunit/160 kD subunit
Preprotein translocase
subunit SecA (ATPase;
RNA helicase)
Chaperonin GroEL
(HSP60 family)
DNA-directed RNA
polymerase; beta
subunit/140 kD subunit
Rubrerythrin
Glyceraldehyde-3phosphate
dehydrogenase/erythros
e-4-phosphate
dehydrogenase
Outer membrane
receptor proteins; mostly
Fe transport

Enrich.
FDR
2.33E-13

# of Cohen’
prots
sf
36 3.1885

QP FDR
4.27E-07

5.32E-12

32

2.5506

9.50E-07

5.32E-12

26

1.5264

8.32E-05

1.42E-11

24

2.7013

1.14E-06

8.86E-11

27

3.3691

5.58E-08

1.99E-10
1.99E-10

21
21

2.0664
1.6682

1.99E-10

22

1.5654

4.58E-06
0.000127
452
0.000129
515

1.99E-10

23

1.4936

0.000254
607

2.75E-10

22

2.9585

7.46E-08

2.75E-10

22

1.9143

4.63E-06

7.43E-10
7.43E-10

21
23

2.2773
1.9770

1.10E-06
1.11E-05

7.43E-10

45

2.0563

2.90E-05
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Table 19 continued.
COG ID

Description

Enrich.
FDR
7.43E-10
7.43E-10

COG00052
COG00185

Ribosomal protein S2
Ribosomal protein S19

COG00443
COG00080
COG00051
COG01454

Molecular chaperone
Ribosomal protein L11
Ribosomal protein S10
Alcohol dehydrogenase;
class IV

8.88E-10
1.12E-09
1.12E-09
9.98E-06
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# of Cohen’
prots
sf
20 1.5196
20 1.6309
25
20
20
21

2.6864
2.0750
1.7237
1.9329

QP FDR
7.50E-05
0.000638
967
7.01E-07
3.51E-06
4.86E-05
7.50E-05

ATPases with chaperone activity; ATP-binding subunit (COG00542),
F0F1-type ATP synthase; beta subunit (COG00055), ATP-dependent Zn
proteases (COG00465), Preprotein translocase subunit SecA (ATPase; RNA
helicase) (COG00653), GTPases - translation elongation factors (COG00050)
and Translation elongation factors (GTPases) (COG00480) were enriched at
enrichment FDR < 1.99E-10 and QP FDR < 0.0003.

Interestingly, alcohol

dehydrogenate COG term (COG01454) was significantly and differentially
enriched like GO analysis of human proteins at enrichment FDR = 9.98E-06 and
QP FDR = 7.50E-05.
COG’s broad functional terms were analyzed likewise to GO and COG
terms (Table 20). We applied same thresholds (enrichment FDR < 0.05, QP,
FDR < 0.05 and Cohen’s f < 1.3769). As is confirmed by COG term analysis,
translation, ribosomal structure and biogenesis (J) were significantly and
differentially enriched (enrichment FDR: 7.00E-258 and QP FDR = 1.48E-10)
(Fig. 34) (Table 20). Also, energy production and conversion (C), carbohydrate
transport and metabolism (G), inorganic ion transport and metabolism (P), and
amino acid transport and metabolism (E) were detected (Fig. 34) (Table 20).
These are partially related to digestion and energy generation.

These COG

functions may be varied in different microbiome. Interestingly, cell motility and
defense mechanisms (V) were found in the COG broad functional analysis result
(enrichment FDR = 1.19E-07 and QP FDR = 2.95E-05) (Fig. 34) (Table 20).
Microbiome is speculated that they may move to find nutrients and defend
themselves from host immune system.
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Table 20 Significant COG functional terms in microbial fecal proteins. “ID”:
COG functional term ID, FDR: FDR-adjusted enrichment test and # of prots: the
number of member proteins.
ID

Description

J

Translation; ribosomal
structure and biogenesis
Function unknown
Not predicted
Energy production and
conversion
Carbohydrate transport and
metabolism
Posttranslational modification;
protein turnover; chaperones
General function prediction
only
Transcription
Replication; recombination
and repair
Signal transduction
mechanisms
Defense mechanisms
Cell wall/membrane/envelope
biogenesis
Amino acid transport and
metabolism
Cell motility
Inorganic ion transport and
metabolism

S
X
C
G
O
R
K
L
T
V
M
E
N
P

Enrich.
FDR
7.00E-258

# of
Cohen’
prots
sf
1,060 4.1810

QP FDR
1.48E-10

1.44E-39
2.42E-37
1.47E-34

159
205
476

2.3167
2.3234
2.2074

3.51E-06
7.05E-07
1.46E-06

1.39E-31

626

3.1924

3.15E-09

1.88E-27

319

4.5972

1.48E-10

1.10E-19

313

1.7545

3.43E-05

6.68E-17
2.51E-16

214
229

2.1878
1.8058

2.77E-07
2.76E-06

1.39E-09

94

1.5192

3.12E-04

1.19E-07
1.26E-05

70
226

2.1949
3.7150

2.95E-05
8.49E-09

1.60E-05

471

2.2311

7.57E-07

5.57E-04
3.44E-03

37
162

1.5247
2.1932

9.60E-05
1.45E-06

147

Figure 34 Line plot showing expression profile of 15 COG functions.
Spectrum counts of member proteins were transferred to COG broad functional
terms. COG function name for corresponding symbol is in “ID” column of table
19. This plot was drown by line plot module of QFAM.
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Figure 34 continued.
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These functions also were dissimilar in different people, which mean that
microbiome may be facing in different environment (human gut). Table 20 has
statistics of significant COG broad functional terms whose expression profiles are
described in figure 34. Figure 34 was produced by plot library of QFAM.

Conclusion
We could identify 2,102 fecal human proteins and 5,453 microbial proteins
from feces of 11 healthy volunteers and confirmed their heterogeneity.

This

number of human fecal proteins is larger than previous studies, 234 proteins from
three samples in Lichtman et al [17] and 446 proteins from two samples in our
previous study [148]. We identified 501 proteins per a MS run that is larger
number than total number of proteins from two or three samples in the previous
studies. We confirmed that host proteins in feces are diverse in human as is
shown in mice feces by Lichtman et al [17]. Host fecal protein’s variance was
disclosed by PCC (Fig. 31) and identification frequency (Table 15) comparisons
with technical replicates and five PBMC proteomes. Figure 31 shows that fecal
proteins are not uniformly identified in individual fecal samples. The QP model
also reveals that expression levels of fecal proteomes are various. We could find
1,610 proteins that are differentially and significantly detected in 11 fecal
proteomes via QP model and effect size filter. We utilized Cohen’s f to enhance
statistical power of our QP model.

Functional enrichment analyses over the

1,610 significant proteins show that human significant proteins are generally
located extracellular regions and are related with digestion, cytoskeleton and
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protein metabolisms, and microbial significant proteins are related with
translation, energy generation and protein metabolisms.
Many immune response proteins were also identified in our fecal
proteome. Identification of immune response proteins in fecal proteomes is a
natural outcome because the gastrointestinal tract is a direct interface of
interaction between host immune system and microbiome including commensal
flora and enteric pathogens. We found 214 immune proteins out of 11 fecal
proteomes. Almost 40 immune proteins were detected in more than half of fecal
samples (> 5 samples), while others are less-frequently identified.

Toll-like

receptor family protein (TLR) plays a key role in the innate immunity, so we
expected TLR proteins in many fecal samples. However, only TLR6 was weakly
identified in one fecal sample.

TLR6 has a fundamental role in pathogen

recognition and induction of innate immune response. We speculate that rare
identification of TLRs is because of their low expression level in cells. We also
expected to see immunoglobulins for innate immunity, such as IGA, IGD, IGE,
IGG and IGM, but none of these are in our fecal proteomes. In place of above
five immunoglobulins, IGJ are strongly and frequently identified. IGJ is involved
in polymer form of IGA and IGM, so IGJ can be an indirect clue of existence of
IGA and IGM. IGJ is also identified in previous studies, but TLR6 is found only in
our study.
Human fecal proteins that were identified by previous studies were
confirmed in our study. We could confirm that 196 proteins of 234 in Lichtman et
al [17] and 243 proteins of 446 in our previous study were identified in our study.
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The number of fecal proteins commonly identified in three studies including our
fecal proteomes is 101. Of the commonly identified 101 proteins, 24 proteins
were immune response proteins including IGJ and DMBT1. Digestion related
proteins, such as, AMY2A and PRSS1, are also commonly found. Many of the
simultaneously found proteins are detected with high SC in our study. Top 25
abundant fecal proteins in table 16 are found in at least one of previous studies.
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CHAPTER V
APPLICATION CASE 2 – HUMAN DIET PROTEOME STUDY

Introduction
What we are eating undoubtedly has a great impact on the relative
abundance and the types of our microbiome living in gastrointestinal tract [165].
For example, western diets, low in carbohydrates and high in simple sugar and
fat, are associated with the decrease of Bacteriodetes in North Americans
[166,167]. This change in gut microbiome is generally detected in feces [168].
For instance, certain type of bacteria are increased or decreased by short-term
dietary changes, such as resistant starch (RS) diets and antibiotics, in the
collected fecal samples.

Antibiotics, effective against autochthonous species

members, such as Helicobacter pylori and Lactobacillus Reuteri, create
significant decrease of these microbes detected in the feces [168]. The microbial
pattern changed by different RS amount in diets is likely associated with how
long the changed diet is taken and its specific nutritional contents, such as more
refined RS [169-171].
RS is one of starch or derivatives of starch and is not fully digested by
human small intestine, while sugars and most starches are rapidly digested and
absorbed as glucose. This undigested RS, dietary fiber, is diet-derived energysource of microbiome living mostly in large intestine. Several scientific reports
showed that high RS diet could result in abundance of specific bacteria in
microbiome,

such

as

Ruminococcus
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bromii,

Eubacterium

rectale,

and

Bifidobacterium adolescentis [165,171-173]. These changes in microbiome are
probably caused by substrate-specific preference of different microbes that can
uptake and degrade RS efficiently. Generally, people inhabiting different places
have dissimilar microbiome, but children in European Union and Burkina Faso
showed similar response to high fiber diets, which Bacteroidetes and Firmicutes
ratio are changed by different amount of dietary RS [174]. Potential increase of
short chain fatty acid and butyrate-producing microbes and decrease of diseasecausing bacteria enable us to associate RS diet with human health.
While the influence of resistant starch on the gut microbial community has
been demonstrated, the precise functional and quantitative relationship between
the gut microbiome and RS amount remains unclear. This chapter focuses on
the

metaproteomics

apart

of

the

integrative

“omics”

metagenomics, metabolomics and metaproteomics.

study

including

Two different diets

containing high and low amounts of RS were treated to 8 patients in crossover
time course design.

Feces after having specific diets were sampled and

analyzed by 2D LC-MS/MS and QFAM.

Methods
Generation of Metaproteome data
The diet study design is summarized in Figure 35. Briefly, 8 patients who
were insulin resistant (HOMA-IR > 50th percentile for sex), overweight or obese
(BMI between 27 and 35 kg/m2), and met other eligibility criteria were enrolled in
the study.
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Figure 35 Experiment design of diet proteome study.

Low RS has 2g

amylose and High RS has 38g amylose. Every diet is treated for two weeks.
Total 8 patients had different diets, as is scheduled in cross over design.
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All subjects were otherwise healthy and not taking any antibiotics, lipidreducing or blood-thinning medications, or hormones. The study protocols were
approved by the Human Subjects Committee of both Children’s Hospital Oakland
Research Institute and Lawrence Berkeley National Laboratory. Written informed
consent was obtained from each subject.

Study participants were randomly

assigned to a sequence of the two experimental diets: a low resistant starch
(LRS) diet containing 2 grams of resistant starch and a high resistant starch
(HRS) diet containing 38 grams of resistant starch. Each diet period was 2 weeks
with 2 weeks baseline washout diet between diet periods (Fig. 35). In both diets,
type 2 RS, a granular form of high amylose cornstarch, was used. Melojel of
Ingredion Inc. was used for LRS diets, while Hi-maize 260 RS was used for the
HRS diets. Following the initial baseline diet and each diet period, fecal samples
were collected.
Sample preparation and LC-MS/MS experiment
Proteins of all fecal samples were extracted by indirect cell lysis method
(Fig. 29) preferred for collection of microbial proteins. Proteins of all the samples
were digested by trypsin and analyzed via 2D LC MS/MS with C18-SCX
(Phenomonex) self-packed nano back column (3 cm C18, 3 cm SCX, 150 µm
i.d.) that serves as the first dimension of the 2D-LC system to capture peptides
and wash away salts and a QExactive MS (Thermo Fisher). QExactive settings
were as follows: the normalized collision energy for HCD was 28 eV, a full scan
resolution of 70,000K from 400-1600 m/z, a HCD MS/MS resolution of 17,500
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with an isolation width of 3 m/z, and the dynamic exclusion was set at 15
seconds. Peptides were not excluded based on charge state and 1 microscan for
both full and MS/MS scans were acquired.

All MS and MS/MS data were

acquired in profile mode.
Quantitation and normalization of metaproteome data
All MS/MS spectra were searched against our customized sequence
database. The database consists of human protein sequences, translated metagenome sequences, proteins of 34 human-gut-isolated microbial species, and
common contaminants (i.e., trypsin and keratin; 36 protein sequences).

We

collected human protein sequences from NCBI RefSeq and microbial proteins
from JGI human microbiome project (IMG-HMP) as is described in our previous
paper [95]. All MS/MS individual runs were searched with the SEQUEST (v.27)
algorithm against our customized FASTA sequence database.

Search

parameters were followed to our prior study [95] (<4 miss-cleavages, 3 Da mass
tolerance window around the precursor ion mass and 0.5 Da for fragment ion
masses). All SEQUEST output files were gathered and filtered using DTASelect
(1.9) at ≥ 2 peptides per protein and the following widely accepted parameters for
all the MS runs: XCorr of at least 1.8, 2.5, 3.5 for +1, +2, and +3 charge states,
respectively and a minimum deltCN for 0.08. All the peptide spectrum matches
(PSM) that could not satisfy a post-database search filter, -10 ≤ ppm ≤ 10, were
excluded out to remove false positives as described in our previous study [95].
Finally 57,397 proteins were quantitatively identified (human: 1,103 and
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microbes: 56,294). Spectrum counts (SC) of protein is normalized as described
below [95]:
!
!!!

𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝑆𝐶! =   

!
!!! 𝑆𝐶!

𝑀

!
!!! 𝑆𝐶!

×𝑆𝐶!

Where, N = the number proteins and M = the number MS runs.
Quantitative analysis of metaproteome data
All the statistical analyses were fulfilled by using R 3.1.3 and Python 2.7.6.
Since people have different gut microbiome and different genetic background,
fecal proteomes are heterogeneous from person to person. Chapter 4 study
showed that human fecal proteome is highly varied. Hence, we considered that
personal variation is important to interpret our proteomics data in terms of diet
type.

Generalized Linear Mixed Model (GLMM) is the expanded model of

generalized linear model (GLM) and able to include random effects in addition to
the usual fixed effects. We set personal variation as random effect to explain
different people’s different fecal proteomes. Our model for the proteome analysis
is SC ~ µ + Diet type + (1|Person). Negative binomial distribution (NB) was
employed as null distribution in GLMM instead of Normal distribution because
spectral count is frequency-based data and NB distribution is generally used for
count-type data analysis, such as read numbers of RNA sequencing.

The

constructed GLMM NB model was compared to null model through chi-square
likelihood ratio test (LR test). All the P-values were adjusted by FDR in order to
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reduce multiple comparison effect. Cut-off FDR is 0.0001. We used ‘lmerTest’
package to construct GLMM NB model [175].
On top of GLMM NB model, effect size (ES) filter was applied to enhance
reproducibility. Combining p-value and ES filter can enhance reproducibility of
proteomics data analysis [128]. As is showed in chapter 3, fold change is widely
used ES, but Cohen’s ES is better ES in terms of statistical power and selection
power filtering false positives. We used ‘selfea’ R package, described in chapter
3, to calculate Cohen’s w that is designed for chi-square test that was used for
GLMM NB model comparison.

Since a number of microbial proteins were

significantly detected, we used very strict statistical filters (FDR-adjusted p-value
(FDR) < 0.0001) to make the expected number of false positives is smaller than
1. When p-value threshold is 0.0001, minimum Cohen’s w for our data was
1.0258 corresponding to 80% statistical power that is recommended level for
reliable hypothesis test. Statistical power is the probability of correctly rejecting
null hypothesis when it is false, so it is directly related statistics with reproducible
result. The expected number of false positives is 0.7 at 0.0001 FDR and 80%
power. The number of significantly detected human proteins is 94, while the
number of microbial proteins is 7,018.
Functional analysis of metaproteome data
Metaproteome data was functionally analyzed by using COG for microbial
proteins and KEGG pathway terms. COG and COG functional terms were
examined by using COG-analysis pipeline of FAM.
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To assign COG ID to

microbial proteins, we used COG-software by following steps suggested by
Kristensen et al [120]. For proteins, COG-software could not assign, PSI-BLAST
search against COG sequences was used with cut off E-value 0.00000001. We
could assign COG ID to 54,290 microbial proteins. To quantitatively analyze
COG IDs, we transferred SC of member proteins, allocated to at least one COG
ID, to COG ID. Same assignment was done to 25 broad COG functional terms.
We applied GLMM NB model and Cohen’s w to get significant COG terms and
their broad functional terms. For COG analysis, 0.0001 FDR thresholds and
1.0258 Cohen’s w were applied. We could examine significantly changed 400
COG terms and 4 COG functional terms across different diet types. Since many
of significant COG terms were supported by only 1 or 2 member proteins, we
filtered out COGs by the number of member proteins (member > 2). This rule
was applied to COG functional terms.

After filtering by minimum member

proteins, remaining COGs were 166 terms and 2 functional terms. For COG
functions, we applied 0.001 FDR of GLMM-NB model and 0.9051 Cohen’s w (the
number of expected false positive is 0.02).
FAM was used to analyze KEGG pathway for human proteins in diet
metaproteome. SC transfer to KEGG pathways was done like COG analysis.
Enrichment test was carried out by QAM module.

FDR threshold for the

enrichment test was 0.05. To quantitatively analyze KEGG pathways, we applied
GLMM NB model and Cohen’s w, 0.05 FDR thresholds and 0.6336 Cohen’s w,
so that the number of expected false positives is 1.
significant KEGG pathways.
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We could identify 20

Identification of translated-metagenome sequences
Undefined translated-metagenome sequences (metagenome proteins)
were defined by BLAST search pipeline of QFAM against whole UniProt DB
downloaded in Dec. 2014. BLAST search, using BLAST 2.2.24, was fulfilled in
Newton cluster of the University of Tennessee (https://newton.utk.edu/).

We

divided 48,284 metagenome proteins into 48 groups and had run 48 BLAST jobs
simultaneously onto 48 cores of Newton cluster.

Sequence similarity was

calculated for every alignment as described below:
𝑆𝑖𝑚𝑖𝑙𝑎𝑟𝑖𝑡𝑦 =

𝐴𝑙𝑖𝑔𝑛𝑒𝑑  𝑙𝑒𝑛𝑔𝑡ℎ
×𝑃𝑒𝑟𝑐𝑒𝑛𝑡  𝑖𝑑𝑒𝑛𝑡𝑖𝑡𝑦
𝑃𝑟𝑜𝑡𝑒𝑖𝑛  𝑙𝑒𝑛𝑔𝑡ℎ

Where aligned length is value of ‘alignment length’ of BLAST result, protein
length is the number of amino acid of a protein and percent identity is ‘% identity’
of BLAST result. We assigned single UniProt ID to a metagenome protein by
95% sequence similarity without gap opens.

At 95% similarity level, 38,543

metagenome proteins were successfully determined.

Results
Generation of diet metaproteome data
From 24 MS runs (8 patients * 3 diets), 57,398 proteins were determined.
Of 57,398 proteins, 56,295 were from microbiome and 1,103 were host human
proteins. This identification bias is caused by indirect protein extraction method
(Fig. 29). Since we collected microbial pellets and removed supernatant, human
proteins, floating in supernatant, were efficiently removed. Filtering out of host
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proteins are required to get more microbial proteins from fecal samples. This diet
proteome study targets understanding of changes in microbiome communities,
so half number of human proteins was identified when compared to human fecal
proteome study of chapter 4.
Much larger number of microbial proteins was detected in this study than
human fecal proteome study (56k of diet proteome vs. 5k of human fecal
proteome). This abundant microbial protein examination is due to two reasons.
First, it is employing indirect protein collection method as is described in chapter
4. Another factor is the metagenome sequencing. As is explained in chapter 4,
species composition of human feces is not known and is various from person to
person. In this study, metagenome sequencing was employed and added to
PSM search, while it wasn’t in human fecal proteome study. Since metagenome
is not annotated, metagenome characterization is required.

Nevertheless,

microbial protein identification is dramatically increased by metagenome
sequences and indirect method.

The number of metagenome proteins,

translated metagenome coding genes, is 48,376 of 56,295 total microbial
proteins.

This is 86% of total microbial protein identifications, which means

showing huge contribution of metagenome proteins to increase of microbial
proteins.
Some species had significant changes in terms of the number of identified
proteins (Table 21). The number of metagenome proteins was increased by RS
amount (26,075 in LRS and 28,776 in HRS).
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Table 21 The number of identified proteins in different species and in
different diets. “SD” is standard deviation of numbers in three different diets.
Species
Aeromonas hydrophila hydrophila ATCC
7966
Desulfovibrio sp. 3_1_syn3
Escherichia coli CFT073
Lactobacillus reuteri CF48-3A
Enterococcus faecalis PC4.1
Shigella flexneri 2a 2457T
Methanobrevibacter smithii F1, DSM 2374
Salmonella enterica enterica sv Typhi Ty2
Blautia hydrogenotrophicus S5a33, DSM
10507
Klebsiella sp. 1_1_55
Streptococcus sp. 2_1_36FAA
Coprococcus sp. HPP0048
Anaerostipes sp. 3_2_56FAA
Ruminococcus lactaris ATCC 29176
Prevotella melaninogenica D18
Clostridium sp. 7_2_43FAA
Dorea formicigenerans ATCC 27755
Coprococcus comes
Lachnospiraceae bacterium 6_1_63FAA
Alistipes putredinis DSM 17216
Dialister invisus DSM 15470
Roseburia intestinalis L1-82
Akkermansia muciniphila ATCC BAA-835
Eubacterium rectale ATCC 33656
Bifidobacterium adolescentis ATCC 15703
Ruminococcaceae bacterium D16
Bacteroides uniformis CL03T00C23
Bifidobacterium adolescentis L2-32
Bacteroides uniformis CL03T12C37
Prevotella copri CB7, DSM 18205
Homo sapiens
Faecalibacterium prausnitzii A2-165
Bacteroides vulgatus ATCC 8482
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Baselin
e
4

LRS

HRS

SD

4

5

0.58

13
12
6
11
11
1
13
72

13
10
2
10
10
1
8
66

11
8
4
7
7
6
8
66

1.15
2.00
2.00
2.08
2.08
2.89
2.89
3.46

20
21
75
58
87
64
45
93
77
90
130
23
104
14
263
41
75
393
44
392
529
893
226
777

9
14
61
67
103
82
31
104
81
89
157
47
145
11
311
38
147
314
38
312
633
723
361
571

15
8
74
74
89
71
50
84
98
115
161
57
111
58
325
102
126
367
111
366
523
760
454
785

5.51
6.51
7.81
8.02
8.72
9.07
9.85
10.02
11.15
14.73
16.86
17.47
21.93
26.31
32.52
36.12
37.03
40.26
40.53
40.81
61.85
89.40
114.64
121.31

Table 21 continued
Species
Bacteroides sp. 1_1_6
Bacteroides sp. D2
Metagenome

Baseline
774
885
23,359
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LRS
389
379
26,075

HRS
320
409
28,766

SD
244.64
283.88
2,703.51

As is reported previously [174], Bacteriodes showed changes by RS amount
(Table 20).

Bacteriodes vulgatus ATCC 8482 had 571 proteins in low RS,

however its number of proteins is increased in high RS up to 785 (Table 21).
Interestingly, all the Bacteriodes species, Bacteriodes sp. D2, Bacteriodes sp.
1_1_6 and Bacteriodes vulgatus ATCC 8482, were remarkably decreased in low
RS when compared to baseline diet (Table 21). These changes are relatively
large, considering changes in other species. The number of human proteins is
not quite changed by different diets (Table 21). Abundance of many species in
fecal samples was not much changed except Bacteroides and Metagenome
(Table 21).
Construction of generalized linear mixed model
Generalized linear mixed model (GLMM) was constructed for comparing
proteomes between different diets. This model considers that SC can be varied
by diet type in different patients. We assumed that eight patients could have
different fecal proteome profiles, even though they are basically same biological
replicates that have same disease and healthy background. GLMM has patients
as random effect and diet type as fixed effect. Negative binomial distribution
(NB) was employed as null distribution in GLMM instead of Normal distribution
because spectral count is frequency-based data and NB distribution is generally
used for count-type data analysis, such as read numbers of RNA sequencing.
NB is widely used distribution in RNA sequencing data comparison [176,177],
while has not been used in proteomics data analysis. NB is robust to over165

dispersion when compared to Poisson that is also basically designed distribution
for count type data. Additionally, NB is uniquely determined by two parameters,
mean and variance. However, the number of replicates in biological studies is
often not enough to estimate mean and variance reliably. Therefore, tools based
on NB for RNA sequencing data comparison, such as DESeq[177] and
edgeR[176], have their own variance functions adjusted for RNA sequencing
data. The constructed GLMM-NB model was compared to null model through
chi-square likelihood ratio test (LR test). All the p-values were adjusted by FDR
in order to reduce multiple comparison effect.

On top of GLMM-NB model,

Cohen’s w was applied because GLMM model used NB distribution.
Using GLMM-NB and Cohen’s w we found 7,113 significant proteins, 94 from
human and 7,018 from microbiome and metagenome, that are differently
detected in different diet types. These significant proteins were picked by 0.0001
FDR and 1.0258 Cohen’s w threshold (Fig. 36). We increased p-value threshold
to reduce the number of expected false positives. The expected false positive in
our results is less than 1. Protein scatter plot in figure 36 shows how many
proteins we filtered out from total proteins. Since fecal proteomes are highly
varied by patients as is shown in chapter 4, we applied rigorous thresholds to
exclude out potential false positives. Cohen’s w was calculated by selfea R
package used in chapter 3 and 4.
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Figure 36 Protein scatter plot of diet proteome comparison. Green dots
mean insignificant microbial proteins, and red dots are insignificant human
proteins. Significant proteins are colored as purple (significant microbial) and
blue (significant human).

Since we used rigorous thresholds to make the

expected number of false positive below 1, almost all the visible spots were
excluded by two lines (FDR threshold (= 0.0001) horizontal line and Cohen’s w (=
1.0258) vertical line).
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Functional analysis using FAM
Functional analysis of diet proteomes was conducted by using FAM. For
this study, we used KEGG pathway analysis for human proteins and COG terms
for microbial proteins. Even though relatively small number of human proteins
was identified in the diet proteome, we analyzed their functional characteristics.
Since we are interested in microbial changes caused by different RS amount,
COG analysis of QFAM helped us to get insights about changes in microbiome.
First, we analyzed human proteins in the diet proteome using KEGG
pathways. FAM was employed to get reliable results using enrichment test and
significance test. Enrichment test was carried out via Fisher’s exact test. For
quantitative comparison GLMM NB model and Cohen’s w were applied. Also,
SC transferring from member proteins to KEGG pathways was done for human
proteins of diet metaproteome. We downloaded up-to-date NCBI BioSystems
DB at the moment of analysis. All the p-values from two tests were adjusted by
FDR. FDR thresholds of two tests were 0.05 and minimum Cohen’s w was
0.6336 for 80% statistical power that is generally recommended level.
With these probability and ES filters, we could get 20 significant KEGG
pathways (Fig. 37).

HIF-1 signaling pathway, biosynthesis of amino acids,

galactose metabolism, central carbon metabolism in cancer, proteasome and
immunoproteasome were enriched almost only in LRS. In other diets, HRS and
baseline, these were not expressed. Since proteasome and immunoproteasome
are related to defense against microbial proteins, we speculate that innate
immune system was turned on against increased species in LRS diets.
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Figure 37 Stacked bar graphs of accumulated spectral counts of 20
significant KEGG pathways.

Y-axis is KEGG pathway and X-axis is

percentage of accumulated spectral counts of 2A (baseline), HRS and LRS
samples. Blue-colored bar is sum of spectral counts in baseline diet. Redcolored bar means expression level (sum of spectral counts) in HRS. Green bars
are from sum of expression level in LRS.
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Interestingly, digestion-related pathways were enriched in both of LRS and HRS,
such as glycolysis, fructose and mannose metabolism, carbon metabolism,
pentose phosphate pathway and glucogenesis.

This may be human body

response to get nutrients from changed diets (baseline to LRS or HRS). Insulin
signaling pathway and starch and sucrose metabolism were enriched in HRS.
These means that uptake of glucose was not efficient in HRS because high
amount of RS in HRS cannot be digested and absorbed by small intestine.
Therefore, these were expressed higher than other diet types.
COG analysis was achieved by employing FAM.

For this study we

employed FAM’s quantitative test only because of time.

Since diet

metaproteomics used metagenome, more than several million sequences are in
protein DB. To conduct the enrichment test, we have to run PSI-BLAST of more
than million sequences, which means that it takes too much long time about a
month in Newton. This is critical disadvantage of QFAM. QFAM analyzes highly
complicated and very large metaproteomics data, so it requires high level of
computing power. Unfortunately, Newton could not afford to run this type of big
data in a reasonable time. Therefore, we used arbitrary threshold instead of the
enrichment test.
We transferred SC of member proteins to COG terms and constructed
GLMM NB model for COG terms. Also, Cohen’s w for COG terms was computed
for quantitative analysis using QAM. P-values were adjusted by FDR. FDR
threshold of GLMM NB model was 0.001 and minimum Cohen’s w for 80%
statistical power was 0.9051. On top of GLMM NB model, we applied arbitrary
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threshold for COG terms by the number of member proteins (> 2). With these
thresholds, we could have 166 significant COG terms (Table 22). Also, heat-map
of significant 166 COGs was drawn by using QFAM’s R graphic library (Fig. 38).
Energy generation and digestion related COG terms were enriched in baseline
diet, such as COG03808, COG01775 and COG01748 (Table 22 and Fig. 38).
Also, ribosomal COGs were significantly enriched, such as COG00261 and
COG00238 (Table 22).

We speculate hat microbiome is growing with baseline

diet, considering significantly enriched translation and DNA replication COG
terms (Table 22).
COG terms analysis in LRS and HRS diets give us insight speculating
changes caused by RS addition. In LRS diet, microbes in human gastrointestinal
track are not quite different from baseline.

Energy generation (COG00716,

COG01013, COG01951, COG00554 and COG01805) is activated and digesting
nutrients, such as amino acids, carbohydrates, lipid metabolism, are turned on
similarly to baseline (Table 22 and Fig. 38). However, microbes seem to adapt
changed nutrients by expressing appropriate proteins and post-translational
modifications (COG00060, COG00254, COG00124, COG00621, COG00525 and
COG01438 for transcription and translation and COG00760, COG00484,
COG00691, COG01066 and COG00740 for post-translational modifications).
Interestingly, cell motility COG terms are started being expressed from LRS diets
(COG01360 and COG01749), which mean that microbes were moving to
somewhere (Table 22). Also, cell wall biogenesis is differentially enriched in LRS
when compared to baseline (Table 22 and Fig. 38).
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Table 22 166 significant COG terms in different diets. COG Func: COG
broad function single digit symbol. Related diets (Rel. Diets) are categorized by
expression level in three diets (Base: Baseline, LRS: low RS and HRS: high RS).
COG ID
COG03808
COG01748
COG01775
COG00040
COG00006
COG01027
COG00176
COG02160
COG03693
COG01830
COG02893
COG01482
COG03345
COG02022
COG00447
COG01260
COG01022
COG02030
COG00261
COG00238
COG00188
COG01918
COG00523
COG02406
COG03937
COG01217

# of
Description
Prot
158 Inorganic pyrophosphatase
13 Saccharopine dehydrogenase and related
proteins
12 Benzoyl-CoA reductase/2-hydroxyglutarylCoA dehydratase subunit;
BcrC/BadD/HgdB
7 ATP phosphoribosyltransferase
4 Xaa-Pro aminopeptidase
3 Aspartate ammonia-lyase
9 Transaldolase
8 L-arabinose isomerase
5 Beta-1;4-xylanase
4 DhnA-type fructose-1;6-bisphosphate
aldolase and related enzymes
4 Phosphotransferase system;
mannose/fructose-specific component IIA
3 Phosphomannose isomerase
3 Alpha-galactosidase
3 Uncharacterized enzyme of thiazole
biosynthesis
3 Dihydroxynaphthoic acid synthase
4 Myo-inositol-1-phosphate synthase
3 Long-chain acyl-CoA synthetases (AMPforming)
3 Acyl dehydratase
35 Ribosomal protein L21
25 Ribosomal protein S18
21 Type IIA topoisomerase (DNA gyrase/topo
II; topoisomerase IV); A subunit
21 Fe2+ transport system protein A
21 Putative GTPases (G3E family)
10 Protein distantly related to bacterial ferritins
5 Uncharacterized conserved protein
25 Predicted membrane GTPase involved in
stress response
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COG
Func
C
E

Rel.
Diets
Base
Base

E

Base

E
E
E
G
G
G
G

Base
Base
Base
Base
Base
Base
Base

G

Base

G
G
H

Base
Base
Base

H
I
I

Base
Base
Base

I
J
J
L

Base
Base
Base
Base

P
R
R
S
T

Base
Base
Base
Base
Base

Table 22 continued.
COG ID
COG01702
COG03706
COG00317
COG00342
COG00716
COG01013
COG01951
COG00554
COG01805
COG00347
COG00436
COG00076
COG00175
COG00444
COG01102
COG00395
COG03534
COG02376
COG01440
COG03669
COG01904
COG03717

# of Description
Prot
6 Phosphate starvation-inducible protein
PhoH; predicted ATPase
5 Response regulator containing a CheY-like
receiver domain and a GGDEF domain
9 Guanosine polyphosphate
pyrophosphohydrolases/synthetases
28 Preprotein translocase subunit SecD
51 Flavodoxins
20 Pyruvate:ferredoxin oxidoreductase and
related 2-oxoacid:ferredoxin
oxidoreductases; beta subunit
5 Tartrate dehydratase alpha
subunit/Fumarate hydratase class I; Nterminal domain
3 Glycerol kinase
3 Na+-transporting NADH:ubiquinone
oxidoreductase; subunit NqrB
31 Nitrogen regulatory protein PII
10 Aspartate/tyrosine/aromatic
aminotransferase
3 Glutamate decarboxylase and related PLPdependent proteins
4 3’-phosphoadenosine 5’-phosphosulfate
sulfotransferase (PAPS reductase)/FAD
synthetase and related enzymes
4 ABC-type dipeptide/oligopeptide/nickel
transport system; ATPase component
3 Cytidylate kinase
10 ABC-type sugar transport system;
permease component
5 Alpha-L-arabinofuranosidase
4 Dihydroxyacetone kinase
4 Phosphotransferase system cellobiosespecific component IIB
4 Alpha-L-fucosidase
4 Glucuronate isomerase
3 5-keto 4-deoxyuronate isomerase

173

COG
Func
T

Rel.
Diets
Base

T

Base

TK

Base

U
C
C

LRS
LRS
LRS

C

LRS

C
C

LRS
LRS

E
E

LRS
LRS

E

LRS

EH

LRS

EP

LRS

F
G

LRS
LRS

G
G
G

LRS
LRS
LRS

G
G
G

LRS
LRS
LRS

Table 22 continued.
COG ID
COG00413
COG01429
COG00452
COG00161
COG00007
COG00214
COG01024
COG02185
COG01788
COG00332
COG00060
COG00254
COG00124
COG00621
COG00525
COG01438
COG02885
COG00860
COG00773
COG02089
COG01360
COG01749
COG00760
COG00484
COG00691
COG01066
COG00740
COG01116

# of Description
Prot
12 Ketopantoate hydroxymethyltransferase
7 Cobalamin biosynthesis protein CobN and
related Mg-chelatases
4 Phosphopantothenoylcysteine
synthetase/decarboxylase
4 Adenosylmethionine-8-amino-7oxononanoate aminotransferase
3 Uroporphyrinogen-III methylase
3 Pyridoxine biosynthesis enzyme
15 Enoyl-CoA hydratase/carnithine racemase
13 Methylmalonyl-CoA mutase; C-terminal
domain/subunit (cobalamin-binding)
6 Acyl CoA:acetate/3-ketoacid CoA
transferase; alpha subunit
3 3-oxoacyl-[acyl-carrier-protein] synthase III
15 Isoleucyl-tRNA synthetase
7 Ribosomal protein L31
5 Histidyl-tRNA synthetase
4 2-methylthioadenine synthetase
3 Valyl-tRNA synthetase
3 Arginine repressor
25 Outer membrane protein and related
peptidoglycan-associated (lipo)proteins
3 N-acetylmuramoyl-L-alanine amidase
3 UDP-N-acetylmuramate-alanine ligase
3 Sialic acid synthase
12 Flagellar motor protein
9 Flagellar hook protein FlgE
5 Parvulin-like peptidyl-prolyl isomerase
4 DnaJ-class molecular chaperone with Cterminal Zn finger domain
3 tmRNA-binding protein
3 Predicted ATP-dependent serine protease
7 Protease subunit of ATP-dependent Clp
proteases
5 ABC-type nitrate/sulfonate/bicarbonate
transport system; ATPase component
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COG
Func
H
H

Rel.
Diets
LRS
LRS

H

LRS

H

LRS

H
H
I
I

LRS
LRS
LRS
LRS

I

LRS

I
J
J
J
J
J
K
M

LRS
LRS
LRS
LRS
LRS
LRS
LRS
LRS

M
M
M
N
N
O
O

LRS
LRS
LRS
LRS
LRS
LRS
LRS

O
O
OU

LRS
LRS
LRS

P

LRS

Table 22 continued.
COG ID
COG01160
COG00312
COG02872
COG04716
COG04198
COG04260
COG00393
COG04475
COG02013
COG02197
COG00039
COG01456
COG03426
COG00778
COG03288
COG00479
COG00711
COG00371
COG00031
COG03643
COG02873
COG00527
COG00747
COG00140
COG01362

# of Description
Prot
6 Predicted GTPases
6 Predicted Zn-dependent proteases and
their inactivated homologs
3 Predicted metal-dependent hydrolases
related to alanyl-tRNA synthetase HxxxH
domain
26 Myosin-crossreactive antigen
19 Uncharacterized conserved protein
8 Putative virion core protein (lumpy skin
disease virus)
6 Uncharacterized conserved protein
5 Uncharacterized protein conserved in
bacteria
3 Uncharacterized conserved protein
3 Response regulator containing a CheYlike receiver domain and an HTH DNAbinding domain
26 Malate/lactate dehydrogenases
8 CO dehydrogenase/acetyl-CoA synthase
gamma subunit (corrinoid Fe-S protein)
7 Butyrate kinase
6 Nitroreductase
6 NAD/NADP transhydrogenase alpha
subunit
6 Succinate dehydrogenase/fumarate
reductase; Fe-S protein subunit
4 F0F1-type ATP synthase; subunit b
3 Glycerol dehydrogenase and related
enzymes
20 Cysteine synthase
13 Glutamate formiminotransferase
13 O-acetylhomoserine sulfhydrylase
9 Aspartokinases
7 ABC-type dipeptide transport system;
periplasmic component
6 Phosphoribosyl-ATP
pyrophosphohydrolase
5 Aspartyl aminopeptidase
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COG
Func
R
R

Rel.
Diets
LRS
LRS

R

LRS

S
S
S

LRS
LRS
LRS

S
S

LRS
LRS

S
TK

LRS
HRS

C
C

HRS
HRS

C
C
C

HRS
HRS
HRS

C

HRS

C
C

HRS
HRS

E
E
E
E
E

HRS
HRS
HRS
HRS
HRS

E

HRS

E

HRS

Table 22 continued.
COG ID
COG00410
COG00160
COG00106
COG00252
COG00145
COG03185
COG00274
COG00504
COG00035
COG00027
COG03363
COG00150
COG00152
COG00167
COG00284
COG01109
COG01080
COG02190
COG03957
COG01820
COG01523
COG00698

# of Description
Prot
4 ABC-type branched-chain amino acid
transport systems; ATPase component
3 4-aminobutyrate aminotransferase and
related aminotransferases
3 Phosphoribosylformimino-5aminoimidazole carboxamide
ribonucleotide (ProFAR) isomerase
3 L-asparaginase/archaeal Glu-tRNAGln
amidotransferase subunit D
3 N-methylhydantoinase A/acetone
carboxylase; beta subunit
10 4-hydroxyphenylpyruvate dioxygenase
and related hemolysins
8 Deoxyribose-phosphate aldolase
8 CTP synthase (UTP-ammonia lyase)
7 Uracil phosphoribosyltransferase
6 Formate-dependent
phosphoribosylglycinamide
formyltransferase (GAR transformylase)
6 Archaeal IMP cyclohydrolase
5 Phosphoribosylaminoimidazole (AIR)
synthetase
4 Phosphoribosylaminoimidazolesuccinocar
boxamide (SAICAR) synthase
4 Dihydroorotate dehydrogenase
3 Orotidine-5’-phosphate decarboxylase
14 Phosphomannomutase
12 Phosphoenolpyruvate-protein kinase (PTS
system EI component in bacteria)
6 Phosphotransferase system IIA
components
6 Phosphoketolase
5 N-acetylglucosamine-6-phosphate
deacetylase
4 Type II secretory pathway; pullulanase
PulA and related glycosidases
4 Ribose 5-phosphate isomerase RpiB
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COG
Func
E

Rel.
Diets
HRS

E

HRS

E

HRS

EJ

HRS

EQ

HRS

ER

HRS

F
F
F
F

HRS
HRS
HRS
HRS

F
F

HRS
HRS

F

HRS

F
F
G
G

HRS
HRS
HRS
HRS

G

HRS

G
G

HRS
HRS

G

HRS

G

HRS

Table 22 continued.
COG ID
COG01638
COG00054
COG00511
COG00245
COG00304
COG00233
COG01534
COG00255
COG01190
COG00568
COG01158
COG00781
COG04775
COG04932
COG00438
COG01209
COG00793
COG00643
COG00840
COG01450
COG00576
COG02077
COG00735
COG01117
COG00004
COG00226
COG00704
COG02368

# of Description
Prot
4 TRAP-type C4-dicarboxylate transport
system; periplasmic component
6 Riboflavin synthase beta-chain
5 Biotin carboxyl carrier protein
3 2C-methyl-D-erythritol 2;4cyclodiphosphate synthase
4 3-oxoacyl-(acyl-carrier-protein) synthase
17 Ribosome recycling factor
5 Predicted RNA-binding protein containing
KH domain; possibly ribosomal protein
4 Ribosomal protein L29
3 Lysyl-tRNA synthetase (class II)
28 DNA-directed RNA polymerase; sigma
subunit (sigma70/sigma32)
18 Transcription termination factor
3 Transcription termination factor
7 Outer membrane protein/protective
antigen OMA87
5 Predicted outer membrane protein
5 Glycosyltransferase
4 dTDP-glucose pyrophosphorylase
3 Periplasmic protease
19 Chemotaxis protein histidine kinase and
related kinases
9 Methyl-accepting chemotaxis protein
4 Type II secretory pathway; component
PulD
5 Molecular chaperone GrpE (heat shock
protein)
5 Peroxiredoxin
6 Fe2+/Zn2+ uptake regulation proteins
6 ABC-type phosphate transport system;
ATPase component
4 Ammonia permease
4 ABC-type phosphate transport system;
periplasmic component
3 Phosphate uptake regulator
3 Aromatic ring hydroxylase
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COG
Func
G

Related
Diets
HRS

H
I
I

HRS
HRS
HRS

IQ
J
J

HRS
HRS
HRS

J
J
K

HRS
HRS
HRS

K
K
M

HRS
HRS
HRS

M
M
M
M
NT

HRS
HRS
HRS
HRS
HRS

NT
NU

HRS
HRS

O

HRS

O
P
P

HRS
HRS
HRS

P
P

HRS
HRS

P
Q

HRS
HRS

Table 22 continued.
COG ID
COG00714
COG01837
COG01461
COG01878
COG01159
COG04864
COG02268
COG00217
COG01624
COG01917
COG01302
COG02859
COG04702
COG03976
COG01875

# of Description
Prot
17 MoxR-like ATPases
8 Predicted RNA-binding protein (contains
KH domain)
8 Predicted kinase related to
dihydroxyacetone kinase
4 Predicted metal-dependent hydrolase
3 GTPase
16 Uncharacterized protein conserved in
bacteria
13 Uncharacterized protein conserved in
bacteria
11 Uncharacterized conserved protein
6 Uncharacterized conserved protein
5 Uncharacterized conserved protein;
contains double-stranded beta-helix
domain
4 Uncharacterized protein conserved in
bacteria
4 Uncharacterized protein conserved in
bacteria
4 Uncharacterized conserved protein
3 Uncharacterized protein conserved in
bacteria
6 Predicted ATPase related to phosphate
starvation-inducible protein PhoH
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COG
Func
R
R

Rel.
Diets
HRS
HRS

R

HRS

R
R
S

HRS
HRS
HRS

S

HRS

S
S
S

HRS
HRS
HRS

S

HRS

S

HRS

S
S

HRS
HRS

T

HRS

Figure 38 Heat-map of significant 166 COG terms. We standardized sum of
transferred SC of each of COG terms. Deeper steel-blue color means higher
expression level in diet metaproteome.

COG terms are clustered by their

expression pattern and broad functional term.
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Figure 38 continued
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In HRS, energy production and uptake of nutrients were similarly expressed to
LRS and baseline. However, cell wall and envelope biogenesis is turned on so
that microbes may need to defense themselves from increase of competing or
host immune system (COG04775, COG04932, COG00438, COG01209 and
COG00793).

Likewise to LRS, microbes are trying to express and modify

appropriate proteins in order to adapt to the changed environment, high amount
of RS (COG00233, COG01534, COG00255 and COG01190 for translation,
COG00568, COG01158 and COG00781 for transcription and COG00576 and
COG02077 for post-translational modification).

Interestingly, HRS also has

differentially enriched cell motility COG terms like LRS. This may mean that
microbes were moving toward new energy source (COG00643, COG00840 and
COG01450).

Conclusion
We could identify 57,398 proteins from 24 MS runs (8 patients * 3 diets).
Of 57,398 proteins, 56,295 were from microbiome and 1,103 were host human
proteins. This seriously unequal protein identification is caused by employing
indirect methods and metagenome. Those two could dramatically increase the
number of identified microbial proteins that are main targets of this study.
With this successful microbial protein identification, we constructed
GLMM-NB model to compare diet metaproteomes. Since the experiment design
is based on cross over, we selected GLMM model by setting patients as random
effect and diet types as fixed effect. High variation of fecal proteome, even within
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same group was also considered while making GLMM model. NB is employed
as null distribution of GLMM model because NB is effective to analyze count type
data, such as spectrum counting of the diet metaproteome. On top of GLMM NB
model, Cohen’s w was combined to enhance statistical power of hypothesis
tests. This GLMM NB model and Cohen’s w could provide reliable statistical
comparisons and were used for finding significantly changed proteins and
functional analysis of the diet metaproteome. We could find 7,113 significantly
changed

proteins

metagenome).

(94

from

human

and

7,018

from

microbiome

and

These significant proteins were picked by 0.0001 FDR and

1.0258 Cohen’s w
Functional analysis of the diet metaproteome provided understanding of
systematic changes in human and microbial community.

KEGG pathway

analysis showed that functional changes in host proteome are immune response
and glucose uptake. COG analysis illustrated that microbial community also had
changes in energy generation, gene and protein expression and cell motility.
Considering those alterations, we speculate that specific bacteria grow as RS
amount in diet is increased because they can use RS as energy source in large
intestine. Then, population growth of specific bacteria stimulates human immune
response including adaptive and innate immunities.

These changes in large

intestine, enhanced host defense and nutrient change, result in expression of
self-defense and cell motility of existing microbes in the microbiome.
All in all, diet metaproteome is highly complicated and very large and
complicated data set.

However, QFAM could appropriately analyze the
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generated metaproteome and could give exciting insights about functional
changes in human host and microbiome.

In spite of high variance within

biological replicates, GLMM NB and Cohen’s w could rigorously compare and
give interesting and reliable analysis results.
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CHAPTER VI
Conclusions

Overview
The ability to analyze metaproteome datasets quantitatively and
functionally, with reliability is an essential requirement in metaproteomics
research. Although metaproteomics has emerged as a promising technique for
deep and wide characterization of the protein complement of microbial
communities, bioinformatic analysis strategies for metaproteomics are currently
inadequate.

In terms of processing speed and sequence-based functional

analysis, required attributes for processing highly complicated and redundant
number of metaproteome sequences, MPA and GalaxyP, mentioned in chapter
1, are not optimal pipelines for metaproteomics.

In contrast to MPA and

GalaxyP, QFAM enables multiprocessing up to 48 CPUs of Newton
computational cluster and COG analysis for poorly annotated metagenome and
microbial metaproteome sequences.

Moreover, QFAM utilize Cohen’s effect

sizes to filter out low-powered hypothesis tests at desired statistical power level.
This quantitative analysis module is applied for all the analysis steps in QFAM,
such as QAM, FAM for BioSystems and FAM for COG analysis. The details of f
QFAM are explained in chapter 2. Chapter 3 illustrated how ‘selfea’, utilized for
quantitative analysis in QAM, could enhance reliability of hypothesis tests in
quantitative proteomics data analysis. Selfea can filter out hypothesis tests that
have low statistical power in order to keep certain level of statistical power. P184

value cannot be reliable evidence at low statistical power. In the benchmark data
test, real noisy data test and Monte Carlo simulation test, selfea could filter out
false positives efficiently, while losing few true positives at high statistical power.
We also demonstrated that QFAM is useful to analyze metaproteome
data. Chapter 4 illustrated how QFAM is applied for human fecal metaproteome
analysis.

This human fecal proteome study compared 29 MS runs from 11

healthy volunteers. Human fecal proteome is highly varying between healthy
individuals. Its variance within group was shown in figure 31 (0.75 to 0.98 PCC
for technical replicates and 0.15 to 0.81 PCC for biological replicates). This
variation was confirmed by 90% statistical power and 0.05 p-value of QFAM.
From BioSystems of QFAM, we could reveal that digestion related proteins and
immune response proteins are differently detected in human fecal proteomes
(Table 18). COG analysis showed that almost all the functions including energy
generation and defense mechanism were variously enriched in microbial fecal
proteomes (Table 20).
Also, QFAM was employed to analyze diet metaproteome data described
in chapter 5.

Fecal metaproteomes were collected from 8 patients at three

different time points. At each time points patients were treated by three different
diets, baseline, low resistant starch (RS) (2 mg) and high RS diet (38 mg). Since
RS amount in diet is known to be associated with changes in microbiome, this
study is designed to investigate quantitative and functional relationship between
RS and the gut microbiome.
was confirmed in chapter 4.

However, fecal proteomes are very dissimilar as
Hence, stringent thresholds were applied for
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selection of significant features in order to make the expected number of false
positives less than 1, and thus results more reliable.

QFAM analyzed diet

proteomes by constructing GLMM NB model and employing Cohen’s w. GLMM
NB model could consider personal fecal proteome variation based on negative
binomial distribution. Proteins, KEGG pathways, COG terms were compared at
80% statistical power and 0.0001 FDR-adjusted p-value. QFAM’s functional and
quantitative analysis revealed that glucose uptake, digestion related pathways
and immune responses were differentially detected in human host proteomes
(Fig. 37).

Through COG analysis, QFAM discovered differentially expressed

microbial functions, such as cell wall construction, cell motility, energy generation
and protein modification (Fig. 38). Based on these findings using QFAM, we
speculated that specific bacteria grow as RS amount in diet is increased because
they can use RS as energy source in large intestine. Then, population growth of
specific bacteria stimulates human immune response including adaptive and
innate immunities. These changes in large intestine, enhanced host defense and
nutrient change, result in expression of self-defense and cell motility of existing
microbes in the microbiome. From two application studies, we could confirm
QFAM is practically useful to biologists by providing functional and quantitative
analysis.

Current status of QFAM and remaining challenges
QFAM can be employed to normal single species proteomics for
quantitative and functional analysis. Since quantitative comparison of proteomes
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has been done by using Student’s t-test or ANOVA based on Normal distribution.
However, spectral counting does not follow Normal distribution, so Student’s ttest and Normal ANOVA are not recommended for proteomics data analysis (Fig.
14). Moreover, Student’s t-test has serious disadvantage in repeated tests using
same dataset. Type I error of Student’s t-test is linearly increased, while ANOVA
can keep Type I error at certain level with multiple tests [98]. Even though QProt
is developed to overcome error rate problem of Student’s t-test, it only enables
two-sample comparison. As was explained in chapter 3, p-value is only valid at
high statistical power that is not achieved in most of biology studies due to limited
money and time. Therefore, using Cohen’s ES with p-value can be applied to
general proteomics and other type of data besides metaproteomics.
Despite the availability of many functional analysis tools, FAM is unique
due to employing two statistical tests, enrichment test and significance test.
Enrichment test using Fisher’s exact test is widely accepted methodology to
enrich functional terms from signatures. However, enrichment test has not been
combined with significance test, to date and to our knowledge. Moreover, FAM’s
significance test uses selfea providing reliable feature selection. Therefore, FAM
can be distinguished from many pre-existing tools by two tests. Usefulness of
these two tests was demonstrated by two application studies in chapter 4 and 5.
Even though QFAM can use 48 CPUs, maximum number of allowed
CPUs in Newton cluster, for unlimited time in Newton cluster, it is not enough to
analyze huge metaproteomics data.

For example, while searching PSMs of

permafrost metaproteome, it took two weeks for one MS run using 48 CPUs.
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Permafrost has 900 megabytes protein database. Since MyriMatch is DB search
engine, its search speed is more dependent on the size of DB. Each MS/MS
spectra is compared with every theoretically generated peptides of the DB after
precursor mass filter.

Narrowing mass tolerance window and more precise

parent mass measurement can reduce the number of comparisons for one
MS/MS spectrum.

However, MS instrument with high mass accuracy and

precision can be very expensive and narrowing mass tolerance window may
result in missing true targets.
De novo sequencing based search algorithm, such as MS-GF+, can
reduce PSM search time. Search speed of MS-GF+ is dependent on generation
of possible de novo sequences rather then DB size. Even though MS-GF+ has
not been used for metaproteomics study, if it can complete PSM search even for
1 gigabytes protein DB within reasonable time, it can replace DB search engine
efficiently. Moreover, MS-GF+ has reliable score system that is confirmed by
several proteomics studies [178]. Therefore, we believe that MS-GF+ can be
good replacement of widely used DB search engines, such as SEQUEST and
Mascot for metaproteomics studies.
The increase of the available CPUs is the best way to reduce PSM search
with QFAM. Although performance test of MyriMatch with 1,000 cores is not
confirmed yet, MyriMatch is expected to get faster with larger number of CPUs as
was tested up to 48 in Newton cluster (Table 4, 5 and 6). QFAM has Python job
controller and can run PSM search and analysis processes using multiple CPUs.
Therefore, increasing the number of CPUs in either Newton or in sun grid engine
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cluster doesn’t matter to QFAM. QFAM’s current job controller is designed only
for sun grid engine, thus if QFAM is installed to different batch-queuing system; it
requires simple update to recognize new job processes.
Increased number of computational cores can speed up COG analysis as
well. COG annotation is one of two most time consuming job in QFAM along
with the PSM search. In order to calculate enrichment test of COG terms, QFAM
tries to annotate all the available protein sequences in protein DB. In human
fecal proteome study of chapter 4, the total number of proteins in DB was
100,000. However, the number of proteins in diet metaproteome DB was several
millions.

This is why we couldn’t implement COG enrichment test for diet

metaproteome study. Another study, Permafrost metaproteome, had two times
more number of proteins than diet proteome study.

Therefore, high

computational power is necessary for QFAM to operate at optimal levels for all
types of metaproteome studies.
QFAM needs to have more options for protein identification. Currently,
QFAM has only one option, MyriMatch and IDPicker, for PSM search. Even
though MyriMatch and IDPicker are useful and accepted tools for protein
identification, users need more options for protein identification.

Basically,

different algorithms in PSM search generate different protein identification.
These identifications can either be combined for greater proteome depth or take
only those identifications that each algorithm finds for higher confidence. Other
PSM search engines are available, such as X!!Tandem [78] and wrapper for
proteomics [79]. MS-GF+ would be good option for metaproteomics because it is
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not dependent on DB size. QFAM may need to provide various search engines,
working with multiple CPUs, to users, such as X!!Tandem and MS-GF+ to
complement MyriMatch/IDPicker.
QFAM is hard to access by untrained end user because it does not have
graphical user interface (GUI), while GalaxyP and MPA provides excellent GUI
interface for easy use. GUI should be able to communicate between user and
analysis server including transferring large metaproteomics data to the server
and receiving analysis results from the server. However, file transfer is limited in
Newton cluster for security purpose. Globus (https://www.globus.org/) or Dropbox
(https://www.dropbox.com/) can be possible solution because these provide easy
and fast data sharing. Data transfer is recently getting easier by aforementioned
tools.
Metaproteomics is promising technique for discovering mechanisms of
unknown microbial communities and is a rapidly growing field available to
microbial ecologist.

However, metaproteomics data is large and highly

complicated, so the current largest challenge and bottleneck is the bioinformatics
data processing. QFAM is developed to analyze this huge and intricate data
quantitatively and functionally at enhanced speed and reliability. Two application
studies in chapter 4 and 5 prove usefulness of QFAM for metaproteome data
analysis. We believe that QFAM can be an excellent tool for metaproteome
experts to improve their analyses of microbial communities.
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